Every Decker book is accompanied by a CD-ROM. BC Decker Inc is committed to providing high-quality electronic publications that complement traditional information and learning methods. Physiologic Basis of Respiratory Disease is accompanied by a dual-platform CD-ROM, which features the complete text and full-color images. The fully searchable PDF files facilitate the exploration of need-to-know information. The disc is also ideal for printing pertinent information necessary for patient education. The book and disc are sold only as a package; neither are available independently, and no prices are available for the items individually. We trust you will find the book/CD package invaluable and invite your comments and suggestions. Access information. Acquire knowledge. Please visit www.bcdecker.com for a complete list of titles in your discipline. Our innovative approach to meeting the informational needs of healthcare professionals ensures that Decker products belong in your library and on your computer.
Brian C. Decker CEO and Publisher
EA
G
IL
L.
R
Mc
L
RIES ATO OR
MEAKIN S -C H
STIE LAB I R
M ONT
Qutayba Hamid, MD, PhD, MRCP, FRCPath Professor of Medicine Department of Medicine McGill University Montreal, Quebec
Joanne Shannon, MD Postdoctoral Fellow Meakins-Christie Laboratories McGill University Montreal, Quebec
James Martin, MD, DSc Professor of Medicine Department of Medicine McGill University Montreal, Quebec
2005 BC Decker Inc Hamilton
Exit
BC Decker Inc P.O. Box 620, L.C.D. 1 Hamilton, Ontario L8N 3K7 Tel: 905-522-7017; 800-568-7281 Fax: 905-522-7839; 888-311-4987 E-mail:
[email protected] www.bcdecker.com © 2005 BC Decker Inc All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the publisher. 05 06 07 08/WPC/9 8 7 6 5 4 3 2 1 ISBN 1-55009-236-7 Printed in the United States of America Sales and Distribution United States BC Decker Inc P.O. Box 785 Lewiston, NY 14092-0785 Tel: 905-522-7017; 800-568-7281 Fax: 905-522-7839; 888-311-4987 E-mail:
[email protected] www.bcdecker.com Canada BC Decker Inc 20 Hughson Street South P.O. Box 620, LCD 1 Hamilton, Ontario L8N 3K7 Tel: 905-522-7017; 800-568-7281 Fax: 905-522-7839; 888-311-4987 E-mail:
[email protected] www.bcdecker.com Foreign Rights John Scott & Company International Publishers’ Agency P.O. Box 878 Kimberton, PA 19442 Tel: 610-827-1640 Fax: 610-827-1671 E-mail:
[email protected] Japan Igaku-Shoin Ltd. Foreign Publications Department 3-24-17 Hongo Bunkyo-ku, Tokyo, Japan 113-8719 Tel: 3 3817 5680 Fax: 3 3815 6776 E-mail:
[email protected]
UK, Europe, Scandinavia, Middle East Elsevier Science Customer Service Department Foots Cray High Street Sidcup, Kent DA14 5HP, UK Tel: 44 (0) 208 308 5760 Fax: 44 (0) 181 308 5702 E-mail:
[email protected] Singapore, Malaysia,Thailand, Philippines, Indonesia, Vietnam, Pacific Rim, Korea Elsevier Science Asia 583 Orchard Road #09/01, Forum Singapore 238884 Tel: 65-737-3593 Fax: 65-753-2145 Australia, New Zealand Elsevier Science Australia Customer Service Department STM Division Locked Bag 16 St. Peters, New South Wales, 2044 Australia Tel: 61 02 9517-8999 Fax: 61 02 9517-2249 E-mail:
[email protected] www.harcourt.com.au
Tel: 52-5-5553-6657 Fax: 52-5-5211-8468 E-mail:
[email protected] Brazil Tecmedd Importadora E Distribuidora De Livros Ltda. Avenida Maurílio Biagi, 2850 City Ribeirão, Ribeirão Preto – SP – Brasil CEP: 14021-000 Tel: 0800 992236 Fax: (16) 3993-9000 E-mail:
[email protected] India, Bangladesh, Pakistan, Sri Lanka Elsevier Health Sciences Division Customer Service Department 17A/1, Main Ring Road Lajpat Nagar IV New Delhi – 110024, India Tel: 91 11 2644 7160-64 Fax: 91 11 2644 7156 E-mail:
[email protected]
Mexico and Central America ETM SA de CV Calle de Tula 59 Colonia Condesa 06140 Mexico DF, Mexico
Notice: The authors and publisher have made every effort to ensure that the patient care recommended herein, including choice of drugs and drug dosages, is in accord with the accepted standard and practice at the time of publication. However, since research and regulation constantly change clinical standards, the reader is urged to check the product information sheet included in the package of each drug, which includes recommended doses, warnings, and contraindications. This is particularly important with new or infrequently used drugs. Any treatment regimen, particularly one involving medication, involves inherent risk that must be weighed on a case-by-case basis against the benefits anticipated. The reader is cautioned that the purpose of this book is to inform and enlighten; the information contained herein is not intended as, and should not be employed as, a substitute for individual diagnosis and treatment.
CONTENTS FOREWORD vii PREFACE ix CONTRIBUTORS xi HISTORY OF THE MEAKINS-CHRISTIE LABORATORIES
13
BREATHING STRATEGIES IN ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASE, 123 James G. Martin
xvii
SECTION III
SECTION I ANATOMY
VENTILATION, PULMONARY CIRCULATION AND GAS EXCHANGE
1
14
HISTOLOGY AND GROSS ANATOMY OF THE RESPIRATORY TRACT, 1
VENTILATION DISTRIBUTION,
133
Joseph Milic-Emili
Richard S. Fraser
15
GAS CONVECTION AND DIFFUSION,
143
Manuel Paiva, Sylvia Verbanck
SECTION II
16
MECHANICS OF BREATHING
LUNG VASCULATURE: FUNCTIONAL INFERENCES FROM MICROSTRUCTURE, 155 Dean E. Schraufnagel
2
STATICS OF THE RESPIRATORY SYSTEM,
15
17
Edgardo D’Angelo, Joseph Milic-Emili
VENTILATION–PERFUSION RELATIONSHIPS,
165
Peter D. Wagner
3
STATICS OF THE LUNG,
27
18
Joseph Milic-Emili, Edgardo D’Angelo
4
ACT OF BREATHING: DYNAMICS,
35
VENTILATION-PERFUSION DISTRIBUTIONS IN DISEASE, 185 Antoni Ferrer, Robert Rodriguez-Roisin
Peter T. Macklem
5
RESPIRATORY MECHANICS IN INFANTS AND CHILDREN,
49
19
PULMONARY EDEMA,
203
René P. Michel, Peter Goldberg
Peter D. Sly, Felicity S. Flack, Zoltán Hantos
6
PHYSICS OF EXPIRATORY FLOW LIMITATION,
20
55
OXYGEN REGULATION OF VASOMOTOR TONE,
237
David Hall, Duncan Stewart, Michael Ward
Jason H.T. Bates
7
ACT OF BREATHING: THE VENTILATORY PUMP,
61
SECTION IV
Peter T. Macklem
8
PULMONARY STATICS IN DISEASE,
RESPIRATORY MUSCLES AND CONTROL OF BREATHING
69
Paolo Carbonara, David H. Eidelman
9
21
STRUCTURE–FUNCTION CORRELATIONS IN PULMONARY FIBROSIS, 77
22
STRUCTURE–FUNCTION RELATIONSHIPS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 85
STRUCTURE–FUNCTION CORRELATIONS IN ASTHMA,
23 24
BIOLOGY OF THE RESPIRATORY MUSCLES,
277
RESPIRATORY MUSCLE FATIGUE,
289
Spyros Zakynthinos, Charis Roussos
105
STRUCTURE–FUNCTION RELATIONSHIPS IN AIRWAY DISEASE: ANALYSIS BY COMPUTED TOMOGRAPHIC IMAGING, 115 Michiaki Mishima
263
Ghislaine Gayan-Ramirez, Marc Decramer
Mara Ludwig
12
ACTIONS OF THE RESPIRATORY MUSCLES, André de Troyer
Manuel G. Cosio, Marina Saetta, Heberto Ghezzo, Simonetta Baraldo
11
251
Immanuela Ravé Moss
Anne Gonzalez, Mara S. Ludwig
10
NEURAL CONTROL OF BREATHING,
25
VENTILATORY MUSCLE INJURY,
309
Xiangyu Wang, Tian-Xi Jiang, W. Darlene Reid, Jeremy Road
26
RESPIRATORY CONSEQUENCES OF NEUROMUSCULAR DISEASE, 319 Stefan Matecki, Basil J. Petrof iii
iv
27
Contents
RESPIRATORY MUSCLES IN SEPSIS,
331
43
Camille Taillé, Sophie Lanone, Jorge Boczkowski, Michel Aubier
28
EICOSANOIDS AND THE LUNG,
495
William S. Powell
44
REHABILITATION OF SKELETAL MUSCLES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 339
LUNG TRANSPLANTATION,
509
Tom Kotsimbos
Thierry Troosters, Rik Gosselink, Marc Decramer
SECTION VI EXERCISE PHYSIOLOGY
SECTION V
45
AIRWAYS AND LUNG DEFENSE 29
GENETICS OF RESPIRATORY DISEASE,
525
Hans C. Haverkamp, Jerome A. Dempsey, Jordan D. Miller, Lee M. Romer, Marlowe W. Eldridge,
349
Scott J. Tebbutt, Andrew J. Sandford, Peter D. Paré
30
PHYSIOLOGIC RESPONSES TO EXERCISE,
46
NEUROHUMORAL CONTROL OF THE AIRWAYS,
363
Marie-Claire Michoud
VENTILATORY FACTORS IN EXERCISE PERFORMANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 541 Carmen Lisboa, Orlando Díaz, Gisella Borzone
31
32
MECHANICS OF AIRWAY NARROWING,
371
Peter D. Paré, Peter T. Macklem, Chun Y. Seow, Brent E. McParland
47
AIRWAY SMOOTH MUSCLE: THE CONTRACTILE PHENOTYPE,
48 381 49
CYTOKINES AND AIRWAY SMOOTH MUSCLE,
389
IMMUNOGLOBULINS AND THE LUNG,
399
SECTION VII SLEEP DISORDERED BREATHING
MUCUS AND ITS ROLE IN AIRWAY CLEARANCE AND CYTOPROTECTION, 409
50
Malcolm King
36
MUCOCILIARY CLEARANCE AND CYSTIC FIBROSIS,
PHYSIOLOGY OF THE UPPER AIRWAYS AND UPPER AIRWAY OBSTRUCTION IN DISEASE,
581
R. John Kimoff
417
Mark R. Elkins, Peter T.P. Bye
37
PERIPHERAL MUSCLE DYSFUNCTION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 567 Richard Debigaré, François Maltais
Salem al-Tamemi, Bruce Mazer
35
REGULATION OF SKELETAL BLOOD FLOW DURING EXERCISE, 555 Sabah N.A. Hussain, Alain S. Comtois
Stephanie A. Shore
34
547
Nicholas C. Duffy, Peter M.A. Calverley
Elizabeth D. Fixman, Barbara Tolloczko, Anne-Marie Lauzon
33
PRACTICAL ASSESSMENT OF EXERCISE LIMITATION,
51
FLUID AND ELECTROLYTE TRANSPORT IN AIRWAYS, 429
CARDIOVASCULAR CONSEQUENCES OF SLEEP-DISORDERED BREATHING, 597 Steven R. Coughlin, Peter M.A. Calverley
THE
John W. Hanrahan
38 39
EPITHELIAL FUNCTION IN LUNG INJURY,
SECTION VIII
439
Yves Berthiaume
CLINICAL RESPIRATORY PHYSIOLOGY
CYTOKINES AND CHEMOKINES IN ASTHMA: AN OVERVIEW, 453
52
NITRIC OXIDE AND THE LUNG,
53
469
VIRAL INFECTIONS AND AIRWAY RESPONSIVENESS,
479
54
Paolo Renzi
42
ROLES OF LIPID MEDIATORS IN ACUTE LUNG INJURY AND PULMONARY FIBROSIS, 489 Takahide Nagase
SEX AND GENDER DIFFERENCES IN AIRWAY BEHAVIOR ACROSS THE HUMAN LIFE SPAN, 611 Margaret R. Becklake, Joanne Shannon
Jennifer S. Landry, David H. Eidelman
41
605
Peter T. Macklem
Meri K. Tulic, Pierre-Olivier Fiset, Zöe Müller, Qutayba Hamid
40
COMPLEXITY AND RESPIRATION: A MATTER OF LIFE AND DEATH,
MEASUREMENT TECHNIQUES IN RESPIRATORY MECHANICS, 623 Jason H.T. Bates
55
ESOPHAGEAL PRESSURE MEASUREMENT, Walter Araujo Zin, Joseph Milic-Emili
639
Contents
56
GUIDE TO THE EVALUATION OF PULMONARY FUNCTION, 649
62 63
SINGLE-BREATH CARBON MONOXIDE DIFFUSING CAPACITY OR TRANSFER FACTOR, 659 David J. Cotton, Brian L. Graham
58
64
SPIROMETRIC PREDICTIONS OF EXERCISE LIMITATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 671
60
65
61
Nicholas R. Anthonisen, Jure Manfreda
67
ASSESSMENT OF ACID–BASE BALANCE: A PHYSICAL-CHEMICAL APPROACH, 699 Sheldon Magder
PHYSIOLOGIC BASIS FOR PULMONARY REHABILITATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 733 Jean Bourbeau, Hélène Perrault
66
Guy Czaika, Alejandro Grassino
EVALUATION OF THE PATIENT WITH OCCUPATIONAL ASTHMA, 727 Catherine Lemière
DETERMINANTS OF DECLINE IN LUNG FUNCTION, 681
ASSESSMENT OF RESPIRATORY MUSCLES,
ASSESSMENT OF FORCED EXPIRATORY FLOWS IN INFANTS, 721 Robert S. Tepper, Debra Turner
Joseph Milic-Emili, Nickolaos G. Koulouris, Claudio Tantucci
59
709
Ron Olivenstein, Rame Taha
Charles G. Irvin
57
AIRWAY HYPERRESPONSIVENESS,
LUNG VOLUME REDUCTION SURGERY,
745
Koji Chihara
DIAPHRAGM RESPONSES TO STIMULATION,
755
François Bellemare, Claude Poirier
689 68
AN INTRODUCTION TO LUNG MORPHOMETRY, R. Heberto Ghezzo
INDEX
777
769
v
FOREWORD P
hysiology has played a crucial role in our understanding of common respiratory diseases, particularly asthma and chronic obstructive pulmonary disease. The MeakinsChristie Laboratories have been at the forefront of this understanding since 1972. This book brings together an extraordinary range of contributions to this field by past and present members of this internationally renowned organization. The historical origins of the Meakins-Christie Laboratories are beautifully described by Peter Macklem, who has done so much to establish a world-class research center. The range of technologies encompassed by the various contributors is quite astounding, indicating how much physiology relates to other scientific approaches to understanding the complexities of lung disease. It is this multidisciplinary approach to lung diseases that has proved to be so successful in elucidating the complex mechanisms involved in many pulmonary diseases and which has been pioneered by the Meakins-Christie Laboratories. The Meakins-Christie Laboratories have led the way in many areas of research into pulmonary diseases. Linking pathology to function seems so obviously important now. It was pioneered by investigators at Meakins-Christie Laboratories, such as William “Whitey” Thurlbeck, and this tradition has been admirably developed and advanced by Jim Hogg and Manuel Cosio. Respiratory epidemiology, and its strong presence at the Laboratories, can trace its origins to the pioneering work of Margaret Becklake. But it is in “hard” physiology where the Meakins-Christie Laboratories have excelled and led the world. This book brings together the contributions of many of the international leaders in respiratory physiology. Not surprisingly, many of them were trained at the Meakins-Christie Laboratories. As such, this book covers a vast range of aspects of respiratory physiology: mechanics, ventilation, gas exchange, respiratory muscles, control of breathing, sleep-disordered breathing, and exercise physiology, as well as the clinical applications of respiratory physiology. The fact that all of the authors are present or past members of the Meakins-Christie Laboratories gives the book an extraordinary coherence; Qutayba Hamid, Joanne Shannon, and Jim Martin have done a superb job in bringing together all this expertise in such a well-ordered manner. In recent years there has been less emphasis on physiology, as funding has largely switched to cell and molecular biology, with the result that many physiology departments have downsized or even closed. Cloning of the human genome was rightly hailed as a great step forward in science,
but only now is it recognized that identifying genes is only a small step toward understanding complex diseases. Interest is swinging back toward physiology, as the field integrates advances in cell and molecular biology with functional changes in whole organisms. It is recognized that physiology is of vital importance in making sense of all the advances in basic science, and the field is now re-emerging as functional genomics and systems biology. The MeakinsChristie Laboratories have always maintained an interest in cell and molecular biology, which is reflected in many chapters of this book, and this institution has been among the first to integrate this into whole animal physiology and its clinical application. This institution has kept the flag of physiology alive, while many other scientific institutions have sacrificed physiology to follow scientific fashion, now to their great regret! This book covers the whole range of respiratory physiology, from relevant basic cell physiology to human respiratory physiology, and includes the important applications of physiology in clinical practice. I cannot think of any other institution in the world whose own associates could cover this topic so comprehensively and effectively. This volume will be of enormous value to all academic respiratory physicians as well as those involved in all aspects of research into pulmonary medicine. I have always been impressed on my visits to the Meakins-Christie Laboratories by the active discussion and interaction taking place between the different research groups-a perfect environment for research. The Meakins-Christie Laboratories have trained scientists from all over the world who have themselves become international leaders, and this is well reflected in the authorship of the chapters. Sadly, some of the prominent acolytes, including Ann Woolcock, Ludwig Engel, and David Flenley, are no longer with us, but the spirit of the Meakins-Christie Laboratories is alive and well. The Meakins-Christie Laboratories have played a major international role in pulmonary research under the leadership of Peter Macklem, Joseph Milic-Emili, and now Jim Martin. This book is an excellent summary of all of these achievements and illustrates how the Meakins-Christie Laboratories have maintained their position at the cutting edge of respiratory science. PETER BARNES London, UK March 2005
vii
PREFACE T
he research interests of the Meakins-Christie Laboratories have evolved from the excellence in respiratory physiology at McGill University initiated by Dr. Ronald Christie many years ago. Its legacy of excellence has been upheld by physiologists such as David Bates, Margaret Becklake, Peter Macklem, and Joseph Milic-Emili. The research performed in the Meakins-Christie Laboratories has always been motivated by its potential clinical relevance. Attempts to develop tests to identify early peripheral airway disease in smokers and the evaluation of the contribution of the respiratory muscles to ventilatory failure are but two examples of the enthusiasm for patient-related issues. In recent years remarkable strides have been made in exploring the cellular and molecular physiology of the lungs and the respiratory skeletal muscles, and the mechanisms underlying respiratory disease have been greatly clarified. The elucidation of the pathobiologic basis for disease has not replaced the need to understand “classical respiratory physiology.” The respiratory physician still requires a familiarity with the fundamental mechanisms of abnormal gas exchange and altered respiratory system mechanics in common diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. The cardinal symptoms of these diseases are largely attributable to gas exchange and respiratory system mechanics. The muscles of the respiratory pump, a term coined by Macklem, Roussos, and coworkers, are affected by altered geometry of the respiratory system such that their pressuregenerating capacities are compromised. Whether true muscle fatigue occurs is still uncertain, but it has been a logical approach to provide rehabilitation with a view to improving
respiratory muscle function. However, attempts to rehabilitate patients with advanced obstructive lung disease have been confounded by skeletal muscle deconditioning and dysfunction, revealing unsuspected systemic effects of COPD on both respiratory and peripheral skeletal muscle. Understanding skeletal muscle biology has therefore become a necessity for the respiratory physician. In this book we have attempted to address most of the currently clinically relevant pulmonary physiology and pathophysiology that the respiratory physician should be familiar with. We have not attempted to be encyclopedic in our approach, and one may argue that the book is not evenhanded in its treatment of the subject. The book has inevitable biases resulting from the fact that the authors are, for the most part, former fellows of the Meakins-Christie Laboratories or have been closely associated with the Laboratories. We believe that this bias does not detract from the intrinsic clinical pertinence of the contents. We gratefully acknowledge the generosity of our colleagues for their contributions to this book. We wish also to acknowledge the patience and encouragement provided by the staff of BC Decker Inc. We hope that the reader will enjoy the read as we have enjoyed the process of creating this book the and renewing our association with our fellow Meakins-Christie Laboratories alumni and other colleagues dedicated to respiratory physiology.
Q. HAMID J. SHANNON J.G. MARTIN
ix
CONTRIBUTORS Nicholas R. Anthonisen, MD, PhD, FRCP Professor Emeritus Department of Internal Medicine University of Manitoba Winnipeg, Manitoba Walter Araujo Zin, MD, PhD Professor of Physiology Carlos Chagas Filho Institute of Biophysics Federal University of Rio de Janeiro Rio de Janeiro, Brazil
Gisella Borzone, MD Associate Professor Pontificia Universidad Catolica de Chile Santiago, Chile Jean Bourbeau, MD Assistant Professor of Medicine Department of Medicine McGill University Montreal, Quebec
Michel Aubier, MD Professor of Pneumology Department of Pneumology Faculté Xavier Bichat. Université Paris 7 Paris, France
Peter T. P. Bye, MBBS, FRACP, PhD Clinical Associate Professor Department of Medicine University of Sydney Sydney, New South Wales
Simonetta Baraldo, PhD Postdoctoral Fellow Cardiothoracic and Vascular Sciences University of Padua Padua, Italy
Peter M. A. Calverley, MB, ChB, FRCP, FRCP(E) Professor of Medicine University of Liverpool Liverpool, United Kingdom
Jason H. T. Bates, PhD, DSc Professor of Medicine Vermont Lung Center University of Vermont Burlington, Vermont
Paolo Carbonara, MD Research Fellow Meakins-Christie Laboratories McGill University Montreal, Quebec
Margaret Becklake, MB, BCh, MD, FRCP(E) Professor of Medicine Departments of Medicine and Epidemiology, Biostatistics and Occupational Health McGill University Montreal, Quebec
Koji Chihara, MD, PhD Chief of Thoracic Surgery Shizuoka City Shizuoka Hospital Shizuoka, Japan
François Bellemare, PhD Research Associate Department of Pneumology Sleep Laboratory Hôtel Dieu of CHUM Montreal, Quebec
Alain S. Comtois, PhD Associate Professor Kinanthropologie Université du Quebec a Montreal Montreal, Quebec
Yves Berthiaume, MD Professeur Titulaire Département de Médecine Université de Montreal Montreal, Quebec
Manuel G. Cosio, MD Professor of Medicine Respiratory Division McGill University Montreal, Quebec
Jorge Boczkowski, MD, PhD Principal Investigator U700 INSERM Paris, France
David J. Cotton, MD, FRCP(C) Professor of Medicine Department of Internal Medicine College of Medicine University of Saskatchewan Saskatoon, Saskatchewan xi
xii
Contributors
Steven Robert Couglin, MSc, PhD Research Fellow Department of Medicine University of Liverpool Liverpool, United Kingdom
Mark R. Elkins, MHSci Honorary Associate School of Physiotherapy University of Sydney Sydney, New South Wales
Guy Czaika, PhD University of Montreal Montreal, Quebec
Antoni Ferrer, MD Senior Associate Physician Servei de Pneumologia Hospital de Sabadell Institut Institut Universitari Corporació Parc Taulí Universitat Autònoma de Barcelona Barcelona, Spain
Edgardo D’Angelo, MD Professor of Human Physiology Istituto di Fisiologia Umana I Univeresità degli Studi di Milano Milan, Italy Richard Debigaré, PT, PhD Assistant Professor Department of Medicine Université Laval Montreal, Quebec Marc Decramer, MD, PhD Professor of Medicine Department of Pneumology Katholieke Universiteit Leauveu Leuven, Belgium Jerome A. Dempsey, PhD Professor of Medicine Department of Population Health Sciences University of Wisconsin-Madison Madison, Wisconsin Orlando Díaz, MD Associate Professor Pontificia Universidad catolica de Chile Santiago, Chile Nicholas C. Duffy, MBChB, MRCP Lecturer Department of Medicine University of Liverpool Liverpool, United Kingdom David H. Eidelman Professor of Medicine Respiratory Division McGill University Montreal, Quebec Marlowe W. Eldridge, MD Assistant Professor of Medicine Population Health Sciences University of Wisconsin-Madison Madison, Wisconsin
Pierre-Olivier Fiset Department of Medicine McGill University Montreal, Quebec Elizabeth D. Fixman, PhD Assistant Professor Department of Medicine McGill University Montreal, Quebec Felicity S. Flack, PhD Division of Clinical Sciences Telethon Institute for Child Health Research University of Western Australia Perth, Western Australia Richard Fraser, MDCM, FRCP(C) Professor of Pathology Department of Pathology McGill University Montreal, Quebec Ghislaine Gayan-Ramirez, PhD Department of Pneumology Katholieke Universiteit Leauveu Leuven, Belgium R. Heberto Ghezzo, PhD, FRSS Research Associate Department of Medicine McGill University Montreal, Quebec Peter Goldberg, MDCM Associate Professor of Medicine Respiratory Medicine McGill University Montreal, Quebec Anne Gonzalez, MD Meakins-Christie Laboratories McGill University Montreal, Quebec
Contributors
Rik Gooselink, PT, PhD Professor of Medicine Katholieke Universiteit Leauveu Leuven, Belgium Brian L. Graham, PhD Professor of Medicine Department of Medicine College of Medicine University of Saskatchewan Saskatoon, Saskatchewan Alejandro Grassino, MD Professor of Medicine Department of Medicine University of Montreal Montreal, Quebec David A. Hall, PhD, MD Respiratory and Clinical Care Fellow Department of Respirology and Critical Care Medicine University of Toronto Toronto, Ontario Qutayba Hamid, MD, PhD, MRCP, FRCPath Professor of Medicine Department of Medicine McGill University Montreal, Quebec John W. Hanrahan, PhD Professor of Physiology Department of Physiology McGill University Montreal, Quebec Zoltán Hantos, MSc, PhD, CSc, DSc Professor of Medicine Medical Informatics Albert Szent-Gyorgyi Medical University Szeged, Hungary Hans C. Haverkamp, MS Predoctoral Fellow Population Health Sciences University of Wisconsin-Madison Madison, Wisconsin Sabah N. A. Hussain, MD, PhD James McGill Professor Department of Medicine McGill University Montreal, Quebec Charles G. Irvin, PhD Professor and Director Vermont Lung Center University of Vermont Burlington, Vermont
Tian-Xi Jiang, MD Research Associate Department of Medicine University of British Columbia Vancouver, British Columbia R. John Kimoff, MD, FRCP(C) Associate Professor Department of Medicine McGill University Montreal, Quebec Malcolm King, PhD, FCCP Professor of Medicine Department of Medicine University of Alberta Edmonton, Alberta Tom Kotsimbos, MD, FRACP Associate Professor Department of Medicine Monash University Melbourne, Victoria Nickolaos G. Koulouris, MD, PhD Associate Professor in Respiratory Medicine Department of Respiratory Medicine University of Athens Athens, Greece Jennifer S. Landry, MD, FRCP(C) Assistant Professor Department of Medicine McGill University Montreal, Quebec Sophie Lanone, PhD U700 INSERM Paris, France Anne-Marie Lauzon, PhD Assistant Professor Department of Medicine McGill University Montreal, Quebec Catherine Lemière, MD, MSc Associate Professor Department of Medicine University of Montreal Montreal, Quebec Carmen Lisboa, MD Professor of Medicine Pontificia Universidad catolica de Chile Santiago, Chile
xiii
xiv
Contributors
Mara S. Ludwig, MD Professor of Medicine Meakins-Christie Laboratories McGill University Montreal, Quebec
Marie-Claire Michoud, MSc, PhD Research Associate Department of Medicine McGill University Montreal, Quebec
Peter T. Macklem, MD, CM, FRCP(C), FRSC Professor Emeritus Department of Medicine McGill University Montreal, Quebec
Joseph Milic-Emili, CM, MD, FRSC Professor Emeritus Department of Physiology McGill University Montreal, Quebec
Sheldon Magder, MD, FRCP(C) Professor of Medicine and Physiology Department of Medicine and Physiology McGill University Montreal, Quebec
Jordan D. Miller, MS Predoctoral Fellow Population Health Sciences University of Wisconsin-Madison Madison, Wisconsin
François Maltais, MD Associate Professor of Medicine Department of Medicine Université Laval Montreal, Quebec
Michiaki Mishima, MD, PhD Professor and Chairman Respiratory Medicine Postgraduate School of Medicine, Kyoto University Kyoto, Japan
Jure Manfreda, MD Associate Professor Internal Medicine University of Manitoba Winnipeg, Manitoba
Zöe Müller Research Assistant Department of Medicine McGill University Montreal, Quebec
James G. Martin, MD, DSc Professor of Medicine Department of Medicine McGill University Montreal, Quebec
Takahide Nagase, MD Professor of Medicine Department of Respiratory Medicine University of Tokyo, The Graduate School of Medicine Tokyo, Japan
Stefan Matecki, MD, PhD Fellow Meakins-Christie Laboratories McGill University Montreal, Quebec
Ronald Olivenstein, MD, FRCP(C) Assistant Professor of Medicine Department of Medicine McGill University Montreal, Quebec
Bruce Mazer, MD Associate Professor of Pediatrics Department of Pediatrics McGill University Montreal, Quebec
Manuel Paiva, PhD Professor of Medicine Laboratoire de Physique Biomédical Université Libre de Bruxelles Brussels, Belgium
Brent E. McParland, MSc, PhD Postdoctoral Fellow Department of Medicine University of British Columbia Vancouver, British Columbia
Peter Paré, MD, FRCP Professor of Medicine Department of Medicine University of British Columbia Vancouver, British Columbia
René P. Michel, MD, CM, FRCP(C) Professor of Pathology Department of Pathology McGill University Montreal, Quebec
Hélène Perrault, PhD Professor and Chair Kinesiology and Physical Education McGill University Montreal, Quebec
Contributors
Basil J. Petrof, MD, FRCP(C) Associate Professor Department of Medicine McGill University Montreal, Quebec
Marina Saetta, MD Professor of Medicine Department of Cardiothoracic and Vascular Sciences University of Padua Padua, Italy
Claude Poirier, MD, FRCP(C) Chargé d’enseignement University of Montreal Montreal, Quebec
Andrew Sanford, PhD Associate Professor of Medicine Department of Medicine University of British Columbia Vancouver, British Columbia
William S. Powell, PhD Professor of Medicine Department of Medicine McGill University Montreal, Quebec Immanuela Ravé Moss, MD, PhD, FAAP Professor of Medicine Departments of Pediatrics and Physiology McGill University Montreal, Quebec W. Darlene Reid, BMR(PT), PhD Associate Professor School of Rehabilitation Sciences University of British Columbia Vancouver, British Columbia Paolo Renzi, MD, FCCP, FRCP(C) Professor of Research Department of Medicine University of Montreal Montreal, Quebec
xv
Dean E. Schraufnagel, MD, FCCP Professor of Medicine Division of Pulmonary, Critical Care and Sleep Medicine University of Illinois at Chicago Chicago, Illinois Chun Y. Seow, PhD Associate Professor Pathology/Laboratory Medicine University of British Columbia Vancouver, British Columbia Joanne Shannon, MD Postdoctoral Fellow Meakins-Christie Laboratories McGill University Montreal, Quebec Stephanie A. Shore, PhD Senior Lecturer in Physiology Department of Environmental Health Harvard School of Public Health Boston, Massachussets
Jeremy Road, MD, FRCP(C) Professor of Medicine Department of Medicine University of British Columbia Vancouver, British Columbia
Peter D. Sly, MD, DSc, FRACP Professor of Medicine Centre for Child Health Research University of Western Australia Perth, Western Australia
Robert Rodriguez-Roisin, MD, FRCP(E) Professor of Medicine Department of Medicine Universitat de Barcelona Barcelona, Spain
Duncan Stewart, MDCM, FRCP, FACC, FAHA Professor of Medicine Department of Cardiology University of Toronto Toronto, Ontario
Lee M. Romer, PhD Lecturer Sport Sciences Brunel University Uxbridge, Middlesex
Rame Taha, MD Research Scientist Department of Anesthesia University of Montreal Montreal, Quebec
Charis Roussos, MD, PhD Professor of Intensive Care Medicine Critical Care and Pulmonary Services University of Athens Medical School Athens, Greece
Camille Taillé Research Fellow U700 INSERM Paris, France
xvi
Contributors
Salem al-Tamemi, MD, FRCP(C) Clinical and Research Fellow Department of Clinical Immunology McGill University Montreal, Quebec
Meri K. Tulic, PhD Research Fellow Meakins-Christie Laboratories McGill University Montreal, Quebec
Claudio Tantucci, MD Professor of Respiratory Medicine Scienze Mediche e Chirurgiche University of Brescia Brescia, Italy
Debra Turner, PhD Adjunt Senior Lecturer Telethon Institute for Child Health Research University of Western Australia Perth, West Australia
Scott James Tebbutt, PhD Clinical Assistant Professor Department of Medicine University of British Columbia Vancouver, British Columbia
Sylvia Verbanck, PhD Respiratory Division Vrye Universiteit Brussel Brussels, Belgium
Robert S. Tepper, MD, PhD Professor of Pediatrics Department of Pediatrics Indiana University Indianapolis, Indiana
Peter D. Wagner, MD Professor of Medicine and Bioengineering Division of Physiology University of California San Diego La Jolla, California
Barbara Tolloczko, PhD Research Associate Department of Medicine McGill University Montreal, Quebec
Xiangyu Wang, MD Postdoctoral Fellow School of Rehabilitation Sciences University of British Columbia Vancouver, British Columbia
Thierry Troosters, PT, PhD Professor of Pulmonary Rehabilitation Department of Rehabilitation Sciences Katholieke Universiteit Leauveu Leuven, Belgium
Michael Ward, PhD, MD, FRCP(C) Associate Professor of Medicine Department of Medicine University of Toronto Toronto, Ontario
André de Troyer, MD, PhD Professor of Physiology Department of Cardiorespiratory Physiology Brussels School of Medicine Brussels, Belgium
Spyros Zakynthinos, MD Associate Professor of Intensive Care Medicine Critical Care and Pulmonary Services University of Athens Medical School Athens, Greece
HISTORY OF THE MEAKINSCHRISTIE LABORATORIES Peter T. Macklem
T
he first quarter of the twentieth century marks the beginning of the history of the Meakins-Christie Laboratories for Respiratory Research. Shortly before his death in 1919, Sir William Osler, then Regius Professor of Medicine at Oxford University, the world’s most renowned physician and McGill University’s most distinguished graduate, wrote to the dean of the faculty of medicine recommending that McGill appoint a full-time chairman of the Department of Medicine who would establish research in the hospital as an essential part of academic medical activities. Until that time the teachers at McGill’s medical school were all part-time physicians who had private practices outside the teaching hospitals. It took the dean some time to act on Sir William’s recommendation, but in 1924 Dr. Jonathan Meakins arrived from the University of Edinburgh to take up his appointment as physician-in-chief of the Royal Victoria Hospital (RVH) and the first full-time chairman of medicine in Canada. Dr. Meakins more than fulfilled his mandate to establish clinical research at the RVH. He wrested control of clinical laboratory services away from the Department of Pathology, so the clinical biochemistry and hematology laboratories became part of the Department of Medicine and provided
Dr. Jonathan Meakins
the department with an extremely valuable research infrastructure. This extraordinary accomplishment made the RVH almost unique in the world. Traditionally, clinical laboratory services are supplied by clinical pathologists, but at the RVH they are supplied by internists. Although this organizational structure has frustrated hospital administrators, it is directly responsible for the tradition of hospital-based clinical research that has made the RVH such a renowned academic institution. Meakins’ efforts to develop research in the RVH did not stop at biochemistry and hematology. In the early 1930s he recruited Ronald Christie for a postdoctoral fellowship at the RVH. Together they published a series of classic papers dealing with the mechanics of breathing in emphysema and mitral stenosis and with blood gas abnormalities in pulmonary edema.1–3 After 7 years in Montreal, Christie returned to England to take up an academic position at St. Bartholomew’s Hospital Medical School, where he rose to the rank of professor and chairman. In the meantime, the Department of Medicine at the RVH had fallen into disarray with the appointment of one individual as physician-in-chief and another as departmental chairman. These two individuals did not see eye-to-eye on any issue, and the department was tainted by acrimony. An interim departmental head was chosen, while a search committee was established by the hospital’s board of directors to find a permanent solution. The solution turned out to be Ronald Christie. Christie had visited McGill at the request of the search committee and had been offered the job. He returned to London confident that the offer would be withdrawn because of the almost impossible conditions he had put on his acceptance, including a whole new wing for the Department of Medicine to match the one recently built for the Department of Surgery. He was therefore surprised to see Mr. David Muir, president of the Bank of Montreal and chairman of the RVH board, waiting outside his office in London one day. All of his conditions had been agreed to, and Christie accepted the job. Ronald Christie returned to Montreal as physician-inchief of the RVH and chairman of the McGill Department of Medicine in 1955, when I was a final year medical student. Shortly after he arrived, he gave a professional lecture to the faculty. Not many people can recall the details of a lecture delivered 50 years previously, but I remember Christie’s well. xvii
xviii
History of the Meakins-Christie Laboratories
Dr. Ronald Christie Dr. Peter Paré
He talked about lung compliance and resistance and how the two combined made up the work of ventilating the lung. He showed how these parameters changed systematically with changes in tidal volume and breathing frequency. He showed that in diseases affecting the mechanical properties of the lung, there was a particular tidal volume and frequency for a given minute ventilation that resulted in minimal work, and this was the breathing pattern. I was entranced. While I understood diseases of other systems, I totally lacked a cohesive framework to understand diseases of the respiratory system. Although I had been taught about complemental air and supplemental air, these terms were never talked about during my clinical years, and classification of lung diseases into obstructive and resistive abnormalities was still in the future. Finally, someone had constructed a framework in which I could begin to understand respiratory function in disease. In retrospect, this lecture was to have an enormous influence on my future. It took some years before I chose to pursue the challenge of respirology, but there is no doubt that Christie’s lecture engendered my interest in this field. When Christie arrived in 1955, there was already a strong infrastructure in place at the RVH. Peter Paré was a young internist who had specialized in respiratory medicine and who had recently joined the attending staff. Darrell “Dag” Munro was an outstanding thoracic surgeon, and Bob Fraser was a young star of the radiology department. Christie brought Dr. David Bates with him. In 1956 and he appointed him director of the newly created respiratory division. Bates and Christie went on to do an extraordinary job of recruiting: Maurice McGregor and his wife Margaret Becklake, from South Africa; William “Whitey” Thurlbeck, another South African pathologist, who was on the staff of the Massachusetts General Hospital; and Joseph Milic-Emili, from the Harvard School of Public Health. Nick Anthonisen, who came from the United States for residency training, stayed and joined the faculty. Charlie Bryan came from the RCAF
to do his PhD degree under Bates. All of these people were to become world leaders in their respective fields. Bates and Christie wrote Respiratory Function in Disease, which became a medical best seller. The title is a tribute to Meakins and Davies, who wrote a book of the same name in the 1920s, of which I have a copy, a treasured gift from Dr. Christie when the Meakins-Christie Laboratories opened. David Bates and Maurice McGregor formed the joint cardiorespiratory service of the RVH and the Montreal Children’s Hospital (MCH). Margaret Becklake established excellence in respiratory epidemiology at McGill, a legacy that persists today and to which she is contributing as much as ever. Milic is world renowned for his contributions to respiratory physiology, particularly for his groundbreaking work on regional lung function using xenon 133 and his studies on the control of breathing. Thurlbeck established McGill as one of the leading centers of respiratory pathology and lung morphometry. Nick Anthonisen, a renowned physician, physiologist, and epidemiologist, went on to become dean of medicine at the University of Manitoba, and Charlie Bryan made many contributions to pediatric respirology, including the introduction of high-frequency oscillatory ventilation for the treatment of acute respiratory distress syndrome of infancy. Those who were already in place also made extraordinary contributions. Bob Fraser became the world’s leading pulmonary radiologist. Peter Paré was renowned for his excellence as a clinician and teacher. He has been responsible for inspiring and instilling clinical excellence in a vast number of respirologists in Canada and around the world. Fraser and Pare wrote Diagnosis of Diseases of the Chest, the book by which all other clinical texts of respiratory disease were judged. Dag Munro performed the world’s second lung transplant. It was a heady time. David Bates deserves great credit for developing respiratory research at McGill in an inclusive multidisciplinary program including clinical, fundamental, and epidemiologic research in both the Royal Victoria and Montreal Children’s Hospitals and spanning the disciplines of respiratory medicine, pathology,
History of the Meakins-Christie Laboratories
Dr. David Bates
epidemiology, cardiology, and radiology. The joint cardiorespiratory service of the RVH and MCH rapidly became world famous. Respiratory research at McGill rivaled that of similar research centers at Harvard, Johns Hopkins, the State University of New York at Buffalo, the University of California, San Francisco, and elsewhere. By 1962, following in Meakins’ footsteps, Christie had become dean of the McGill Faculty of Medicine. In 1967 he retired. Maurice McGregor replaced him as dean, and David Bates became chairman of the Department of Physiology. I was appointed director of the Respiratory Division at the RVH. Almost as soon as I was appointed, Peter Paré, my lifelong friend and professional colleague, told me that his brother, Paul Paré, then a vice president of Imperial Tobacco, was going to be made president. He suggested that we approach Paul to support respiratory research at the RVH. Our pitch was that the tobacco industry was causing lung disease and that since it was incapable of undertaking research into the diseases it was causing, it should support the research of scientists who could investigate how smoking led to disease. Paul, a man of great integrity, agreed. This led to negotiations with the Canadian Tobacco Manufacturer’s Council, the consortium of Canadian tobacco companies. They agreed to donate $300,000 to McGill to build new laboratories for respiratory research and to provide overhead costs for the first 10 years of operation. Today, this amount seems minuscule, but we were able to tap into federal resources to match those funds, so we had $600,000 to work with. After much discussion and some initial setbacks, we scaled our plans and settled on a two-storey addition to the Pathological Institute, conveniently located adjacent to Thurlbeck’s lung morphometry laboratory. The plans were sent to tender, the contract was awarded, and work began. The egg was fertilized and the Meakins-Christie Laboratories were conceived.
xix
I had a pretty fair idea of how I wanted the laboratories to operate. I had spent an unforgettable year and a half with Jere Mead and Jim Whittenberger at the Harvard School of Public Health and had also spent time in Dick Reilly’s department at the Johns Hopkins School of Hygiene working with Don Proctor and Sol Permutt. The attitude in both institutions was identical and wonderful—that work should be fun. In both places much of the day was spent exploring, discussing, and dissecting new ideas. The idea of change and innovation was not only welcomed, it was fostered. Almost daily, furious arguments (but neverquarrels) would break out, out of which spectacularly stupid and, more than occasionally, spectacularly brilliant ideas would emerge. And we had the academic freedom to pursue them. When I was in Boston, Jere Mead and I would drive to and from work every day. We would argue about the hot topic of the time and decide what we were going to play with that day. One such morning we were arguing hotly about the role of airway wall compliance in limiting expiratory flow, when Jere had an idea. He suggested that we push a catheter into the lung, push it right through the parenchyma and the visceral pleura, and then continue pulling it until the other end, which was widened into a bell shape, caught in a small airway. Then we could measure the pressure in small airways and partition the pressure drop and the resistance between central and peripheral airways. Such was the spirit of academic freedom in the laboratories that Jim Whittenberger directed, that we were able to start on this idea within half an hour, and within a week we had most of the methodologic problems solved. This was science heaven. This was what I wanted for the Meakins-Christie Laboratories. To achieve this, the laboratories were designed for procedures, not as individual private fiefdoms. There was a laboratory for animal mechanics, another for human mechanics, an exposure chamber, a gas exchange laboratory, and radioactive gas laboratories for both animals and humans. The sharing of laboratories, although it presented problems in scheduling and the setting up of equipment, promoted interactions among scientists with similar interests, which I hoped would stimulate new and exciting ideas. I was convinced that creative people interacting with other creative people with common interests would come up with more original ideas than they would conducting their science in isolation. One big room, the chief technician’s domain, had tables and chairs and always fresh coffee. Everyone—technicians, secretaries, research fellows, and research directors—was encouraged to eat lunch in that room. One day, I arrived late; every seat was taken, but a junior research fellow from France immediately stood up and offered me his seat. One of the technicians piped up, “What are you doing that for?!” I was pleased. That was exactly the sort of atmosphere I had hoped to establish. Large blackboards were put up in every room to encourage expression and discussion. The fellows’ offices were adjacent to the research directors’ offices. Doors were kept open, appointments unnecessary. Talking is one of the strongest stimuli to innovation. Thus, our weekly research seminar was the highlight of the week’s activities. In order to embolden shy research trainees to comment and ask
xx
History of the Meakins-Christie Laboratories
Dr. Paul Paré
questions, beer was freely available to loosen their tongues. Although probably the research directors drank more than the trainees, this worked. The beer seminars were held in the evening and were open-ended. Many memorable ones went on past midnight. One visiting VIP said, “I’m told that here I won’t get past my first slide, so I’m going to start with my second.” This was a great compliment. From the beginning, the laboratories were designed to be interdisciplinary, and physiologists, physicians, epidemiologists, pathologists, radiologists, and biomedical engineers were invited to participate. The laboratories were open in the sense that anyone who wanted to collaborate with one of the scientists working there was welcome to do so. After a long gestation period, the Meakins-Christie Laboratories for Respiratory Research were born in August 1972. At the opening ceremonies we were tackled by the media about the propriety of accepting tainted tobacco money. When the reporters heard that the money was given carte blanche,
with no strings attached, to investigate, among other things, how smoking damaged the lungs, this issue was resolved. In creating the laboratories, we tried to make the concept that research should be fun, that secrecy was anti-innovative, and that free and open discussion was essential, the core of our philosopy. Judging from the list of distinguished scientists who have contributed to this book, I think we succeeded. I pay homage to some exceptional people with whom I collaborated, who were extraordinarily creative and who even after death command immense influence over their survivors. They stand as proof of the vitality of freedom, openness, and creativity in science. In particular, I am talking about Whitey Thurlbeck, Ann Woolcock, Harold Menkes, Fred Douglas, David Flenley, and Ludwig Engel. These people enriched my life extraordinarily and would have similarly enriched this book if they were still with us. During their time at McGill they promoted the vision of intellectual freedom and openness, so they deserve much credit for not only persistence of this vision in the Meakins-Christie Laboratories but also for promoting it in their own institutions. I cannot finish without pointing out that Jim Higg contributed hugely to the early years of the laboratories. He and Ann Woolcock were among my first research fellows. What a start that was! I directed the Meakins-Christie Laboratories from 1972 until 1979, when I resigned to take up new challenges. The leadership of the Meakins-Christie Laboratories passed into the capable hands of Joseph Milic-Emili and then Jim Martin. It has continued to grow in size, influence, and contributions to new knowledge. Clearly, it is in wise and capable hands.
REFERENCES 1. Christie RV, Mclntosh CA. The measurement of intrapleural pressure in man and its significance. J Clin Invest 1934;13:279. 2. Christie RV. The elastic properties of the emphysematous lung and their clinical significance. J Clin Invest 1934;13:295. 3. Christie RV, Meakins JC. The intrapleural pressure in congestive heart failure and its clinical significance. J Clin Invest 1934;13:323.
CHAPTER 1
HISTOLOGY AND GROSS ANATOMY OF THE RESPIRATORY TRACT Richard S. Fraser
T
he lower respiratory tract extends from the larynx to the most distal portions of the lung parenchyma. Its airways can be considered in two groups: conducting and transitional.1,2 The former comprises those whose walls do not contain alveoli and are thick enough to prevent gas diffusing into the adjacent lung parenchyma. They include the trachea, bronchi, and membranous (nonalveolated) bronchioles; the latter are defined structurally by the absence of cartilage in their walls. These airways, along with their accompanying arteries and veins, lymphatic vessels, nerves, interlobular septa, and pleura, constitute the nonparenchymal portion of the lung. As the name suggests, transitional airways have both conductive and respiratory functions. They consist of respiratory bronchioles and alveolar ducts; in addition to conducting gas to and from the most peripheral portion of the lung, each has alveoli on its wall that serve in gas exchange. Alveoli associated with the transitional airways and with the more distal alveolar sacs constitute the lung parenchyma. It has been estimated that approximately 87% of the total lung volume is alveolar, 6% of which is composed of tissue, and the remainder of which is gas.3 Both the right and the left lung are enveloped by a thin layer of connective tissue (the visceral pleura), which focally extends into the parenchyma, dividing it into several lobes (upper, middle, and lower on the right side and upper and lower on the left). A potential space (the pleural cavity) separates the visceral pleura from the parietal pleura, which lines the chest wall, mediastinum, and diaphragm.
CONDUCTING AIRWAYS The basic branching pattern of the conducting zone is dichotomous (that is, the parent branch divides into two parts). As a general rule, the angles made by daughter branches with their parent vary with their diameter1: when the branches are of equal size, the angles tend to be equal; when the branches are of different size, the smaller branch usually makes a larger angle with the parent. Through
common usage, the designation main bronchi is applied to the bronchi arising at the bifurcation of the trachea and extending to the origin of the upper lobe bronchus on each side; the terms upper, middle, and lower lobe bronchi are used for the corresponding bronchi supplying individual lobes, and the term intermediate bronchus is applied to the airway segment between the right upper lobe bronchus and the origins of the right middle and lower lobe bronchi. The basic morphology of the conducting airways is similar and consists of a surface epithelium composed largely of ciliated and secretory cells overlying subepithelial tissue that consists predominantly of connective tissues and glands (Figure 1-1). The proportion and type of these elements vary at different levels of the conducting system.
EPITHELIUM The tracheal and proximal bronchial epithelium are composed predominantly of tall, columnar ciliated and goblet cells, and smaller, somewhat triangular, basal cells (Figure 1-2).4 Ciliated cells are about five times more numerous than goblet cells in the central airways, and the ratio is even greater peripherally.5 They have thin, tapering bases that are attached firmly to the underlying basal lamina. The cells are also attached to one another at their apical surfaces by tight junctions,6 forming a barrier physically impermeable to most substances,7 and laterally to one another and to basal cells by desmosomes. Intercellular spaces containing numerous microvilli are present between the cells, especially at their basal aspects.8 Emanating from the surface of each ciliated cell are approximately 200 to 250 cilia, as well as numerous shorter microvilli (Figure 1-3), which, in addition to microvilli located in the intercellular space, are important in the transepithelial movement of fluid and electrolytes.9 Goblet cells account for about 20 to 30% of cells in the more proximal airways5 and decrease in number distally, so that only occasional cells are present in normal membranous bronchioles.10 Ultrastructurally, the apical portion of the cytoplasm is distended by numerous membrane-bound, electron-lucent secretory granules. Histochemical studies
2
Anatomy
FIGURE 1-2 Conducting airway epithelium and lamina propria (electron micrograph). Ciliated cell (short straight arrow), goblet cell (long straight arrow), basal cell (black curved arrow), and subepithelial fibroblast (empty curved arrow).
FIGURE 1-1 Conducting airway (hematoxylin-eosin stain). Subsegmental bronchus showing cartilage (c), mucous glands (short arrows), bronchial artery (long arrow), and muscle (m). Reproduced with permission from Fraser RS, Müller NL, Colman N, Paré PD, Diagnosis of Diseases of the Chest, IV edition. Philadelphia: WB Saunders; 1999.
have shown these to contain predominantly neutral mucin and sulfomucins.11 However, variation in both ultrastructural and histochemical features has been demonstrated in different airways, and cells with a large proportion of nonsulfated sialomucins have also been identified.12 Basal cells are relatively small, somewhat triangular cells whose bases are attached to the basement membrane and whose apices normally do not reach the airway lumen. They are more abundant in the proximal airways, where they form a more or less continuous layer, and gradually diminish in number distally, so that they are difficult to identify in bronchioles.13,14 They function as a reserve from which the epithelium is repopulated, both normally and after airway injury,14 and are involved in the attachment of columnar epithelial cells to the basement membrane.15 Clara cells (nonciliated bronchiolar secretory cells) are found primarily in membranous bronchioles, in which they constitute the majority of the epithelium along with ciliated cells.16 They are columnar or (in the more distal airways) cuboidal in shape and bulge somewhat into the airway lumen, slightly projecting above the surrounding ciliated cells. The cytoplasm contains a prominent Golgi apparatus, abundant granular endoplasmic reticulum and mitochondria, and numerous membrane-bound, electron-dense granules. The latter contain a number of lipids and proteins,17 including a 10 kDa protein known as Clara cell-specific
FIGURE 1-3 Ciliated cell (electron micrograph). Apical portion of cell showing cilia (long arrow) and microvilli (short arrow). Secretory granules (g) of a goblet cell can be seen in the adjacent cell. Reproduced with permission Fraser RS, Müller NL, Colman N, Paré PD, Diagnosis of Diseases of the Chest, IV edition. Philadelphia: WB Saunders; 1999.
Histology and Gross Anatomy of the Respiratory Tract
protein (CC10, CC16, Protein 1) that may have a role in the regulation of local inflammatory and immune reactions,18 several surfactant apoproteins,19 and a leukocyte protease inhibitor.20 In addition to these secretory functions, there is evidence that Clara cells act as progenitor cells in the regeneration of damaged bronchiolar epithelium.21 Neuroendocrine cells constitute about 1 to 2% of bronchial epithelial cells in neonates22 and 0.5% in adults.23 They are attached at their bases to the basement membrane and have tapering apices that extend toward and may or may not reach the airway surface. Ultrastructurally, the cytoplasm contains numerous membrane-bound, electron-dense neurosecretory granules (Figure 1-4) that contain a variety of peptides, including gastrin-releasing peptide (bombesin), calcitonin, calcitonin gene–related peptide, somatostatin, substance P, endothelin, and enkephalin.24 These peptides appear to be secreted mostly at the basal aspect of the cell, although some may also be released via lateral cytoplasmic processes to affect adjacent epithelial cells, or into the airway lumen itself. The principal functions of the cells are believed to be related to the local effects of these secreted peptides. The cells appear as early as 8 weeks in the human fetus and increase in number thereafter,25 suggesting a role in the control of lung development. Cells of the immune system are present within the epithelium of all conducting airways. Dendritic and Langerhans’ cells are structurally similar cells that possess elongated cytoplasmic extensions and an organelle-rich cytoplasm; Langerhans’
cells have characteristic pentalaminar cytoplasmic structures termed Birbeck granules.26 Dendritic cells are found throughout the lung, including the alveolar septa, peribronchiolar connective tissue, and bronchus-associated lymphoid tissue26; Langerhans’ cells appear to be present only within airway epithelium. In this location, their number is considerably greater in proximal than in distal branches.27 Langerhans’ cells express cell surface receptors for immunoglobulins,26 and it is believed that they act as antigen-processing and antigen-presenting cells and as stimulators of T-cell proliferation.28 Lymphocytes (predominantly T cells) are present throughout the conducting airway epithelium, usually singly.29 Although they are undoubtedly involved in processing and reacting to inhaled antigens, it is also possible that they have a role in modifying airway epithelial cell function. Greater numbers of lymphocytes can be seen as lymphoid aggregates in the lamina propria and submucosa (bronchusassociated lymphoid tissue), usually in the setting of acute or chronic airway injury. Mast cells are also found in small numbers within the airway epithelium.30 A basement membrane underlies the epithelium over its entire basal aspect. Its primary function is to provide an attachment for the epithelium to the underlying connective tissue. On the epithelial side, this attachment is mediated by adhesion molecules and by hemidesmosomal junctions with basal cells31; on the opposite side, anchoring fibrils emanate from the basement membrane and intertwine with collagen fibers in the upper lamina propria.
SUBMUCOSA
FIGURE 1-4 Neuroendocrine cell (electron micrograph). Basal portion of two cells, one of which is adjacent to the basement membrane (straight arrows). The cytoplasm contains numerous electron-dense neurosecretory granules (curved arrows). Reproduced with permission from Fraser RS, Müller NL, Colman N, Paré PD, Diagnosis of Diseases of the Chest, IV edition. Philadelphia: WB Saunders; 1999.
3
AND
LAMINA PROPRIA
The subepithelial tissue can be subdivided into a lamina propria, situated between the basement membrane and the muscularis mucosa, and a submucosa, consisting of all the remaining airway tissue. The lamina propria consists principally of a network of capillaries, a meshwork of reticulin fibers continuous with the basement membrane, and bundles of elastic and nerve fibers. Ultrastructural examination shows the presence of a population of fibroblasts located immediately beneath the basement membrane (the attenuated fibroblast sheath) that have been speculated to be capable of interaction with adjacent epithelial cells and to be involved with the regulation of local inflammatory and reparative processes.32 The submucosa contains cartilage, muscle, and other supportive connective tissue elements, as well as the major portion of the tracheobronchial glands. The airway wall can also be considered as being composed of inner and outer layers, the former extending from the lumen to the outermost layer of smooth muscle and the latter from the smooth muscle to the airway adventitial–parenchymal boundary.33 Tracheal cartilage plates consist of about 16 to 20 U-shaped structures oriented in a horizontal plane with their open ends directed posteriorly.34 The posterior (membranous) portion of the wall is free of cartilage. The spaces between the plates contain smooth muscle, tracheal glands, and collagenous and elastic tissue. The U-shape of the cartilage plates is maintained in the main bronchi; however, they become smaller and irregular in shape in lobar and segmental bronchi and disappear altogether in membranous bronchioles.
4
Anatomy
Elastic tissue in the lamina propria tends to be clustered in bundles oriented in a longitudinal direction. These bundles are especially well developed in the posterior portion of the trachea and main bronchi, where they form well-defined ridges.35 Prominent elastic thickening is also present in the lamina propria at bronchial branch points. The cartilage plates are connected by bundles of fibroelastic tissue arranged predominantly in a longitudinal direction. At numerous sites, particularly in smaller airways, elastic fibers emanating from these longitudinally arranged bundles intermingle with the elastic tissue of the lamina propria.1 These fibers are believed to help transmit to the more rigid and stronger cartilaginous fibrous tissue the tension that arises in the airway epithelium and lung parenchyma during breathing. Tracheal muscle is found predominantly in the membranous portion, where it is organized in both longitudinal and transverse bundles (Figure 1-5); the latter are attached to the inner perichondrium close to the tip of the cartilaginous rings (the bundles joining each ring posteriorly).36 Although somewhat less prominent, transverse fibers can also be found between the cartilage rings in the anterior portion. In the bronchi, muscle is organized in bundles close to the epithelium adjacent to the lamina propria. In the larger airways, the orientation is mainly circumferential, as in the trachea. In the more distal branches, the muscle is obliquely oriented and arranged in branching and anastomosing bundles that form irregular spirals in the airway wall. The proportion of muscle relative to airway diameter is greater in smaller airways.37 Loose connective tissue consisting of proteoglycans and mature collagen occupies much of the remainder of the submucosa. This tissue is continuous with connective tissue in the adjacent pulmonary arteries as well as that in the perivenous tissue near the hilum and in the interlobular and pleural interstitium. This interdependence of connective tissue is important in maintaining the overall structure of the lung and in providing a scaffold for the more delicate connective tissue of the parenchyma.
FIGURE 1-5 Posterior tracheal wall (hematoxylin-eosin stain). Lamina propria (p), transverse muscle bundle (T), longitudinal muscle bundle (L), and mucous glands (m).
Tracheobronchial glands are specialized extensions of the airway surface epithelium into the submucosa. Both the number and size of the glands are greater in the more proximal airways,38 and they are absent altogether in the smallest bronchi and bronchioles. The secretory portion of the gland is connected to the surface by a duct of variable length whose lining is similar to that of the surface airway epithelium (Figure 1-6). Multiple branched secretory tubules arise from the collecting duct. They are lined proximally by mucus-secreting cells that contain several histochemically different types of mucin and distally by serous cells.39 The latter have been shown to contain a variety of substances that are potentially important in local airway defense, including lysozyme, lactoferrin, transferrin, and a protease inhibitor. Myoepithelial cells are present between the basement membrane and both types of epithelial cell40 and are presumably responsible in part for expulsion of glandular secretions. Many cells concerned with airway defense are found in the airway lamina propria and submucosa. Lymphocytes can be identified either singly or in clusters, the latter being variously termed lymphoid nodules, lymphoid aggregates, or bronchus-associated lymphoid tissue (BALT).41 Lymphoid aggregates are composed of well-defined but unencapsulated
FIGURE 1-6 Bronchial gland (hematoxylin-eosin stain). Collecting duct (D), mucous cells (m), and serous cells (arrows).
Histology and Gross Anatomy of the Respiratory Tract
clusters of mature lymphocytes, with smaller numbers of dendritic cells and lymphoblasts. The cells extend into the overlying epithelium, which is often flattened and lacks mucus or ciliary differentiation. Small, thin-walled blood vessels are present within the aggregates, possibly serving as a site for cell migration to and from the circulation. Plasma cells, primarily IgA and IgG in type, are common in the tracheobronchial wall, particularly in proximal bronchi in association with tracheobronchial glands, and in the lamina propria close to the basement membrane.42 Isolated macrophages can be found throughout the lamina propria and submucosa and tend to be more numerous in individuals exposed to noxious materials such as cigarette smoke and inorganic dust. Mast cells can be found throughout the lung in airway, alveolar, pleural, and interlobular interstitial tissue, as well as in airway epithelium.43 Although the cells are structurally similar, there appear to be differences in mediator content between them, suggesting variable functions.44
TRANSITIONAL AIRWAYS
5
however, muscle and elastic tissue continue in a spiral fashion surrounding the alveolar mouths.47 Bronchiolar-type epithelium and lamina propria are absent in alveolar ducts. The contribution of transitional airways to gas exchange is probably substantial; in one investigation, approximately 35% to 40% of all alveoli in three acini were found to be located in these structures.45
RESPIRATORY TISSUE Alveoli are demarcated by septa composed of a continuous layer of epithelial cells overlying a thin interstitium (Figure 1-8). The former consists principally of two morphologically distinct cells, type I and type II; alveolar macrophages are also present on the epithelial surface. The interstitium contains capillaries involved in gas exchange, as well as connective tissue and a variety of cells responsible for maintaining alveolar shape and defense. Type I alveolar cells cover approximately 95% of the alveolar septal surface.48 The nucleus of this cell type is small and covered by a thin rim of cytoplasm containing few organelles. The rest of the cytoplasm extends as a broad
The number and length of airways from the terminal membranous bronchiole to the alveolar sac as well as the pattern of their branching are quite variable.45,46 Some of this irregularity may be related to spatial constraints imposed by pleura, interlobular septa, and larger airways and vessels. On average, however, there are probably about two to three respiratory bronchioles and four to six alveolar ducts between the terminal bronchiole and the alveolar sacs. The surface of respiratory bronchioles is lined by a low columnar to cuboidal epithelium that gradually decreases in extent as the number of alveoli increases. In first- and second-order bronchioles, it is usually complete on one side, where it overlies a lamina propria and muscle continuous with that of the terminal bronchiole (Figure 1-7). As the number of alveoli increases, the lamina propria diminishes;
FIGURE 1-7 Respiratory bronchiole (hematoxylin-eosin stain). Epithelium (arrows), pulmonary artery (A), and distal branches (B). Reproduced with permission from Fraser RS, Müller NL, Colman N, Paré PD, Diagnosis of Diseases of the Chest, IV edition. Philadelphia: WB Saunders; 1999.
FIGURE 1-8 Alveoli (hematoxylin-eosin stain). Septa are composed of capillaries and a small amount of connective tissue (short arrow). In some foci (curved arrow), the latter appears to be thicker. Precapillary arteriole (a). (Airspaces contain fluid and red blood cells secondary to left heart failure.) Reproduced with permission from Fraser RS, Müller NL, Colman N, Paré PD, Diagnosis of Diseases of the Chest, IV edition. Philadelphia: WB Saunders; 1999.
6
Anatomy
FIGURE 1-10 Type II epithelial cell (electron micrograph). Secretory granules with lamellar inclusions (arrows).
FIGURE 1-9 Air–blood barrier (electron micrograph). Red blood cell (R), capillary lumen (L), and alveolar airspace (A). Type I epithelial cytoplasm (long arrows) and endothelial cytoplasm (short arrows) are separated by a small amount of fused epithelial–endothelial basement membrane. (The interstitial tissue adjacent to the capillary is abnormally thickened by collagen.)
sheet 50 m or more over the alveolar surface and is about 0.3 to 0.4 m thick (Figure 1-9). Adjacent type I cells are joined to one another by tight junctions that provide a more or less complete barrier to the diffusion of fluid and watersoluble substances into the alveolar airspace.49 The cell cytoplasm contains pinocytotic vesicles that can theoretically transport material in either direction across the air–blood barrier. Type II epithelial cells tend to be located near corners where alveoli meet.50 Their cytoplasm contains a welldeveloped endoplasmic reticulum, a prominent Golgi complex, and numerous membrane-bound, secretory granules (Figure 1-10). The latter contain characteristic lamellar inclusions that are the source of surfactant, the substance responsible for modifying alveolar surface tension.51 Type II cells have a number of other important functions. A small number are mitotically active and are able to differentiate into type I cells, repopulating the alveolar surface as the latter die. There is also evidence that type II cells synthesize a variety of substances involved in alveolar structure and defense, including fibronectin and ␣1-antitrypsin,52,53 and are able to suppress lymphocyte proliferation and enhance macrophage function in the alveolar septa.54 Surfactant can be identified on transmission electron microscopy as an extremely thin (4 nm) layer of osmiophilic
material that covers the alveolar epithelial surface.55 It appears to consist of two components: (1) a film facing the alveolar airspace, which is composed of densely spaced, highly surface-active phospholipids, and (2) a deep layer containing surface-active phospholipids in a different physicochemical configuration and linked to proteins. Components of the superficial layer are thought to be recruited from the deeper layer (hypophase) during expansion of the lung and may reenter it at low lung volumes. The hypophase contains aggregates of lipid termed tubular myelin that have a characteristic fingerprint-like pattern. A more or less continuous basement membrane is present adjacent to the type I and type II cells. Focally, it is fused with the basement membrane underlying the endothelial cells of the alveolar capillaries. Connective tissue, as well as endothelial and epithelial cell nuclei, tend to be absent from this region of basement membrane fusion. This portion of the septum—consisting of the thin type I cell sheet, the endothelial cell cytoplasm, and the fused basement membranes—is about 0.4 to 0.5 m thick and is the principal site of gas exchange across the air–blood barrier. Elsewhere, endothelial and epithelial basement membranes are separated by an interstitial space of variable width that contains connective tissue (including elastic and collagen fibers) and a variety of cells.56 The most prominent of these is the myofibroblast (contractile interstitial cell), which, as the name suggests, has ultrastructural features suggestive of both fibroblast and muscle differentiation (Figure 1-11).57 Possible functions of these cells include local regulation of alveolar gas exchange (V˙/Q˙) (their contraction resulting in a reduction in capillary bloodflow), regulation of the fluid content of the alveolar interstitium, and production of connective tissue, both in the normal state and in pathologic alveolar fibrosis.56,57 Scattered macrophages are present in the alveolar interstitium and on its epithelial surface. Ultrastructurally, they have prominent surface microvilli and an abundance of membrane-bound primary and secondary lysosomes.58
Histology and Gross Anatomy of the Respiratory Tract
FIGURE 1-11 Alveolus with interstitial cell (electron micrograph). Interstitial cell nucleus (arrow), collagen (T), and capillary lumen (L).
Although they are morphologically similar, it is possible that these and other pulmonary macrophages have different functional capabilities. In fact, they have been considered to form several groups on the basis of their anatomic location59: (1) the airway macrophage, situated on or beneath the epithelial lining of conducting airways; (2) the alveolar interstitial macrophage; (3) the alveolar surface macrophage; (4) the intravascular macrophage, located adjacent to the capillary endothelial cell60; and (5) the pleural macrophage.61 In addition to macrophages, a variety of other cells involved in parenchymal defense can be found in the alveolar interstitium, including mast cells,62 lymphocytes, and CD4, Ia⫹dendritic cells.63 Numerically, the alveolar macrophage is the most important nonepithelial cell in the parenchyma. Bronchoalveolar lavage of normal human airspaces yields a cell population including approximately 95% macrophages; dendritic cells (0.5%), lymphocytes (1 to 2%), monocyte-like cells of uncertain nature (2%), and polymorphonuclear leukocytes (less than 1%) account for the remainder.63 The number of alveoli in the adult human lung has been estimated to be about 300 ⫻106.64 However, one group documented considerable variation in this figure among different individuals, with computed values ranging from 212 ⫻106 to 605 ⫻106.65 In adults, both maximal diameter and depth of the alveolus (measured from the opening at the alveolar duct or sac to the base) are about 250 to 300 m.66
7
FIGURE 1-12 Secondary lobule and acinus (hematoxylin-eosin stain). Interlobular septa (curved arrows), pleura (p), central bronchiole (b), and respiratory bronchiole (straight arrow). The tissue between straight lines corresponds approximately to an acinus. Reproduced with permission from Fraser RS, Müller NL, Colman N, Paré PD, Diagnosis of Diseases of the Chest, IV edition. Philadelphia: WB Saunders; 1999.
the periphery of the lung, where they are continuous with the pleura (Figure 1-13). They are most numerous in the apical, anterior, and lateral aspects of the upper lobe and in the lateral and anterior regions of the lower lobes. In the central regions of the lung, septa are often difficult to identify or absent altogether. Because of this deficiency, there is an alternative definition of the lobule as consisting of pulmonary parenchyma supplied by a cluster of three to five terminal bronchioles.67 The pulmonary acinus comprises all lung tissue distal to the terminal bronchiole and is composed of respiratory bronchioles, alveolar ducts, alveolar sacs, alveoli, and their accompanying vessels and connective tissue (see Figure 1-12).
LUNG UNIT The most widely accepted subdivisions of lung parenchyma that have been proposed as the fundamental “unit” of lung structure are the secondary lobule and the pulmonary acinus. The former can be defined as the smallest discrete portion of the lung surrounded by connective tissue septa (Figure 1-12). It is somewhat polyhedral in shape, usually measures 1 to 2.5 cm in diameter, and contains a central membranous bronchiole, which gives rise to several respiratory bronchioles. Interlobular septa are best developed in
FIGURE 1-13 Interlobular septa (electron micrograph). Septa (arrows) are clearly evident as a result of thickening by carcinoma.
8
Anatomy
Measurements of acinar diameter vary between 6 and 10 mm, depending to some extent on the technique and the pressure at which the lung is inflated.68
CHANNELS OF PERIPHERAL AIRWAY AND ACINAR COMMUNICATION The best understood of these structures are alveolar pores, small discontinuities in the alveolar septa also known as pores of Kohn. The size of the aperture is usually between 2 and 10 m, and there are as many as 5 to 20 pores per alveolus.69,70 They are generally round, and their edges are lined by type I epithelial cells. By transmission electron microscopy, they are usually free of cellular or other material in airway-fixed material; however, in vascular-perfused tissue, they are typically occluded by a thin film of surfactant.69 Since it is probable that vascular-perfused tissue more closely represents the normal state of the alveolar airspace, the presence of this surfactant casts some doubt on the significance of the pores as a mechanism for collateral ventilation. Direct communications between alveolar sacs and membranous bronchioles (canals of Lambert)71 consist of epitheliallined tubular structures that, in lungs fixed in deflation, range in diameter from practically “closed” to 30 m in diameter. It is not known whether they provide accessory communication solely within acini or whether interacinar connections capable of subserving collateral ventilation occur as well. The results of experimental studies in both animals and humans indicate that particles considerably larger than either alveolar pores or most canals of Lambert are able to pass through collateral channels in lung parenchyma.72 The precise anatomic correlate of these pathways is unclear.
FIGURE 1-14 Pulmonary artery (hematoxylin-eosin stain). Conventional (c) and accessory (a) branches.
PULMONARY ARTERIES
penetrating the adjacent parenchyma directly.73 The smaller branches ramify to form the capillary network of the alveoli. The pulmonary capillaries form a dense network of short interconnecting segments (Figure 1-15).64 Measurements of the external diameter of these segments in fresh lung average about 8.6 m; assuming the average thickness of the capillary endothelium to be about 0.3 m, the average internal capillary diameter is thus about 8 m. However, these values vary substantially with both lung volume and capillary pressure.74,75 The average axial length of capillary segments is about 10 m. At all levels of the arterial tree, the intima is very thin, consisting of an endothelial cell layer and its adjacent basement membrane. The endothelial cells tend to be organized in an interlocking mosaic.76 Like type I epithelial cells, they possess cytoplasm that extends as thin, plate-like processes measuring as little as 0.1 to 0.3 m in thickness. Short, microvillus-like projections are present on the luminal surface, particularly in arteries.77 These greatly increase the cell
Pulmonary arteries are intimately related to the airways and divide with them, a branch accompanying the adjacent airway to the level of the respiratory bronchioles. In addition to these “conventional” vessels, many accessory branches arise at points other than corresponding airway divisions and extend directly into the adjacent lung parenchyma (Figure 1-14). Elastic arteries include the main pulmonary artery and its lobar, segmental, and subsegmental branches extending approximately to the junction of bronchi and bronchioles. The elastic laminae are located in the media and are organized in layers, which become less numerous as the vessels decrease in size. At a diameter of about 1,000 to 500 m, only two layers—internal and external—can be identified, at which point the vessels are considered muscular arteries. Beginning at a diameter of about 100 m, the arteries gradually lose their medial smooth muscle to become arterioles, so that, at a diameter of about 70 m, the vessels are composed solely of a thin intima and a single elastic lamina that is continuous with the external elastic lamina of the parent artery. Arterioles continue to divide within the acinus, some accompanying bronchioles and alveolar ducts to the level of the alveolar sacs and others
FIGURE 1-15 Pulmonary capillaries (hematoxylin-eosin stain). En face view of an alveolar wall shows numerous interconnecting capillary segments.
PULMONARY VASCULATURE
Histology and Gross Anatomy of the Respiratory Tract
9
parenchyma or in the connective tissue septa that delimit the secondary lobules. As in the pulmonary arterial system, numerous supernumerary vessels join the veins as they run to the hilum.83 Histologically, pulmonary venules are indistinguishable from arterioles. Veins have a variable number of elastic laminae, between which are small bundles of smooth muscle cells. No valves are present within venous lumina. However, regularly spaced annular constrictions related to local accumulations of smooth muscle have been identified in the veins of some animals and have been hypothesized to be important in the control of pulmonary bloodflow.84
BRONCHIAL VASCULATURE
FIGURE 1-16 Pulmonary capillary endothelial cell (electron micrograph). Red blood cell (R), endothelial cell caveolae (long arrows), and type I epithelial cell (short arrow).
surface area and may play a role in the metabolism of various blood substances as well as facilitating metabolite transfer between the blood and the endothelial cells. Small vesicles (caveolae intracellulare) can also be seen in endothelial cells, particularly those lining alveolar capillaries (Figure 1-16). In the latter, they are most prominent in the relatively thick, non–gas-exchanging part of the cell, at either the luminal or the abluminal surface.78 Small electron-dense granules, considered to represent enzyme complexes responsible for various metabolic functions, can be seen at the bases of the vesicles. In addition to metabolic activity, the vesicles are believed to function in the transport of fluid and proteins between blood and interstitial tissues and across the air–blood barrier.79 Adjacent endothelial cells are joined by tight junctions.79 For the most part, these are continuous; however, occasional intercellular clefts measuring up to 4 nm in thickness can be observed in alveolar capillaries. As determined by freeze–fracture techniques, these junctions are less complex than those of the alveolar epithelium, suggesting that the main site of solute impermeability in the air–blood barrier is the epithelium. The complexity of the endothelial junctions is variable in different parts of the vasculature, being greater in arterioles than in the more permeable venules, and greater in the base than at the apex of the lung.80 Several cell types can be found within the arterial–arteriolar wall in addition to smooth muscle and endothelial cells. Pericytes are located between the basement membrane and endothelial cells, predominantly in capillaries but also to some extent in arterioles. They have thin microfilament-containing processes that extend toward and attach to the endothelial cell surface.81 Mast cells are also present in the connective tissue adjacent to pulmonary vessels, where they have been hypothesized to function as mediators of hypoxic vasoconstriction.82
PULMONARY VEINS Unlike pulmonary arteries, pulmonary veins and venules are not associated with airways and course instead in the
Most individuals have two to four bronchial arteries, a relatively common pattern being one on the right (originating from the third intercostal artery) and two on the left (arising directly from the aorta).85 At the hila, the vessels form an intercommunicating circular arc around the main bronchi from which several branches (usually two or three on opposite sides of the airway wall) extend into the peribronchial connective tissue (see Figure 1-1). These branches send smaller twigs into the bronchial wall that ramify to form a vascular plexus in the submucosa. The latter can comprise as much as 10 to 20% of the volume of the normal subepithelial tissue, and it has been hypothesized that significant airway narrowing may occur when these vessels become congested.86 Most arteries stop at the level of the terminal bronchioles. The bronchial circulation has a dual venous drainage. One portion, related to the trachea and proximal bronchi, drains into the bronchial veins to the right side of the heart via the azygos and hemiazygos veins. The other, which drains the major portion of the intrapulmonary bronchial flow,87 originates in anastomoses with small precapillary and postcapillary pulmonary vessels and courses via the pulmonary veins into the left atrium.
LYMPHATIC SYSTEM Lymph flows along two major pathways in the lung, one located in the peribronchovascular connective tissue and the other in interlobular septal connective tissue (Figure 1-17).88 Anastomotic channels up to 4 cm long connect the two pathways, particularly in the basal portion of the lower lobes. Lymphatic capillaries originate in the region of the distal respiratory bronchioles.89 Some lymphatics are located immediately adjacent to alveolar airspaces in the interlobular, peribronchial, and perivascular connective tissue. These channels have been termed juxtaalveolar lymphatics because of their close topographic and possible functional relationship with the alveolar airspaces.90 Histologically, pulmonary lymphatics can be divided into capillaries and collecting channels, the latter defined by the presence of mural smooth muscle cells or valves. With the use of scanning electron microscopy, three types of vessel have been distinguished91: (1) relatively broad, ribbon-like structures that are closely linked to lymphatic capillaries (reservoir lymphatics); (2) tubular structures that may
10
Anatomy
FIGURE 1-17 Perivascular lymphatic (hematoxylin-eosin stain). Membranous bronchiole (M), pulmonary artery (A), and lymphatic distended by fluid (L).
contain valves and extend for long distances without side branches (conduit lymphatics); and (3) complexes of plexiform vessels that surround the arteries, veins, and bronchi (sacculotubular lymphatics). The basement membrane beneath lymphatic capillary endothelial cells is discontinuous, and intercellular junctions are absent between some endothelial cells. The resulting gaps in the vessel wall provide a relatively easy route for interstitial fluid that has leaked from alveolar septal capillaries to enter the lymphatic capillary lumen. The cytoplasm of the endothelial cells contains numerous microfilaments, which have been hypothesized to constitute an actin-like contractile system that regulates opening or closing of the intercellular gaps.89 Numerous valves 1 to 2 mm apart direct lymph flow in both the pleural and intrapulmonary lymphatics. Although they appear to be bicuspid in two-dimensional histologic sections, stereomicroscopic studies have shown most to be monocuspid and shaped like a funnel.89 They are well adapted to unidirectional flow since they cannot be inverted and are easily occluded by flow in an abnormal direction.
chest wall, diaphragm, and mediastinum.92 The two join at the hila. Extensions of visceral pleura into the underlying lung form fissures (one major and one minor on the right and a single major one on the left) that divide the lung into lobes. The visceral pleura can be considered to consist of three layers (Figure 1-18): (1) a superficial endopleura, composed of a continuous layer of mesothelial cells overlying a thin network of collagen and elastic fibers; (2) an external elastic lamina, which consists of a layer of collagen and elastic tissue whose thickness varies,93 possibly as a result of differences in pleural stress during the respiratory cycle; and (3) a vascular (interstitial) layer that consists of connective tissue containing lymphatic and blood vessels. The last-named is continuous with the interstitial tissue of the interlobular septa and overlies a thin internal elastic lamina that encases the entire lung parenchyma and separates alveoli from the pleura, interlobular septa, and bronchovascular bundles. The parietal pleura consists of a layer of connective tissue adjacent to the endothoracic fascia of the chest wall. It is divided into two parts by a layer of fibroblastic tissue, with most of the vessels being located in the part furthest from the pleura. Mesothelial cells form a continuous layer overlying the entire visceral and parietal pleural surface. Their size and shape vary with transpulmonary pressure, the cells becoming more flattened as the lung expands.92 Characteristically, the cell surface is covered by numerous long, thin microvilli. Fine strands approximately 150 nm in diameter emanate from the surface glycocalyx and extend between the microvilli; it has been suggested that fluid trapped in compartments formed by these strands and by the microvilli themselves protects the mesothelial cells from the trauma of normal pleural movement.94 Mesothelial cells are metabolically active and appear to have several functions. They are likely to be responsible, at least in part, for regulating the composition and amount of pleural fluid, and there is evidence that they have the ability to produce components of the submesothelial connective tissue.95 Surface-active phospholipids similar to alveolar
PLEURA The pleural space is enclosed by the visceral pleura, which covers the lungs, and by the parietal pleura, which lines the
FIGURE 1-18 Visceral pleura (elastic van Giesen stain). Mesothelial cells (thin arrow), external elastic lamina (thick arrows), internal elastic lamina (curved arrow), and interstitial layer (T).
Histology and Gross Anatomy of the Respiratory Tract
surfactant, most likely produced by mesothelial cells, have been found in the pleural space, where they may act as lubricants to facilitate pleural surface movement.96
PULMONARY INNERVATION The lung is innervated by fibers that travel in the vagus nerve and in nerves derived from the second to fifth thoracic ganglia of the sympathetic trunk.97 These fibers carry afferents and efferents of the parasympathetic and sympathetic autonomic nervous systems. In addition, there is pharmacologic and physiologic evidence for a nonadrenergic, noncholinergic, neural inhibitory efferent system (nonadrenergic inhibitory system), the anatomic pathway of which has not been well defined.98 Although both excitatory and inhibitory components have been demonstrated in rodents, the human lung does not seem to have an excitatory pathway. The vagus nerve contains preganglionic, parasympathetic efferent fibers and afferent fibers from various lung receptors. The sympathetic fibers are largely postganglionic efferent in type. Fibers of these two systems enter the hila, join with branches from the cardiac autonomic plexus, and form large posterior and smaller anterior plexuses in the peribronchovascular connective tissue. From these plexuses arise peribronchial and perivascular nerve fibers that extend distally. These connect with ganglia in the airway wall (Figure 1-19), where the vagal preganglionic fibers synapse with postganglionic neurons. At numerous points along their course, the airway nerves send out branches into the submucosa and mucosa that terminate in bronchial muscle, mucous glands, and small blood vessels. Thicker fibers thought to be largely of an afferent sensory type bypass the ganglia. Some of these originate in receptors within the airway epithelium and lamina propria, tracheobronchial smooth muscle, the perichondrial tissue of large airways, the pulmonary parenchyma, and the pulmonary and bronchial arteries and veins.99 Afferent receptors themselves have been divided into three groups on the basis of
11
their distribution and physiologic response to various stimuli. The irritant or cough receptors are located predominantly in the trachea and large bronchi, their number decreasing progressively as the smaller peripheral airways are approached.100 They are highly arborized myelinated nerve fibers with numerous free nerve endings that terminate in the airway epithelium. Their stimulation results in reflex bronchoconstriction, and their role is probably to inhibit inhalation of toxic material.101 The second major group of myelinated afferent nerves originates in stretch receptors. The latter are found in airway smooth muscle, where they are organized in tendril-like structures closely applied to the surface of individual muscle cells. They are responsible for sending information regarding lung volume to the respiratory center; integration of their input results in “off-switch” activity in the respiratory center. The third type of lung afferent originates in the J (juxtacapillary) receptor.102 The nerve endings of these small, nonmyelinated fibers are situated in the lung parenchyma adjacent to alveolar septa and pulmonary capillaries and in the walls of the conducting airways. Efferent innervation of the lung includes preganglionic fibers from vagal nuclei, which descend in the vagus to synapse with postganglionic neurons in the ganglia around the airways, and postganglionic fibers from the cervical sympathetic ganglia. Postganglionic cholinergic fibers supply the mucous glands of the large airways and the goblet cells, their stimulation causing an increase in secretion in both structures. Vagal efferent fibers also supply airway smooth muscle as well as pulmonary and bronchial vascular smooth muscle; stimulation of these cholinergic fibers causes airway smooth muscle contraction (resulting in airway narrowing) and vascular smooth muscle relaxation (leading to pulmonary and bronchial vascular dilatation). The nerves to the pulmonary arteries run in the perivascular adventitia as far as parenchymal arterioles and connect extensively with the peribronchial nerves. Two plexuses of cholinergic fibers have been identified in the larger vessels, one located in the outer adventitia, and the other at the adventitia–media junction; in smaller vessels, only a single (inner) plexus is present.103 Many nerves related to the pulmonary veins extend into the inner media, where they form a complex subendothelial network. The bronchial arteries contain a prominent nerve plexus at the media–adventitia junction, presumably consisting of efferent supply to the smooth muscles of these vessels; this plexus also sends numerous branches to the bronchial mucous glands.
RESPIRATORY MUSCLES
FIGURE 1-19 Bronchial wall innervation (hematoxylin-eosin stain). Connective tissue in the periphery of an airway wall shows a nerve (curved arrow) and ganglion (straight arrow). M ⫽ mucus gland.
The respiratory muscles can be divided into four groups, each with different functions and mechanisms of action— the upper airway muscles, the diaphragm, the intercostal and accessory inspiratory muscles, and the abdominal muscles. These muscles can be considered to be “primary” (those that routinely contract during tidal breathing in normal individuals) and “accessory” (those that are not normally active during tidal breathing but are recruited when the demand for ventilation increases). The diaphragm is the
12
Anatomy
principal primary muscle of inspiration104; others include the scalene, parasternal, and external intercostal muscles. The accessory inspiratory muscles include the sternocleidomastoid, pectoralis, serratus anterior, trapezius, and latissimus dorsi muscles. The expiratory muscles include the abdominal, internal intercostal, and triangularis sterni muscles. The abdominal muscles include the rectus and transverse abdominis muscles and the external and internal oblique muscles; although these muscles are generally regarded as expiratory in function, they may also play an active role in inspiration.105 The diaphragm has a complex three-dimensional structure. Its central portion (the central tendon) consists of a sheet of connective tissue fibers that has a shape similar to that of a broad-bladed boomerang. The costal (chest wall) muscle fibers arise anteriorly from the xyphoid process and around the convexity of the thorax from ribs 7 to 12. Additional crural fibers arise from the lateral margins of the lumbar vertebrae. All these fibers converge toward the central tendon and are inserted into it nearly perpendicular to its margin. The greatest respiratory excursion occurs in the posterolateral portion of the hemidiaphragms, where the muscle fibers are longest. There is evidence that the diaphragm is, in fact, two distinct muscles that have separate nervous and vascular supplies, as well as functions. The costal portion of the diaphragm is mechanically in series with the intercostal and accessory muscles, and its contraction can result in both descent of the diaphragm and elevation of the rib cage; by contrast, the crural portion is in parallel with the costal portion of the diaphragm, and its contraction results in descent of the diaphragm without elevation of the rib cage.106 The diaphragm is composed of three types of muscle fiber that have different histochemical profiles, related to the different myosin heavy-chain isotypes expressed by the cells107: (1) slow-twitch oxidative fatigue-resistant units (type 1); (2) fast-twitch oxidative glycolytic fatigue-resistant units (type 2a); and (3) fast-twitch glycolytic fatigable units (type 2b). Type 1 represents approximately 50% of the muscle fibers, type 2a about 20%, and type 2b about 30%. The relative proportions of the different types of motor fibers present in the diaphragm may be important in the pathogenesis of muscle fatigue and ventilatory failure. Histologically, the muscular portion comprises multiple muscle fascicles of variable size containing individual muscle fibers that also have different ultrastructural characteristics.108 The diaphragm has an abundant blood supply derived from the phrenic and intercostal arteries and from branches of the internal thoracic (mammary) arteries. Flow can increase to approximately 250 mL/min/100 g of muscle during maximal activation (about half of the maximal bloodflow to the heart).109 An extensive lymphatic network drains fluid via collecting vessels into mediastinal channels.108
REFERENCES 1. Von Hayek H. The human lung. New York: Hafer; 1960. 2. Nagaishi C. Functional anatomy and histology of the lung. Baltimore: University Park Press; 1972.
3. Stone KC, Mercer RR, Freeman BA, et al. Distribution of lung cell numbers and volumes between alveolar and nonalveolar tissue. Am Rev Respir Dis 1992;146:454. 4. Gail DB, Lenfant CJM. State of the art—cells of the lung: biology and clinical implications. Am Rev Respir Dis 1983; 127:366. 5. Rhodin JAG. The ciliated cell: ultrastructure and function of the human tracheal mucosa. Am Rev Respir Dis 1966;93:1. 6. Godfrey RWA, Severs NJ, Jeffrey PK. Freeze–fracture morphology and quantification of human bronchial epithelial tight junctions. Am J Respir Cell Mol Biol 1992;6:453. 7. Herard AL, Zahm JM, Pierrot D, et al. Epithelial barrier integrity during in vitro wound repair of the airway epithelium. Am J Respir Cell Mol Biol 1996;15:624. 8. Widdicombe JH, Gashi AA, Basbaum CB, et al. Structural changes associated with fluid absorption by dog tracheal epithelium. Exp Lung Res 1986;10:57. 9. Nathanson I, Nadel JA. Movement of electrolytes and fluid across airways. Lung 1984;162:125. 10. Ebert RV, Terracio MJ. The bronchiolar epithelium in cigarette smokers: observations with the scanning electron microscope. Am Rev Respir Dis 1975;111:4. 11. Marsan C, Cava E, Roujeau J, et al. Cytochemical and histochemical characterization of epithelial mucins in human bronchi. Acta Cytol 1978;22:562. 12. Spicer SS, Schulte BA, Chakrin LW. Ultrastructural and histochemical observations of respiratory epithelium and gland. Exp Lung Res 1983;4:137. 13. Tamai S. Basal cells of the human bronchiole. Acta Pathol Jpn 1983;33:125. 14. Boers JE, Ambergen AW, Thunnissen FBJM. Number and proliferation of basal and parabasal cells in normal human airway epithelium. Am J Respir Crit Care Med 1988;157:2000. 15. Evans MJ, Cox RA, Shami SG, et al. Junctional adhesion mechanisms in airway basal cells. Am J Respir Cell Mol Biol 1990;3:341. 16. Widdicombe JG, Pack RJ. The Clara cell. Eur J Respir Dis 1982;63:202. 17. Massaro GD, Singh G, Mason R, et al. Biology of the Clara cell. Am J Physiol 1994;266:L101. 18. Jorens PG, Sibille Y, Goulding NJ, et al. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995;8:1647. 19. Phelps DS, Floros J. Localization of pulmonary surfactant proteins using immunohistochemistry and tissue in situ hybridization. Exp Lung Res 1991;17:985. 20. DeWater R, Willems LNA, Van Muijen GNP, et al. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am Rev Respir Dis 1986;133:882. 21. Evans MJ, Cabral-Anderson LJ, Freeman G. Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest 1978;38:648. 22. Ito T, Nakatani Y, Nagahara N, et al. Quantitative study of pulmonary endocrine cells in anencephaly. Lung 1987;165:297. 23. Boers JE, den Brok JL, Koudstaal J, et al. Number and proliferation of neuroendocrine cells in normal human airway epithelium. Am J Respir Crit Care Med 1996;154:758. 24. Becker KL. The coming of age of a bronchial epithelial cell. Am Rev Respir Dis 1993;148:1166. 25. Watanabe H. Pathological studies of neuroendocrine cells in human embryonic and fetal lung. Light microscopical, immunohistochemical and electron microscopical approaches. Acta Pathol Jpn 1988;38:59. 26. Hance AJ. Pulmonary immune cells in health and disease. Dendritic cells and Langerhans’ cells. Eur Respir J 1993; 6:1213.
Histology and Gross Anatomy of the Respiratory Tract 27. Schon-Hegrad MA, Oliver J, McMenamin PG, et al. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991;173:1345. 28. Van Haarst JM, Verhoeven GT, de Wit HJ, et al. CD1a⫹ and CD1a⫺ accessory cells from human bronchoalveolar lavage differ in allostimulatory potential and cytokine production. Am J Respir Cell Mol Biol 1996;15:752. 29. Erle DJ, Pabst R. Intraepithelial lymphocytes in the lung. A neglected lymphocyte population. Am J Respir Cell Mol Biol 2000;22:398–400. 30. Lamb D, Lumsden A. Intraepithelial mast cells in human airway epithelium: evidence for smoking-induced changes in their frequency. Thorax 1982;37:334. 31. Mette SA, Pilewski J, Buck CA, et al. Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo. Am J Respir Cell Mol Biol 1993;8:562. 32. Evans MJ, Van Winkle LS, Fanucchi MV, Plopper CG. The attenuated fibroblast sheath of the respiratory tract epithelial–mesenchymal trophic unit. Am J Respir Cell Mol Biol 1999;21:655–7. 33. Bai A, Eidelman DH, Hogg JC, et al. Proposed nomenclature for quantifying subdivisions of the bronchial wall. J Appl Physiol 1994;77:1011. 34. Reid L. Visceral cartilage. J Anat 1976;122:349. 35. Monkhouse WS, Whimster WF. An account of the longitudinal mucosal corrugations of the human tracheo-bronchial tree, with observations on those of some animals. J Anat 1986; 122:681. 36. Hakansson CH, Mercke U, Sonesson B, et al. Functional anatomy of the musculature of the trachea. Acta Morphol Neerl Scand 1976;14:291. 37. Matsuba K, Thurlbeck WM. A morphometric study of bronchial and bronchiolar walls in children. Am Rev Respir Dis 1972; 105:908. 38. Whimster WF, Lord P, Biles B. Tracheobronchial gland profiles in four segmental airways. Am Rev Respir Dis 1984;129:985. 39. Lamb D, Reid L. Histochemical types of acidic glycoprotein produced by mucous. 40. Meyrick B, Sturgess JM, Reid L. A reconstruction of the duct system and secretory tubules of the human bronchial submucosal gland. Thorax 1969;24:729. 41. Holt PG. Development of bronchus associated lymphoid tissue (BALT) in human lung disease: a normal host defense mechanism awaiting therapeutic exploitation? Thorax 1993;48:1097. 42. Soutar CA. Distribution of plasma cells and other cells containing immunoglobulin in the respiratory tract of normal man and class of immunoglobulin contained therein. Thorax 1976;31:158. 43. Brinkman GL. The mast cell in normal bronchus and lung. J Ultrastruct Res 1968;23:115. 44. Caughey GH. Serine proteinases of mast cell and leukocyte granules. A league of their own. Am J Respir Crit Care Med 1994;150:S138. 45. Pump KK. Morphology of the acinus of the human lung. Dis Chest 1969;56:126. 46. Parker H, Horsfield K, Cumming G. Morphology of distal airways in the human lung. J Appl Physiol 1971;31:386. 47. Young CD, Moore GW, Hutchins GM. Connective tissue arrangement in respiratory airways. Anat Rec 1980;198: 245. 48. Crapo JD, Barry BE, Gehr P, et al. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982;125:332.
13
49. Bartels H. The air–blood barrier in the human lung: a freeze–fracture study. Cell Tissue Res 1979;198:269. 50. Parra SC, Burnette R, Rice HP, et al. Zonal distribution of alveolar macrophages, type II pneumocytes, and alveolar septal connective tissue gaps in adult human lungs. Am Rev Respir Dis 1986;133:908. 51. Bakewell WE, Viviano CJ, Dixon D, et al. Confocal laser scanning immunofluorescence microscopy of lamellar bodies and pulmonary surfactant protein A in isolated alveolar type II cells. Lab Invest 1991;65:87. 52. Crouch EC, Moxley MA, Longmore W. Synthesis of collagenous proteins by pulmonary type II epithelial cells. Am Rev Respir Dis 1987;135:1118. 53. Boutten A, Venembre P, Seta N, et al. Oncostatin M is a potent stimulator of ␣1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor- and interferon-␥. Am J Respir Cell Mol Biol 1998; 18:511. 54. Paine R III, Mody CH, Chavis A, et al. Alveolar-epithelial cells block lymphocyte proliferation in vitro without inhibiting activation. Am J Respir Cell Mol Biol 1991;5:221. 55. Hawgood S, Shiffer K. Structures and properties of the surfactant-associated proteins. Annu Rev Physiol 1991;53:375. 56. Weibel ER, Bachofen H. Structural design of the alveolar septum and fluid exchange. In: Fishman AP, Renkin EM, editors. Pulmonary edema. Bethesda, MD: American Physiological Society; 1979. p. 1. 57. Kapanci Y, Assimacopoulos A, Irle C, et al. “Contractile interstitial cells” in pulmonary alveolar septa: a possible regulator of ventilation/perfusion ratio? J Cell Biol 1974;60:375. 58. Pratt SA, Smith MH, Ladman AJ, et al. The ultrastructure of alveolar macrophages from human cigarette smokers and nonsmokers. Lab Invest 1971;24:331. 59. Brain JD, Sorokin SP, Godleski JJ. Quantification, origin, and fate of pulmonary macrophages. In: Brain JD, Proctor DF, Reid LM, editors. Respiratory defense mechanisms. New York: Marcel Dekker; 1977. p. 849. 60. Dehring DJ, Wismar BL. Intravascular macrophages in pulmonary capillaries of humans. Am Rev Respir Dis 1989;139: 1027. 61. Frankenberger M, Passlick B, Hofer T, et al. Immunologic characterization of normal human pleural macrophages. Am J Respir Cell Mol Biol 2000;23:419–26. 62. Fox B, Bull TB, Gut A. Mast cells in the human alveolar wall: an electron microscopic study. J Clin Pathol 1981;34: 1333. 63. Van Haarst JMW, Hoogsteden HC, De Wit HJ, et al. Dendritic cells and their precursors isolated from human bronchoalveolar lavage: immunocytologic and functional properties. Am J Respir Cell Mol Biol 1994;11:344. 64. Weibel ER, Gomez DM. Architecture of the human lung. Science 1962;137:577. 65. Angus GE, Thurlbeck WM. Number of alveoli in the human lung. J Appl Physiol 1972;32:483. 66. Weibel ER. Morphometry of the human lung. New York: Academic Press; 1963. 67. Reid L. The secondary lobule in the adult human lung, with special reference to its appearance in bronchograms. Thorax 1968;13:110. 68. Lui YM, Taylor JR, Zylak CJ. Roentgen-anatomical correlation of the individual human pulmonary acinus. Radiology 1973;109:1. 69. Takaro T, Price HP, Parra SC. Ultrastructural studies of apertures in the interalveolar septum of the adult human lung. Am Rev Respir Dis 1979;119:425. 70. Kawakami M, Takizawa T. Distribution of pores within alveoli in the human lung. J Appl Physiol 1987;63:1866.
14
Anatomy
71. Lambert MW. Accessory bronchiole–alveolar communications. J Pathol Bacteriol 1955;70:311. 72. Martin HB. Respiratory bronchioles as the pathway for collateral ventilation. J Appl Physiol 1966;21:1443. 73. Pump KK. The circulation in the peripheral parts of the human lung. Dis Chest 1966;49:119. 74. Kendall MW, Eissmann E. Scanning electron microscopic examination of human pulmonary capillaries using a latex replication method. Anat Rec 1980;196:275–83. 75. Glazier JB, Hughes JMB, Maloney JE, et al. Measurements of capillary dimensions and blood volume in rapidly frozen lungs. J Appl Physiol 1969;26:65. 76. Heath D, Smith P. The pulmonary endothelial cell. Thorax 1979;34:200. 77. Smith U, Ryan JW, Michie DD, et al. Endothelial projections as revealed by scanning electron microscopy. Science 1971;173:925. 78. Smith U, Ryan JW. Substructural features of pulmonary endothelial caveolae. Tissue Cell 1972;4:49. 79. Schneeberger EE. Structural basis for some permeability properties of the air–blood barrier. Fed Proc 1978;37:2471. 80. Yoneda K. Regional differences in the intercellular junctions of the alveolar-capillary membrane in the human lung. Am Rev Respir Dis 1982;126:893. 81. Meyrick B, Reid L. Ultrastructural findings in lung biopsy material from children with congenital heart defects. Am J Pathol 1980;101:527. 82. Nadziejko CE, Loud AV, Kikkawa Y. Effect of alveolar hypoxia on pulmonary mast cells in vivo. Am Rev Respir Dis 1989;140:743. 83. Hislop A, Reid L. Fetal and childhood development of the intrapulmonary veins in man: branching pattern and structure. Thorax 1973;28:313. 84. Schraufnagel DR, Patel KR. Sphincters in pulmonary veins: an anatomic study in rats. Am Rev Respir Dis 1990;141:721. 85. Cudkowicz L. Bronchial arterial circulation in man: normal anatomy and responses to disease. In: Moser KM, editor. Pulmonary vascular diseases. New York: Marcel Dekker; 1979. p. 111. 86. Mariassy AT, Gazeroglu H, Wanner A. Morphometry of the subepithelial circulation in sheep airways: effect of vascular congestion. Am Rev Respir Dis 1991;143:162. 87. Deffebach ME, Charan NB, Lakshminarayan S, et al. The bronchial circulation—small, but a vital attribute of the lung. Am Rev Respir Dis 1987;135:463. 88. Lauweryns JM. The blood and lymphatic microcirculation of the lung. In: Sommers SC, editor. Pulmonary pathology decennial; 1966–1975. New York: Appleton-Century-Crofts; 1975. p. 1. 89. Lauweryns JM, Baert JH. Alveolar clearance and the role of the pulmonary lymphatics. State of the art. Am Rev Respir Dis 1977;115:625.
90. Lauweryns JM. The juxta-alveolar lymphatics in the human adult lung. Histologic studies in 15 cases of drowning. Am Rev Respir Dis 1970;102:877. 91. Scfraufnagel DE. Forms of lung lymphatics: a scanning electron microscopic study of casts. Anat Rec 1992;233:547. 92. Wang N-S. Anatomy and physiology of the pleural space. Clin Chest Med 1985;6:3. 93. Mariassy AT, Wheeldon EB. The pleura: a combined light microscopic, scanning, and transmission electron microscopic study in the sheep: I. Normal pleura. Exp Lung Res 1983;4:293. 94. Andrews PM, Porter KR. The ultrastructural morphology and possible functional significance of mesothelial microvilli. Anat Rec 1973;177:409. 95. Rennard SI, Jaurand M-C, Bignan J, et al. Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 1984;130:267. 96. Hills BA. Graphite-like lubrication of mesothelium by oligolamellar pleural surfactant. J Appl Physiol 1992;73:1034. 97. Spencer H, Leof D. The innervation of the human lung. J Anat 1964;98:599. 98. Richardson JB. Nonadrenergic inhibitory innervation of the lung. Lung 1981;195:315. 99. Sant’Ambrogio G. Nervous receptors of the tracheobronchial tree. Annu Rev Physiol 1987;49:611. 100. Laitinen A. Ultrastructural organization of intraepithelial nerves in the human airway tract. Thorax 1985;40:488. 101. Sant’Ambrogio G. Information arising from the tracheobronchial tree of mammals. Physiol Rev 1982;62:531. 102. Fox B, Bull TB, Guz A. Innervation of alveolar walls in the human lung: an electron microscopic study. J Anat 1980;131:6832. 103. Amenta F, Cavallotti C, Ferrante F, et al. Cholinergic innervation of the human pulmonary circulation. Acta Anat 1983;117:58. 104. De Troyer A, Loring SH. Actions of the respiratory muscles. In: Roussos C, editor. The thorax. In: Lenfant C, editor. Lung biology in health and disease. New York: Marcel Dekker; 1995. p. 535–63. 105. De Troyer A. Mechanical role of the abdominal muscles in relation to posture. Respir Physiol 1998;53:341. 106. Supinski G, DiMarco AF, Hussein F, et al. Analysis of the contraction of series and parallel muscles working against elastic loads. Respir Physiol 1995;87:141. 107. Edwards RHT, Faulkner JA. Structure and function of the respiratory muscles. In: Roussos C, editor. The thorax. In: Lenfant C, editor. Lung biology in health and disease. New York: Marcel Dekker; 1995. p. 185–217. 108. Leak LV. Gross and ultrastructural morphologic features of the diaphragm. Am Rev Respir Dis 1979;119 Suppl:3. 109. Comtois AS, Rochester DF. Respiratory muscle blood flow. In: Roussos C, editor. The thorax. In: Lenfant C, editor. Lung biology in health and disease. New York: Marcel Dekker; 1995. p. 633–61.
CHAPTER 2
STATICS OF THE RESPIRATORY SYSTEM Edgardo D’Angelo, Joseph Milic-Emili
T
he static mechanical properties of the respiratory system and its component parts are studied by determining the corresponding volume–pressure (V–P) relationships. These relationships are usually represented as single functions, implying that pressures depend on volume alone and that the pressure across any respiratory structure is represented by a single value. Neither of these assumptions is correct since static pressures differ depending on the previous volume and time history of the respiratory system. Thus, the quasistatic V–P curves that are obtained as volume is changed in progressive steps from residual volume (RV) to total lung capacity (TLC) and back again are loops. Plastoelastic and, in most instances, viscoelastic properties of the lung and chest wall, as well as differences in the sequence of recruitment and derecruitment of lung units between inflation and deflation, are responsible for the presence of these loops. Moreover, the static pressure across the lung and chest wall varies at different sites because of the effects of gravity and because of the different shapes of these structures.1 Also, the static pressure across the respiratory system may become nonuniform under conditions involving airway closure. Nevertheless, for the sake of simplicity, the quasistatic V–P relationships will be hereafter considered as single functions.
V–P RELATIONSHIPS DURING RELAXATION RESPIRATORY SYSTEM During relaxation of the respiratory muscles, the net pressure developed by the respiratory system (Prs) results from the forces exerted by its elastic elements and equals the difference between alveolar pressure (Palv) with the airway opening closed, or mouth pressure with the glottis open, and body surface pressure (Pbs). Conversely, Prs indicates the pressure that the respiratory muscles must exert to maintain that lung volume with open airways. This applies, however, only when the shape of the respiratory system is the same whether the respiratory muscles are active or not. For a given volume, the elastic energy, and hence the elastic pressure, is minimal for the configuration occurring during relaxation and is increased whenever that configuration is changed.
The V–P curve of the relaxed respiratory system is shown in Figure 2-1. In the middle volume range, the relationship is almost linear, whereas it curves markedly above 85% and below 15% of vital capacity (VC). The tangent to the V–P curve represents the compliance of the respiratory system (Crs). The volume at Palv 0 is the resting volume of the respiratory system: during quiet breathing, it usually corresponds to the lung volume at the end of a spontaneous expiration, which is, by definition, the functional residual capacity (FRC). Measurements of lung volume and mouth pressure do not normally pose major technical problems. However, voluntary relaxation of the respiratory muscles is difficult to obtain, and there is evidence that tonic respiratory muscle activity is often present in awake subjects.2 Certainly, the quasistatic V–P relationships obtained in the paralyzed subject better reflect the elastic forces that develop in the respiratory system and its component parts. Their comparison with those in the awake subject is, however, problematic (see below).
LUNG
AND
CHEST WALL
Because the chest wall (w) and lung (L) are placed pneumatically in series, the volume changes of the chest wall (Vw) and the lung (VL) should be the same (except for shifts of blood) and equal to that of the respiratory system (Vrs), whereas, under static, relaxed conditions, Prs Palv Pw PL. It follows that the reciprocal of the compliance of the respiratory system equals the sum of the reciprocals of lung and chest wall compliance. Because Pw indicates the pressure exerted by the relaxed chest wall, it follows that when the respiratory muscles contract at fixed volumes, Palv Pw PL Pmus. The pressure exerted by the lung is the difference between alveolar and pleural surface pressure, PL Palv Ppl; that exerted by the chest wall is the difference between pleural surface and body surface pressure, Pw Ppl Pbs. Thus, during relaxation, Pw Ppl, whereas during muscle contraction at constant lung volume, Ppl Pw Pmus and Ppl Palv PL. In humans, Ppl is usually obtained from esophageal pressure measurements; the interpretation of these measures requires, however, some caution.3,4
16
Mechanics of Breathing
FIGURE 2-1 Quasistatic V–P curve of the total respiratory system during relaxation in a sitting posture, with a spirogram showing subdivisions of lung volume. The broken lines indicate the volume change due to gas compression at total lung capacity and the expansion at residual volume (RV) during relaxation against an obstruction. ERV expiratory reserve volume; IC inspiratory capacity; VC vital capacity. Adapted from Agostoni E and Hyatt R.2
FIGURE 2-2 Quasistatic V–P curves of lung (PL), chest wall (Pw), and total respiratory system (Prs) during relaxation in a sitting posture. The static forces of lung and chest wall are indicated by the arrows in the drawings. The dimensions of the arrows are not to scale; the volume corresponding to each drawing is indicated by the horizontal broken lines. VC vital capacity. Adapted from Agostoni E and Hyatt R.2
The V–P relationships of the lung and chest wall in the sitting position are shown in Figure 2-2: the former increases its curvature with increasing lung volume, whereas the opposite is true for the latter. The fall in Crs at high lung volumes is therefore mainly due to the decrease in CL, whereas at low lung volume it reflects the decreased Cw. In the tidal volume range, the V–P relationships of both the lung and chest wall are nearly linear, and CL and Cw are about the same. In the sitting posture, they amount to 4% VC per 1 cm H2O, or 0.2 L/cm H2O. In normal young subjects, the resting volume of the lung (PL 0) is close to RV, and the lung recoils inward over nearly all the VC. Hence, the resting volume of the respiratory system occurs when the inward recoil of the lung is balanced by the outward recoil of the chest wall, that is, Pw PL 0. This volume depends on posture (see below). A detailed description of the quasistatic behavior of the lung is given elsewhere in this book (see Chapter 3, “Statics of the Lung”).
RIB CAGE, DIAPHRAGM,
AND
ABDOMINAL WALL
Lung volume changes occur because of the displacement of the rib cage facing the lung (rc,L) and of the diaphragm– abdomen (di-ab). From this viewpoint, these two structures may be considered to operate in parallel: hence Pw Prc,L Pdi-ab, and Vw Vrc,L Vdi-ab. Wade5 and Agostoni and colleagues6 computed these volumes by means of geometric approaches, which, however, involve questionable assumptions. The V–P curves obtained with these procedures are shown in Figure 2-3. They indicate that (1) the volume contributed by the diaphragm–abdomen displacement is greater than that contributed by the displacement of the pulmonary part of the rib cage; (2) the volume contributed by the pulmonary part of the rib cage at FRC is about the same in the supine and erect postures, changes in FRC with posture being therefore essentially due to displacement of the diaphragm–abdomen; (3) at any given lung volume, the contribution of the pulmonary part of the rib cage is larger in the
Statics of the Respiratory System
17
FIGURE 2-3 Quasistatic V–P curves of pulmonary rib cage (upper diagrams) and abdomen–diaphragm (lower diagrams) during relaxation in sitting (left diagrams) and supine postures (right diagrams). The abdomen–diaphragm is thought to be placed in parallel with the pulmonary rib cage, that is, that facing the lung. Data on the volume contribution of the pulmonary rib cage (Vrc,L) and diaphragm (Vdi) and those on pressures of the chest wall (Pw), diaphragm (Pdi), and abdomen (Pab) are from Agostoni and Hyatt.2 The horizontal broken line indicates the volume at functional residual capacity.
supine than in the erect posture; (4) the compliance of the pulmonary part of the rib cage (Crc,L) and of the diaphragm– abdomen (Cdi-ab) decreases progressively below FRC, whereas Crc,L increases more than Cdi-ab with increasing lung volume above FRC; and (5) the V–P curve of the pulmonary part of the rib cage does not change its shape with posture, whereas that of the diaphragm–abdomen becomes markedly more concave in the erect posture, probably because of postural tonus of the abdominal muscles, and greater distortion of the abdominal wall due to the greater top-to-bottom difference in abdominal pressure in the erect than in the supine posture.7 Konno and Mead showed that partitioning of chest wall volume could be achieved without any assumptions being made when the two parallel pathways were represented by the rib cage (rc) and the abdominal wall (ab,w): hence Vw Vrc Vab,w, whereas the pressures across the two pathways are Pw and abdominal pressure (Pab), respectively.8,9 Figure 2-4 shows the V–P curves obtained with this approach. They confirm some conclusions reached with the aforementioned approach: (1) the volume of the rib cage or of its pulmonary part at FRC is nearly the same in all postures, despite different lung volumes; and (2) the relationship between the volume contributed by the two parts over the VC shifts rightward when the subject moves from the supine to the erect posture. Because of the lifting and expansion of the rib cage, Vdi-ab (Wade and Agostoni approach) is shared partly by rib cage and partly by abdominal wall displacement (Konno and Mead approach); a comparison between the volume partitioning obtained with the two approaches suggests that the fraction of the volume displaced by the diaphragm not shared by the abdominal wall is roughly 0.5 during a VC maneuver.
Mead redefined the pressure acting on the rib cage, taking into account that (1) this structure is facing both the lungs and the abdominal contents, being affected partly by Ppl and partly by Pab, and (2) the diaphragm operates in series with the rib cage, insofar as transdiaphragmatic pressure (Pdi Pw Pab) acts to move the ribs out and up.10 Hence, in Mead’s model, the pressure exerted by the passive rib cage should be given by Prc (1 f ) Pw fPab kPdi, where f is the fraction of the internal surface of the rib cage not facing the lung, and k, which includes the pertinent geometric features, is the fraction of transdiaphragmatic pressure acting on the rib cage; setting Kfk, Prc (lK) Pw KPab. When Pdi 0 and, hence, Pw Pab, as in the erect posture at or above FRC, Prc Pw, which was the primitive definition of the pressure developed by the passive rib cage. On the other hand, when Pdi ⬆ 0, as in the erect posture below FRC, or in the supine posture over most of the VC, Prc should be higher than Pw and closer to Pab the smaller the lung volume since f increases with decreasing lung volume. Indeed, it appears that Prc Pab when K1, as should be the case near RV, owing to the cranial position of the diaphragm. Unfortunately, the values of K and their dependence on lung volume are not known with precision, particularly in the supine posture. However, assuming that K changes linearly from 0.9 to 0.2 between RV and TLC, in both the standing and supine postures, it appears that, with decreasing lung volume, no progressive decrease in rib cage compliance occurs in Mead’s model, implying that the increasing stiffness of the chest wall observed below FRC is due essentially to the diaphragm, particularly in the supine posture. On the other hand, as in the previous models, there
18
Mechanics of Breathing
FIGURE 2-4 Quasistatic V–P curves of rib cage (upper diagrams) and abdominal wall (lower diagrams) during relaxation in standing (left diagrams) and supine (right diagrams) postures, according to Mead’s model of the chest wall (see text). Data on the volume contribution of the rib cage (Vrc) and abdominal wall (Vab,w) and those on pressures of the chest wall (Pw) and abdomen (Pab) are from Konno and Mead.9 The effective pressure developed by the passive rib cage (Prc) was computed with use of the equation Prc (1 K) Pw KPab, on the assumption that K varied linearly from 0.9 to 0.2 over the vital capacity range in both postures (see text). The horizontal broken line indicates the volume at functional residual capacity.
is a rightward displacement of the curve when the subject changes from the erect to the supine posture. Other models of the chest wall have been proposed in addition to those mentioned above, yet it can be shown that in all of them the same force balance equations apply for the rib cage and the abdominal compartment, respectively.11–13 Indeed, common to all models are the assumptions that (1) the rib cage and the abdominal wall can move independently, that is, Vab,w and Vrc are unique functions of Pab and Prc, respectively, thus allowing the compliance to be obtained as the ratio between the changes in compartmental volume and pressure, and (2) the relaxed rib cage and abdomen move with one degree of freedom, that is, without significant distortion. Although some results suggest that coupling between the rib cage and the abdominal wall can be ignored, it is questionable whether forces acting on small areas of the rib cage surface, such as diaphragmatic tension, should be considered to affect the rib cage motion in the same manner as those acting on relatively large fractions of the rib cage surface, such as (1 f) Pw or fPab.14,15 In fact, distortion of the relaxed rib cage should be expected to take place whenever Pw ⬆ Pab, and hence Pdi ⬆ 0, as in the supine posture or in the erect posture below FRC. Indeed, rib cage distortion occurs with contraction of the diaphragm in tetraplegic subjects, with electrophrenic stimulation both in animals and humans, and in normal subjects during voluntary and involuntary respiratory acts.16–21 In the dog, the relationships between indices of pulmonary rib cage
motion and Pw, as well as between indices of abdominal wall motion and Pab, obtained during isolated diaphragm contractions, fall close to their respective relaxation lines, thus indicating high rib cage flexibility and, hence, negligible mechanical coupling between pulmonary and abdominal rib cage compartments.17,22,23 The pattern of motion of the relaxed rib cage during immersion in seated subjects suggests that rib cage flexibility is fairly large also in humans.14 On the other hand, Ward and colleagues concluded that in human subjects, coupling between the pulmonary and abdominal rib cage should ensure transmission to the pulmonary rib cage of a substantial fraction of the force acting on the abdominal rib cage.24 These authors, however, pointed out the several theoretical and technical limitations of their approach.
EFFECTS
OF
POSTURE
As shown in Figure 2-5, the V–P curve of the lung does not change appreciably with posture, whereas that of the chest wall does, mainly because of the effect of gravity on the abdomen. Indeed, when the effect of gravity in the erect posture is simulated in the supine subject by applying negative pressure around the lower abdomen, the V–P curve of the respiratory system becomes almost equal to that in the sitting posture.16 The relaxed abdomen has been likened to a container filled with liquid, in which part of the wall is distensible.25 The level at which the abdominal pressure is equal to ambient pressure, the “zero level,” depends on the equilibrium
Statics of the Respiratory System
19
FIGURE 2-5 Pressure contributed by various parts of the respiratory system in the sitting and supine postures. The upper diagrams show the V–P relationships of the chest wall and the pressures contributed by the diaphragm and abdomen. The circles indicate the resting volume of the respiratory system. The lower diagrams show the V–P relationships of chest wall, lung, and total respiratory system. Adapted from Agostoni E and Hyatt R.2
among the elastic forces of the abdominal wall, diaphragm, rib cage, and lung and the gravitational force of the abdominal contents. The position of the zero level with respect to the lung height determines whether gravity exerts inflationary or deflationary effects on the respiratory system. At the end of a normal expiration, that is, at the resting volume of the respiratory system, the zero level of Pab is about 3 to 4 cm vertically beneath the diaphragmatic dome in the erect posture, close to the ventral and dorsal wall of the abdomen in the supine and prone postures, respectively, and midway between the two sides in the lateral decubitus.25 As a consequence, the resting volumes of both the chest wall and respiratory system decrease from the erect posture, to the lateral, prone, and supine postures. The zero level of abdominal pressure shifts, however, with lung volume, but by different degrees in the standing and horizontal postures. In erect posture, the hydrostatic pressure applied on the abdominal surface of the diaphragm is about 20 cm H2O at RV and nil at about 55% VC (the resting volume of the chest wall), whereas at higher volumes it is above atmospheric pressure. In the supine position, as in
the other horizontal postures, changes in Pab over the VC are nearly half those occurring in the upright posture, and shift of the zero level with lung volume is accordingly smaller, whereas Vab,w is larger in the erect posture. The reduced compliance of the abdominal wall in the erect posture should, in turn, be attributed to the larger average hydrostatic pressure applied to the anterior abdominal wall. In the lateral posture, the action of gravity on the abdomendiaphragm is expiratory in the lower part and inspiratory in the upper part. Because the two lungs have different sizes, the V–P relationships should therefore differ somewhat between the right and left lateral decubitus. Indeed, in anesthetized paralyzed subjects, FRC was found to be 0.24 L (2% VC) larger in the right than in the left lateral decubitus.26
EFFECTS
OF
AGING
The static behavior of the respiratory system—lungs and chest wall—changes throughout life. From young adulthood on, the VC decreases almost linearly with age, the decrease being due to an increase in the RV, as TLC remains essentially unchanged.27–29 The recoil of the lung decreases with
20
Mechanics of Breathing
age, particularly at high lung volume, whereas its resting volume increases substantially.28–31 On the other hand, the recoil of the chest wall increases and its resting volume decreases with age: hence, the V–P curve of the chest wall becomes less steep, pivoting around a point at about mid–lung volume, where its recoil remains the same.29 The increase of FRC with age is therefore mainly due to the decrease of lung recoil and is less marked than that of RV. Since in the midvolume range the compliance of the lung increases whereas that of the chest wall decreases, the compliance of the respiratory system becomes only slightly smaller with age.29
EFFECTS
OF
ANESTHESIA
AND
PARALYSIS
The most evident effect of general anesthesia in normal supine subjects is the fall in FRC: according to Rehder and Marsh, this is given by FRC10.2 0.23 age 47 weight/height, where FRC is expressed as a percentage of awake FRC and age, weight, and height are given in years, kilograms, and centimeters, respectively.32 Such a decrease occurs also in the prone posture, but not in the sitting posture, and probably in the lateral decubitus.26,33 The tonic activity of both inspiratory rib cage muscles and diaphragm has been suggested to augment the chest wall recoil in awake subjects.34–36 However, this tone is minimal in the supine position, when FRC is larger, and larger in the erect posture, when FRC is zero, and the presence of diaphragmatic tone is controversial.35,36 Perhaps tonic activity affects only the shape of the diaphragm, as recent studies have documented changes in the shape of the diaphragm not followed by any evident cephalad displacement with induction of anesthesia and paralysis.36–38 Expiratory activity that appears in abdominal muscles with anesthesia does not seem to be a major factor in lowering FRC since the latter does not decrease further with muscular paralysis.39,40 The shape of the chest wall also changes with anesthesia: the anteroposterior diameters of both the rib cage and abdomen decrease, and the transverse diameters increase, but it is unclear whether the volume of the thoracic cavity is effectively reduced because of these dimensional changes.36,41–43
Increases in intrathoracic blood volume up to 0.3 L have been reported to occur with anesthesia–paralysis.36,42 Although this might account for part of the fall in FRC, the lack of an established relationship between the increases in intrathoracic blood volume and the concurrent reductions in FRC precludes any firm conclusion concerning their impact. Figure 2-6 shows the V–P curves of the respiratory system, lung, and chest wall obtained in supine, normal subjects before and after anesthesia and after anesthesia and paralysis. They indicate that the decrease in FRC with anesthesia reflects the increase in the elastic recoil of the respiratory system that takes place at all lung volumes. This increase is independent of the depth of anesthesia, is not affected by muscle paralysis or prevented by large, repeated lung inflations, and does not change with time.40,44 Similar to the FRC changes, those changes in mechanical properties of the respiratory system also exhibit large intersubject variability, suggesting that the same factors could be responsible for both changes. The decrease in Crs is mainly due to changes in lung mechanics.40,45 Several mechanisms can lower CL, such as increased smooth muscle tone or stimulation of other contractile elements in the airways or lung parenchyma, atelectasis or small airway closure, and changes in surfactant function. It is presently impossible to tell which of these mechanisms is the main cause of the decrease in CL. Lung V–P curves on inflation from FRC are often S-shaped, a fact that could be indicative of alveolar recruitment (see Chapter 3, “Statics of the Lung”). In normal supine anesthetized paralyzed subjects, atelectasis developing at FRC is eliminated with positive end-expiratory pressure.46 Such alveolar recruitment can quantitatively account for both the increase in CL and the leftward shift of the static V–P curve of the lung observed with positive end-expiratory pressure in some normal supine anesthetized paralyzed subjects.47 However, similar changes in lung mechanics have been observed also in normal seated subjects after maintained hyperinflation and have been attributed to changes in either pulmonary blood volume or airway muscle tone.48–50 It is also still unclear whether the decrease in CL during anesthesia is
FIGURE 2-6 Mean quasistatic V–P curves of the respiratory system, lung, and chest wall from five normal subjects on deflation from airway opening pressure (Pao) of 30 cm H2O while awake, anesthetized, and anesthetized and paralyzed. Pes esophageal pressure; Ptp transpulmonary pressure; TLC total lung capacity. Adapted from Westbrook PR et al.40
Statics of the Respiratory System
primarily due to any of the mechanisms mentioned above. It has been suggested that changes in CL are, in fact, secondary to changes in chest wall function leading to volume reduction as conditions where ventilation occurs at low lung volumes are eventually associated with decreases in compliance, probably due to higher surface tension.40,51 This sequence of events contrasts, however, with the observation that in supine anesthetized paralyzed subjects, CL, although increased with positive end-expiratory pressure, remains substantially lower than that reported for awake supine subjects at comparable lung volumes.2,47 The V–P relationship of the chest wall seems to undergo only minor changes with anesthesia and paralysis in the supine posture. Static compliance in the mid-volume range is similar to that reported for awake supine subjects during relaxation, but the static V–P curve either shifts to the right or becomes less curved at low lung volumes.2,40,45,47,52 Indeed, the increase in chest wall compliance with positive end-expiratory pressure in anesthetized paralyzed subjects is only one-fourth of that occurring over the same range of lung volume during relaxation in awake supine subjects.2,47
V–P RELATIONSHIPS DURING STATIC MUSCULAR EFFORT ALVEOLAR PRESSURE Figure 2-7 shows the maximum static inspiratory and expiratory pressures exerted for 1 to 2 seconds in the lung at different volumes in the upright posture. The horizontal distance between the outer, solid curves, and the relaxation curve gives the net pressure exerted by the contraction of the respiratory muscles, represented by the broken lines. The expiratory pressures are larger when the chest is inflated, whereas the inspiratory pressures are larger when it is deflated. This behavior depends upon the mechanical advantage and the force–length relationship of the agonist muscles, besides being influenced by the mechanical features of the passive structures involved, by the action of the antagonist muscles, and by possible inhibition of the effort.
21
Indeed, the length of the expiratory muscles increases with lung volume, the opposite being true for the inspiratory muscles. The maximum inspiratory pressure exerted by children is nearly the same as that of adults at most lung volumes. This has been related to the smaller radius of curvature of the rib cage of the diaphragm and of the abdominal wall in the children.53,54 At large lung volumes, however, the maximum expiratory pressures exerted by adults are markedly greater than those of children, probably because of greater development of accessory expiratory muscles in adults. Women do not develop as high maximum pressures as men of similar age.54 Some of this difference seems to be due to the difference in strength of the accessory muscles, but use might be important as respiratory muscle strength can be increased by training.55,56 The decrease in the maximum respiratory pressures with age, their difference between sexes, and their scattering among subjects parallel those observed for the maximum strength of other groups of muscles in the body.55 Pressure swings during respiratory effort are inversely related to the compliance of the fluid that fills the respiratory system. Because of the dependence of gas compliance upon absolute pressure, differences in pressure swings may become very large if the same efforts are made at low ambient pressure. At high altitude, therefore, the V–P diagram is very much curtailed, although the actual mechanics of the chest are not changed.57
ABDOMINAL
AND
THORACIC PRESSURES
Whereas transthoracic pressure measurements give the resultant of the actions of all muscles that act simultaneously, a separation of the contributions of inspiratory and expiratory muscles may be done through transdiaphragmatic (Pdi) and transabdominal (Pab) pressure measurements. The pressures on the thoracic and abdominal sides of the diaphragm at different lung volumes during static inspiratory, expiratory, and expulsive efforts are shown in Figure 2-8. During maximum inspiratory effort, Pab remains roughly as at relaxation in
FIGURE 2-7 V–P relationships during maximum static inspiratory and expiratory efforts (Pmus Prs) and during relaxation (Prs) in the sitting posture. The broken lines indicate the net pressure contributed by muscles. Adapted from Agostoni E and Hyatt R.2
22
Mechanics of Breathing
trained subjects. Up to about 60% VC, Pdi remains almost constant as the volume increases, and then it decreases progressively. Hence, maximum Pdi (horizontal distance between solid and broken lines) is similar to maximum transthoracic pressure (horizontal distance between solid line and ordinate at zero pressure). In untrained subjects, however, Pab often increases at high lung volumes because of abdominal muscle contraction, as revealed by electromyography.58–62 In these subjects, Pdi is roughly the same at all lung volumes. During a moderate expiratory effort above resting volume, Pdi is nil as the diaphragm is relaxed. During a maximum effort, there is an abdominal–thoracic pressure difference (see Figure 2-8).63 Since at these volumes the diaphragm is not passively distended, this pressure is attributable to diaphragmatic contraction. With decreasing lung volumes, the pressure contributed by diaphragm contraction increases progressively.64 During expulsive efforts, the muscles of the abdominal wall contract more vigorously than during maximum expiratory efforts, and the diaphragm also increases its activity. Pab reaches its maximum and Ppl is smaller than during maximum expiratory efforts, suggesting that, in this instance, the action of the muscles of the abdominal wall on the rib cage is more than balanced by diaphragmatic contraction. The pressure differences between maximum expulsive and expiratory efforts decrease with lung volume, disappearing at RV. At large and mid–lung volumes, the values of Pdi are generally higher during maximum expulsive than during maximum inspiratory efforts, indicating that the diaphragm yields the largest abdominal–thoracic pressure difference when the lower ribs are pulled down and in by the contraction of the muscles of the abdominal wall.53 Indeed, the lateral diameter of the rib cage at the xiphoid level, relative to its value at the same lung volume during relaxation, is reduced by the activity of the expiratory muscles and increased by the inspiratory muscles.65 Bellemare and Bigland-Ritchie showed, with singletwitch occlusion, that the diaphragm is maximally activated during maximum expulsive efforts at end-expiration.66 When reporting a similar study, Gandevia and McKenzie concluded that the same applies to the diaphragm during
inspiratory efforts at end-expiration.67 Maximal activation of the diaphragm during maximum expulsive efforts, but not during maximum inspiratory efforts, was also shown by Hershenson and colleagues.68 Differences in Pdi between the two maneuvers seem, however, to be caused by the different length and/or shape of the contracted diaphragm, rather than by level of activation. Indeed, from fluoroscopic examination of the diaphragm during maximal diaphragmatic inspiratory efforts with or without superimposed maximum expulsive efforts, Hillman and colleagues concluded that diaphragmatic length is greater during the combined maximum efforts and that the greater length was responsible for the associated larger Pdi.69 Moreover, from the records of change in the configuration of the rib cage and abdomen, they inferred that the diaphragm is being stretched for the entire duration (3 to 5 seconds) of the combined maximum efforts and suggested that pleiometric contraction of the diaphragm provides an additional explanation for the larger Pdi during this maneuver. Similarly, Gandevia and colleagues, using digital sequential radiography, found that the diaphragm length decreased by about 20% during maximal inspiratory efforts but was essentially unchanged during maximal expulsive efforts with the glottis open.70
UPPER VOLUME EXTREME A balance between the elastic force, which rises markedly at both volume extremes, and that of the agonist muscles, which decreases at both extremes (see Figure 2-7), seems to set the upper volume limit in those subjects in whom, at the end of maximum inspiration, the abdominal muscles do not contract.71 In some subjects, however, the abdominal muscles contract at full inspiration, as shown by their marked electrical activity.59–62 Hence, in these subjects, the limit to the upper volume extreme (TLC) is set also by the contraction of the antagonist muscles. It is difficult to assess whether the decrease in the force of the agonist muscles at high lung volumes depends only on mechanical disadvantage or also on a reflex inhibition of the effort.72 Marked increases of TLC have been reported to occur during acute asthmatic attacks.73–76 Most of these results are probably due
FIGURE 2-8 Lung volume against pressure above (continuous line) and below (broken line) the diaphragmatic dome during maximum static inspiratory, expiratory, and expulsive efforts. Adapted from Agostoni E and Hyatt R.2
Statics of the Respiratory System
to technical artefacts.77–79 Those increases that do occur are, in general, caused by loss of lung recoil since increased strength of the inspiratory muscles could be demonstrated in only one subject.79 Finally, small but significant increases in TLC were found in normal subjects breathing 6% carbon dioxide; the mechanism was unclear, but since lung recoil was unaltered, changes in the chest wall were probably responsible.80
LOWER VOLUME EXTREME In normal adults, the RV is determined by a static balance between the elastic force exerted by the respiratory system and that of the respiratory muscles. The patency of most airways at RV is shown by the finding that a positive expiratory pressure rapidly applied to the respiratory system at or near RV produces a sudden expiration of a volume of air greater than that which could be squeezed from the intrathoracic airways.81 The diaphragm is contracted at RV, as shown both by the presence of electrical activity and by a Pdi that is higher than at relaxation (see Figure 2-8).64,82 The marked contraction of the diaphragm seems to be related to the simultaneous activation of the abdominal muscles rather than to a reflex because it is negligible when the lung volume is reduced to the same extent by an external force.83 In elderly humans, the static balance described above does not occur because expiration at low lung volume proceeds so slowly that it is ended by an abrupt inspiration before the expiratory flow has ceased, and, therefore, no static balance is achieved.81 In these subjects, however, the main cause of the increased RV is airway closure, which occurs over a much greater portion of the lung than in young subjects.84 Airway closure also affects the setting of RV indirectly. When airway closure involves a large fraction of the lung, the communicating lung units will have to have a lower volume to the same extent that the closed units have a higher volume. Hence, the open units reach a flowlimiting condition, thus contributing to the flow-time– limited RV of old subjects.84
REFERENCES 1. Agostoni E. Mechanics of the pleural space. Physiol Rev 1972;52:57–128. 2. Agostoni E, Hyatt R. Static behavior of the respiratory system. In: Macklem PT, Mead J, editors. Handbook of physiology. The respiratory system, mechanics of breathing. Vol. III. Bethesda, MD: American Physiological Society; 1986. p. 113–30. 3. D’Angelo E. Techniques for studying the mechanics of the pleural space. In: Otis AB, editor. Techniques in life science, part II. Vol. P415. Amsterdam: Elsevier; 1984. p. 1–32. 4. Milic-Emili J. Measurements of pressures in respiratory physiology. In: Otis AB, editor. Techniques in life science, part II. Vol. P412. Amsterdam: Elsevier; 1984. p. 1–22. 5. Wade OL. Movements of the thoracic cage and diaphragm in respiration. J Physiol (Lond) 1954;124:193–212. 6. Agostoni E, Mognoni P, Torri G, et al. Relation between changes of rib cage circumference and lung volume. J Appl Physiol 1965;20:1179–86. 7. Strohl KP, Mead J, Banzett RB, et al. Regional differences in abdominal muscle activity during various maneuvers in humans. J Appl Physiol 1981;51:1471–6.
23
8. Konno K, Mead J. Measurement of the separate volume changes of rib cage and abdomen during breathing. J Appl Physiol 1967;22:407–22. 9. Konno K, Mead J. Static volume–pressure characteristics of the rib cage and abdomen. J Appl Physiol 1968;24:544–8. 10. Mead J. Mechanics of the chest wall. In: Hutas I, Debreczeni LA, editors. Advances in physiological sciences. Vol. 10. Oxford: Pergamon Press; 1981. p. 3–11. 11. Macklem PT, Macklem DM, De Troyer A. A model of inspiratory muscle mechanics. J Appl Physiol 1983;55:547–57. 12. Hillman DR, Markos J, Finucane K. Effect of abdominal compression on maximum transdiaphragmatic pressure. J Appl Physiol 1990;68:2296–304. 13. Boynton BR, Barnas GM, Dadmun JT, et al. Mechanical coupling of the rib cage, abdomen, and diaphragm through their area of apposition. J Appl Physiol 1991;70: 1235–44. 14. Agostoni E, Gurtner G, Torri C, et al. Respiratory mechanics during submersion and negative-pressure breathing. J Appl Physiol 1966;21:251–8. 15. Deschamps C, Rodarte JR, Wilson TA. Coupling between rib cage and abdominal compartments of the relaxed chest wall. J Appl Physiol 1998;65:2265–9. 16. Zechman FW, Musgrave FS, Mains RC, et al. Respiratory mechanics and pulmonary diffusing capacity with lower body negative pressure. J Appl Physiol 1967;22:247–50. 17. D’Angelo E, Sant’Ambrogio G. Direct action of the contracting diaphragm on the rib cage in rabbits and dogs. J Appl Physiol 1974;36:715–19. 18. Danon J, Druz WS, Goldberg NB, et al. Function of isolated paced diaphragm and cervical accessory muscles in C1 quadriplegics. Am Rev Respir Dis 1979;119:909–19. 19. D’Angelo E. Cranio-caudal rib cage distortion with increasing inspiratory airflow in man. Respir Physiol 1981;44:215–37. 20. Crawford ABH, Dodd D, Engel LA. Change in rib cage shape during quiet breathing, hyperventilation and single inspirations. Respir Physiol 1983;54:197–209. 21. McCool FD, Loring SH, Mead J. Rib cage distortion during voluntary and involuntary breathing acts. J Appl Physiol 1985;58:1703–12. 22. Jiang J, Demedts M, Decramer M. Mechanical coupling of upper and lower canine rib cages and its functional significance. J Appl Physiol 1998;64:620–6. 23. D’Angelo E, Michelini S, Miserocchi G. Local motion of the chest wall during passive and active expansion. Respir Physiol 1973;19:47–59. 24. Ward ME, Ward JW, Macklem PT. Analysis of human chest wall motion using a two-compartment rib cage model. J Appl Physiol 1992;72:1338–47. 25. Duomarco JL, Rimini R. La presion intrabdominal en el hombre. Buenos Aires: El Ateneo; 1947. 26. Hedenstierna C, Bindslev L, Santesson J, et al. Airway closure in each lung of anesthetized human subjects. J Appl Physiol 1981;50:55–64. 27. Needham CB, Rogan MC, McDonald I. Normal standard for lung volumes, intrapulmonary gas mixing and maximum breathing capacity. Thorax 1954;9:313–25. 28. Pierce JA, Ebert RV. The elastic properties of the lungs in the aged. J Lab Clin Med 1958;51:63–71. 29. Turner JM, Mead J, Wohl MB. Elasticity of human lungs in relation to age. J Appl Physiol 1968;25:664–71. 30. Frank NR, Mead J, Ferris BC Jr. The mechanical behaviour of the lungs in healthy elderly persons. J Clin Invest 1957;36:1680–7. 31. Gibson CJ, Pride NB, O’Cain C, et al. Sex and age differences in pulmonary mechanics in normal nonsmoking subjects. J Appl Physiol 1976;41:20–5.
24
Mechanics of Breathing
32. Rehder K, Marsh M. Respiratory mechanics during anesthesia and mechanical ventilation. In: Macklem PT, Mead J, editors. Handbook of physiology. The respiratory system, mechanics of breathing. Vol. III. Bethesda, MD: American Physiological Society; 1986. p. 737–52. 33. Rehder K, Sittipong R, Sessler AD. The effects of thiopental– meperidine anesthesia with succinylcholine paralysis on functional residual capacity and dynamic lung compliance in normal sitting man. Anesthesiology 1972;37: 395–8. 34. Muller N, Volgyesi G, Becker L, et al. Diaphragmatic muscle tone. J Appl Physiol 1979;47:279–284. 35. Druz WS, Sharp JT. Activity of respiratory muscles in upright and recumbent humans. J Appl Physiol 1981;51:1552–61. 36. Krayer S, Rehder K, Beck KC, et al. Quantification of thoracic volumes by three-dimensional imaging. J Appl Physiol 1987;62:591–8. 37. Krayer S, Rehder K, Vettermann J, et al. Position and motion of the human diaphragm during anesthesia–paralysis. Anesthesiology 1989;70:891–8. 38. Drummond GB, Allan PL, Logan MR. Changes in diaphragmatic position in association with the induction of anaesthesia. Br J Anaesth 1986;58:1246–51. 39. Freund F, Roos A, Dodd RB. Expiratory activity of the abdominal muscles in man during general anesthesia. J Appl Physiol 1964;19:693–7. 40. Westbrook PR, Stubbs SE, Sessler AD, et al. Effects of anesthesia and muscle paralysis on respiratory mechanics in normal man. J Appl Physiol 1973;34:81–6. 41. Vellody VP, Nassery M, Dius WS, et al. Effects of body position change on thoracoabdominal motion. J Appl Physiol 1978;45:581–9. 42. Hedenstierna G, Löfström B, Lundh R. Thoracic gas volume and chest–abdomen dimensions during anesthesia and muscle paralysis. Anesthesiology 1981;55:499–506. 43. Hedenstierna G, Strandberg A, Brismar B, et al. Functional residual capacity, thoracoabdominal dimensions, and central blood volume during general anesthesia with muscle paralysis and mechanical ventilation. Anesthesiology 1985;62:247–54. 44. Rehder K, Mallow JE, Fibuch EE, et al. Effects of isoflurane anesthesia and muscle paralysis on respiratory mechanics in normal man. Anesthesiology 1974;41:477–85. 45. D’Angelo E, Robatto F, Calderini E, et al. Pulmonary and chest wall mechanics in anesthetized paralyzed humans. J Appl Physiol 1991;70:2602–10. 46. Brismar B, Hedenstierna G, Lundquist H, et al. Pulmonary densities during anesthesia with muscular relaxation—a proposal of atelectasis. Anesthesiology 1985;62:422–8. 47. D’Angelo E, Calderini E, Tavola M, et al. Effect of PEEP on respiratory mechanics in anesthetized paralyzed humans. J Appl Physiol 1992;73:1736–42. 48. Goldberg HS, Mitzner W, Adams K, et al. Effect of intrathoracic pressure on pressure–volume characteristics of the lung in man. J Appl Physiol 1975;38:411–17. 49. Hillman DR, Finucane KE. The effect of hyperinflation on lung elasticity in healthy subjects. Respir Physiol 1983;54: 295–305. 50. Duggan CJ, Castle WD, Berend N. Effects of continuous positive airway pressure breathing on lung volume and distensibility. J Appl Physiol 1990;68:1121–6. 51. Young SL, Tierney DF, Clements JA. Mechanism of compliance change in excised rat lungs at low transpulmonary pressure. J Appl Physiol 1970;29:780–5. 52. Sharp JT, Johnson FN, Goldberg NB, et al. Hysteresis and stress adaptation in the human respiratory system. J Appl Physiol 1967;23:487–97.
53. Agostoni E, Mead J. Statics of the respiratory system. In: Fenn WO, Rahn H, editors. Handbook of physiology. Respiration. Vol. I. Washington, DC: American Physiological Society; 1964. p. 387–409. 54. Cook CD, Mead J, Orzalesi MM. Static volume–pressure characteristics of the respiratory system during maximal efforts. J Appl Physiol 1964;19:1016–22. 55. Ringqvist T. The ventilatory capacity in healthy subjects. An analysis of causal factors with special reference to the respiratory forces. Scand J Clin Lab Invest Suppl 1966; 88:5–179. 56. Leith DB, Bradley M. Ventilatory muscle strength and endurance training. J Appl Physiol 1976;41:508–16. 57. Rahn H, Otis AB, Chadwick LB, et al. The pressure–volume diagram of the thorax and lung. Am J Physiol 1946; 146:161–78. 58. De Troyer A, Estenne M. Limitation of measurements of transdiaphragmatic pressure in detecting diaphragmatic weakness. Thorax 1981;36:169–74. 59. Mills JN. The nature of the limitation of maximal inspiratory and expiratory efforts. J Physiol (Lond) 1950;111:376–81. 60. Campbell EJM. An electromyographic study of the role of the abdominal muscles in breathing. J Physiol (Lond) 1952;117: 222–33. 61. Campbell EJM, Green JH. The variations in intra-abdominal pressure and the activity of the abdominal muscles during breathing; a study in man. J Physiol (Lond) 1953; 122:282–90. 62. Delhez L, Petit JM, Milic-Emili J. Influence des muscles expirateurs dans la limitation de l’inspiration. (Etude electromyographique chez l’homme.) Rev Franc Etud Clin Biol 1959;4:815–18. 63. Agostoni E, Rahn H. Abdominal and thoracic pressures at different lung volumes. J Appl Physiol 1960;15:1087–92. 64. Agostoni E, Torri G. Diaphragm contraction as a limiting factor to maximum expiration. J Appl Physiol 1962;17:427–8. 65. Agostoni E, Mognoni P. Deformation of the chest wall during breathing efforts. J Appl Physiol 1966;21:1827–32. 66. Bellemare F, Bigland-Ritchie B. Assessment of human diaphragm strength and activation using phrenic nerve stimulation. Respir Physiol 1984;58:263–77. 67. Gandevia SC, McKenzie DK. Activation of the human diaphragm during maximal static efforts. J Physiol (Lond) 1985;367:45–56. 68. Hershenson MB, Kikuchi Y, Loring SH. Relative strengths of the chest wall muscles. J Appl Physiol 1988;65:852–62. 69. Hillman DR, Markos J, Finucane KE. Effect of abdominal compression on maximum transdiaphragmatic pressure. J Appl Physiol 1990;68:2296–304. 70. Gandevia SC, Gorman RB, McKenzie DK, et al. Dynamic changes in human diaphragm length: maximal inspiratory and expulsive efforts studied with sequential radiography. J Physiol (Lond) 1992;457:167–76. 71. Mead J, Milic-Emili J, Turner JM. Factors limiting depth of a maximal inspiration in human subjects. J Appl Physiol 1963;18:295–6. 72. Agostoni E. Statics. In: Campbell EJM, Agostoni E, NewsonDavis J, editors. The respiratory muscles. Mechanics and neural control. London: Lloyd-Luke; 1970. p. 48–79. 73. Woolcock AJ, Mead J. Lung volume in exacerbations of asthma. Am J Med 1966;41:259–73. 74. Anderson SD, McBvoy JDS, Bianco S. Changes in lung volumes and airway resistance after exercise in asthmatic subjects. Am Rev Respir Dis 1972;106:30–7. 75. Freedman S, Tattersfield AE, Pride NB. Changes in lung mechanics during asthma induced by exercise. J Appl Physiol 1975;38:974–82.
Statics of the Respiratory System 76. Peress L, Sybrecht C, Macklem PT. The mechanism of increase in total lung capacity during acute asthma. Am J Med 1976;61:165–9. 77. Brown R, Ingram RH Jr, McFadden BR Jr. Problems in the plethysmographic assessment of changes in total lung capacity in asthma. Am Rev Respir Dis 1978;118:685–92. 78. Shore S, Milic-Emili J, Martin C. Reassessment of body plethysmographic technique for the measurement of thoracic gas volume in asthmatics. Am Rev Respir Dis 1982;126:515–20. 79. Stanescu DC, Rodenstein D, Cauberghs M, et al. Failure of body plethysmography in bronchial asthma. J Appl Physiol 1982;52:939–48. 80. Rodarte JR, Hyatt RB. Effect of acute exposure to CO2 on lung mechanics in normal man. Respir Physiol 1973;17:135–45.
25
81. Leith DE, Mead J. Mechanisms determining residual volume of the lungs in normal subjects. J Appl Physiol 1967;23:221–7. 82. Delhez L, Troquet J, Damoiseau J, et al. Influence des modalites d’execution des maneuvres d’expiration forcee et hyperpression thoraco-abdominale sur l’activite electrique du diaphragme. Arch Int Physiol Biochem 1964;72:76–94. 83. Agostoni E, Gurtner G, Torri C, Rahn H. Respiratory mechanics during submersion and negative-pressure breathing. J Appl Physiol 1966;21:251–8. 84. Davis C, Campbell EJM, Openshaw P, et al. Importance of airway closure in limiting maximal expiration in normal man. J Appl Physiol 1980;48:695–701.
CHAPTER 3
STATICS OF THE LUNG Joseph Milic-Emili, Edgardo D’Angelo
P
ulmonary mechanics has been reviewed extensively in the literature.1–3 Since then, however, it has been recognized that gravity plays an important role in determining the behavior of the lungs in the intact thorax. In the present account, we review first the static behavior of isolated lungs and then that of the lungs in the intact thorax. The effect of gravity on respiratory mechanics is also discussed in greater detail elsewhere in the book (see Chapter 2, “Statics of the Respiratory System” and Chapter 14, “Ventilation Distribution”). In this chapter, we focus mainly on the major determinants of the morphology of the lung volume–pressure (V–P) relationship, such as the critical closing and opening pressures of the peripheral airways and airspaces, and the concurrent derecruitment and recruitment of lung units during volume cycling. This information is presently of considerable clinical relevance because the current “open-lung strategy,” which is designed to keep the airways and alveoli open in mechanically ventilated patients, is based on the analysis of the morphology of the quasistatic V–P relationships of the lung, or its surrogate, the respiratory system.
STATIC BEHAVIOR OF THE ISOLATED LUNG
(Paw), the V–P loops become consistent, undergoing about a five-fold volume change between minimal (V0) and maximal (V30) inflation. This volume range is approximately that which a subject would achieve between residual volume (RV) and a maximal inspiratory effort to achieve total lung capacity (TLC). At the high end, the lung stiffens, presumably due to both connective tissue stiffness and increasing surface tension. With inflation to Paw ⬎30 cm H2O, volume will continue to increase, although at a relatively low rate, until the lung ruptures and leaks develop. An upper Paw limit of less than 25 cm H2O would significantly underestimate maximum physiologic volume. This would be particularly likely when lungs were being studied after atelectasis because opening of atelectatic alveoli might still be incomplete. Small volume cycles (see Figure 3-1), such as occur during tidal breathing in vivo, require small pressure changes and involve little hysteresis. When the lung is filled with saline (see Figure 3-1), there is much less recoil than with air filling because of the absence of surface forces. Figure 3-2 shows static V–P curves of a freshly excised dog lung with repeated cycling between Paw of ⫺5 and 30 cm H2O. Inspection of this figure reveals several features that will be described below. In this analysis, the absence of atelectasis is assumed.
STATIC V–P CURVES Static V–P curves of the excised lungs were first obtained in 1849 by Hutchinson, who studied two human lungs immediately postmortem.4 Since then, many such studies on the lungs of different species have been reported, but adequate data pertaining to normal human lungs are still lacking. Accordingly, the lungs of other mammals will be used for purposes of illustration. V–P relationships vary somewhat among species and are dependent on experimental parameters such as temperature and prior volume history. When these sources of variability are held constant, however, V–P relationships are highly reproducible. Typical quasistatic V–P behavior is illustrated in Figure 3-1. When starting from the completely degassed (atelectatic) state, a high transpulmonary pressure is needed to begin inflation (see Figure 3-1), the critical pressures for opening atelectatic units being in the order of 30 cm H2O. With repeated cycling between 0 and 30 cm H2O airway pressure
STATIC V–P HYSTERESIS The V–P curve during lung deflation is not the same as during lung inflation, reflecting static hysteresis. This may involve three main mechanisms: plastic behavior of tissue elements and true tissue hysteresis; surface hysteresis; and differences in the sequence of recruitment and derecruitment of lung units between inflation and deflation.5–7
RESTING LUNG VOLUME This is the volume at zero Paw, which is commonly referred to as “minimal volume” or “minimal air.” These terms are misnomers because if Paw is decreased to below zero, there is a further decrease in lung volume (see Figure 3-2). The term “resting volume of lung” (Vr,L) seems to be more appropriate. The magnitude of Vr,L varies with the animal species. During deflation, in the example in Figure 3-2, Vr,L amounts to about 16% of the volume at a transpulmonary pressure of 30 cm H2O (V30). In exsanguinated dog and cat
28
Mechanics of Breathing 100
Air
100
Lung volume (% V30)
Saline
Volume (% TLC)
D
50
V(% V30) = 106-91e(-0.1 P)
80 60 40
max.Po max.Po
20
min.Po
C B
0 A
min.Po
TGV
-10
V(% V30) = 114-459e(-0.12 P)
Minimal air
0
10
20
30
Static transpulmonary pressure (cm H2O)
0
10
20
30
Pressure (cm H2O)
FIGURE 3-1 Four inflation–deflation maneuvers in an excised rabbit lung generating characteristic V–P curves. A, Inflation from the degassed (atelectatic) state shows that transpulmonary pressures of 30 cm H2O are required before there is substantial reopening of alveoli. On deflation to 0 cm H2O, emptying is incomplete. B, Repeated cycles between 0 and 30 cm H2O show stable curves: the lung is now much more easily inflated than in (A) but still becomes relatively stiff near 30 cm H2O. C, Small volume cycles (such as in tidal breaths in vivo) occur between 3 and 8 cm H2O. D, With air replaced by saline, the lung shows much less recoil over the same volume range. Adapted from Hoppin FG et al.5
lungs, Vr,L amounts to 10 to 20% of V30, but higher values have been reported in humans.2,6 For example, in the study by Stigol and colleagues, Vr,L ranged between 18 and 60% V30, which suggests that these results may not represent normal behavior but have probably been influenced by the presence of stable foam in the airways.8 The variability of pulmonary blood content may also affect the “minimal volume.” In studies on excised cat lungs, Frank, repeating an earlier observation by von Basch, found that, with pulmonary vascular engorgement, Vr,L increases by a small amount.9,10 Vr,L depends, among other factors, on the previous volume history of the lungs. As shown in Figures 3-1 and 3-2, it is lower during inflation than during deflation.
TRAPPED-GAS VOLUME In older texts, where the term “minimal air” is used to define the volume of gas in the freely collapsed lung, it is stated that this gas is trapped by closure of noncartilaginous airways, the assumption being that, at zero Paw, the airways leading to all pulmonary alveoli are closed. Kleinman and colleagues were the first to point out that at Vr,L some airways must remain patent throughout their length.11 In fact, when Paw is decreased to below zero, there is a further decrease in lung volume (see Figure 3-2). When a critical Paw of about ⫺3 to ⫺5 cm H2O is reached, however, expulsion of gas from the lung ceases, suggesting that all pulmonary pathways are now closed.6 The volume of gas
FIGURE 3-2 Quasistatic V–P curves obtained with a freshly excised dog lung. Lung gas volume is expressed as a percentage of the volume at a transpulmonary pressure of 30 cm H2O (% V30). Filled and open circles: exponential relationships during lung deflation and inflation, respectively. Pc ⫽ maximum airway closing pressure; Po ⫽ maximum airway opening pressure; TGV ⫽ trapped gas volume. In excised lung preparations, airway pressure corresponds to transpulmonary pressure. Adapted from Glaister DH et al.6
trapped behind the closed airways is generally referred to as trapped-gas volume (TGV). Hughes and colleagues demonstrated that it was the terminal bronchioles that closed.12
AIRWAY CLOSING PRESSURE The critical transpulmonary pressure (PL) at which lung emptying ceases has been termed the minimum airway closing pressure (Pc,min). Since some airways begin to close at PL values higher than Pc,min, the term maximum airway closing pressure (Pc,max) should refer to the PL at which airway closure begins during deflation.6 In excised dog lungs, Pc,min is in the order of ⫺2.5 cm H2O, whereas in excised “normal” human lungs, it is close to zero.6,8 In openchest rabbits, cats, and dogs, Pc,min ranges between ⫺1 and ⫺2 cm H2O.13 Less information is available with regard to Pc,max. Some inferences can, however, be drawn from the analysis of the shape of the static deflation V–P relationships of the lung.
EXPONENTIAL CHARACTER
OF
V–P CURVES
As shown in Figure 3-2, in the volume range between V30 and about 20% V30, the relationship between volume and pressure during deflation can be described with good approximation by the following exponential function: V ⫽ Vmax ⫺ b · e⫺KPL
(3-1)
where Vmax is the predicted volume at infinite PL, PL is static transpulmonary pressure, K is a constant, and b is the difference between Vmax and the predicted lung volume at zero PL.6 Thus, above 20% of V30, the static deflation V–P curve is of exponential character, as defined by Equation 3-1. Such a function has also been shown to fit in vivo V–P relationships in humans.14 The nonlinearity of the V–P curves makes it difficult to use accepted terms such as compliance, which presuppose a linear system. Instead, we may use Equation 3-1 to describe a curve above the inflection
Statics of the Lung
point, and, in particular, we may consider the constant K to be an index of the compliance of the lung or lobe. At volumes lower than 20% of V30, the experimental relationship during lung deflation deviates to the left of the exponential function as a result of progressive airway closure, beginning at the point where the experimental curve starts to deviate from the exponential function (inflection point indicated as max Pc on the deflation V–P curve in Figure 3-2). Clearly, when the airways leading to parts of the lung close, a greater change in PL will be required to produce a given volume change, and hence the overall lung compliance will be reduced, resulting in a shift to the left of the V–P curve. If this interpretation is correct, the PL at the inflection point on the deflation curve should represent maximum Pc, and the pressure at which TGV is reached reflects the minimum Pc. In view of the complexities of the multitudinous pathways within the lung, it seems reasonable for there to be a range of Pc values rather than a unique value pertinent to all airways, the difference between maximum and minimum Pc reflecting the range of Pc inhomogeneity within the lung. Similar inhomogeneity is found within single lobes. The maximum Pc has been found to correspond to the “closing volume” measured with single-breath tests, supporting the notion that it reflects airway closure.15 The finding of negative Pc,min indicates that, at low volumes, at least some of the peripheral airways offer resistance to collapse. A full discussion of the factors stabilizing the peripheral airways can be found elsewhere.16 The closing pressures for airways are less negative than those for alveoli. Indeed, in experiments on rabbits, cats, and dogs, Cavagna and colleagues demonstrated that Pc,min for the airways amounts to ⫺1 to ⫺2 cm H2O, whereas that for the alveoli ranges between ⫺3 and ⫺6 cm H2O.13 As a result, during lung deflation, TGV is usually reached before onset of atelectasis. This is a useful functional feature because smaller values of PL are required to reopen closed airways than to reopen closed alveoli (compare curves A and B in Figure 3-1).
AIRWAY OPENING PRESSURE The PL necessary to reopen a closed airway would be expected to be greater than that required to close it because surface forces would be different under the two circumstances.16 Indeed, as shown in the example of Figure 3-2, during lung inflation from TGV there is very little volume change until a critical PL of about 10 cm H2O is reached. This pressure probably represents the minimum airway opening pressure (Po,min). As for closing pressure, different airways also appear to have a range of opening pressures. An estimate of the maximum airway opening pressure (Po,max) may be possible by analysis of the inflation V–P curves of the lung. In the range between the lung volume corresponding to Po,min (about 10 cm H2O of PL) and about 36% of V30, the slope of the inflation curve increases progressively (see Figure 3-2). This phenomenon probably reflects, at least in part, progressive opening of closed airways, that is, progressive recruitment of lung units that were initially at their TGV. At lung volumes higher than about 36% of V30, the
29
relationship between volume and pressure again fits an exponential function of the type described by Equation 3-1. The point where the experimental curve joins the exponential function (inflection point on the inflation curve in Figure 3-2) probably reflects Po,max, the latter being about 5 cm H2O higher than Po,min.
ISOTROPIC BEHAVIOR
OF THE
LUNG
Isotropic behavior implies that all parts of the lung fill or empty proportionately.2 In studies on excised dog lobes, Frank has shown that there is a small difference in the static V–P relationships between the upper and lower lobes but not between the right and left upper lobes or the right and left lower lobes.17 This has also been demonstrated in dogs and rabbits, but not in humans.18–20 However, some indirect evidence suggests that in humans there may also be differences similar to those observed in dogs and rabbits.21 Morphometric studies in isolated lungs of various species have shown that the alveoli expand relatively uniformly over most of the V–P curve, in the sense that all undergo a proportional increase in size and that this increase is equal in all directions.22–25 In experiments on excised dog lungs, Hughes and colleagues found that during lung inflation and deflation the percentage changes of bronchial length and diameter for airways of different sizes were approximately the same and that changes in length, and in many cases of diameter, were reasonably well correlated with changes in the cube root of absolute lung volume.26 All of these findings are consistent with the notion that in the absence of airspace or airway closure, the isolated lungs or lobes expand relatively uniformly. However, studies with radioactive xenon have shown that at times there may be substantial differences in static mechanical behavior between and within lobes of dogs and monkeys.6,15 This is associated with substantial inhomogeneity in both critical opening and closing pressures.6,15 The fact that the bulk elastic properties of whole lobes are exponential when all units are ventilating implies that the individual respiratory units also have exponential properties. In this context, the inhomogeneity of opening and closing pressures is unimportant as the exponential properties are descriptive of the ventilation range beyond that where sequential opening and closing is occurring. If the units comprising a lobe have different values of K, then the lobe cannot be homogeneous and isotropic. It is not possible, however, to detect any such inhomogeneity within a lobe from its V–P curve. Such inhomogeneity may instead be detected by studying the distribution of ventilation and washout characteristics of an inspired bolus of tracer gas.27
PREVIOUS VOLUME HISTORY The effect of different inflation volumes (ie, different previous inflation volume history) on the quasistatic V–P curves of an isolated dog lung can be seen in Figure 3-3. Similar curves are obtained when studying the individual lobes.6 Figure 3-3A shows the effect of ventilating the lung between 30 cm H2O (V30) and successively lower end-deflation pressures from 20 to 2.5 cm H2O. The traces were obtained as a continuous recording through five cycles. In this pressure range, lungs
30
Mechanics of Breathing 1 2 Volume
A 100 mL
3 4
5
0
5
10
15
20
25
30
Airway pressure (cm water)
Volume
B 100 mL
1 2 3 4
Opening pressure Closing pressure
-5
0
5
10
15
20
25
30
Airway pressure (cm water)
FIGURE 3-3 Quasistatic V–P curves obtained by cycling a freshly excised dog lung between a transpulmonary pressure of 30 cm H2O and successively lower end-deflationary pressures. For clarity, this figure has been divided in two panels, curve 1 of B being the same as curve 4 of A. The maximal opening and closing pressures are indicated. Note the different scales on the abscissae in A and B. Adapted from Glaister DH et al.6
adapted in a single cycle. Figure 3-3B shows the effect of ventilating the same lung between V30 and successively reduced airway pressures from ⫹5 to ⫺5 cm H2O. So long as the preparation is cycled between V30 and volumes above Pc,max, the behavior shown in Figure 3-3A (curves l to 4) is always observed: all V–P curves have a common deflation limb, and the separate inflation limbs are fairly straight. In contrast, as soon as the end-deflationary pressure is allowed to fall below Pc,max (curve 5), the V–P characteristics are altered. The curve exhibits the classic sigmoid shape, the progressive reduction in compliance
reflecting airway closure; that is, the more units are closed, the smaller is the overall volume change for a given pressure change. In this case, the inflation curves exhibit a distinct “knee,” which may be explained by reopening of most of the units closed during deflation. The initial inflation phase below the “knee” in the curve should reflect inflation of the units still open at the end of the deflation, coupled possibly with the reopening of a relatively small number of closed units. In the vicinity of the knee, there is rapid reopening of most of the closed units. During lung deflation, the onset of airway closure (Pc,max) occurs at the same pressure and volume at all ventilation ranges (see Figure 3-3B). This suggests that the presence or absence of airway closure during ventilation can be closely gauged by relating the end-deflationary pressure to Pc,max. The progressive decrease in compliance during the initial part of the inflation curves mimics the increasing degree of closure as the end-deflationary pressure is reduced. Interestingly, the opening pressures of all curves are approximately the same, even though the corresponding lung volumes are highly sensitive to the ventilation range. The increase in volume between inflation curves 1 to 4 in Figure 3-3B probably mainly reflects a progressively greater number of units with open airways as the end-deflationary pressure is increased from Pc,min to Pc,max. The pattern of opening of units can also be seen in Figure 3-4, which depicts V–P loops as the dog lung in Figure 3-3 is cycled between TGV and successively higher end-inflation volumes. Between ⫺5 and ⫹12 cm H2O, there is virtually no hysteresis and the compliance is constant because virtually all units are closed and we are simply observing the compliance of the airways between the trachea and the site of closure. As the inflation range is increased to ⫹20 cm H2O, just above the knee on the curve, there is a change in behavior. The first inflation is curve 2a, and deflation is along curve 2. During subsequent inflations, the steady-state curve 2b is attained. The deflation limb of the cycle does not alter during this period. We can attribute this behavior to the changing pattern of opening of units. During the first cycle, all units tend to resist opening until a pressure of about 17 cm H2O, and then, at the knee of curve 2a, massive opening occurs. During deflation, units initially decrease in volume, with a few closing; massive closure then occurs below the inflection point. During subsequent inflations, there is a much greater distribution of opening pressures, and hence the knee is less sharply defined. Similarly, the first inflation to 25 cm H2O (curve 3a) exhibits a sharp knee just above the previous highest inflation pressure as units not hitherto opened are opened up, but again, on repeated inflation to the same pressure (curve 3b), these units open more readily, and the sharp knee is smoothed out. A further increase in inflation pressure to 30 cm H2O (curves 4a and 4b) shows the same features, suggesting that the airways subtending some units were still closed at an inflation pressure of 25 cm H2O. This, however, may also reflect recruitment of atelectatic alveoli (microatelectasis), which could not be visually detected on the lung surface of the excised lung.
Volume
Statics of the Lung
100 mL
4b 4a
4
3 3b 3a
2
2a 2b
1a and b –5
0
5
10
15
20
25
30
Airway pressure (cm water)
FIGURE 3-4 Quasistatic V–P curves obtained by cycling the same excised dog lung as in Figure 3-3 between a transpulmonary pressure of ⫺5 cm H2O and successively higher end-inflationary pressures. Adapted from Glaister DH et al.6
The “knee” on the inflation curve of the lung (see Figures 3-3 and 3-4) has been commonly termed “lower inflection point.” This, however, is a misnomer because an inflection point is said to occur where the slope of a curve changes direction (from increasing to decreasing or vice versa). Thus, in reality, the “knee” reflects the point on the inflation V–P curve where the rate of change in the slope dV/dPL is highest, as a result of substantial but not complete airway opening. In studies on mechanically ventilated patients, it has often been assumed that the “knee” reflects reopening of atelectatic alveoli, whereas in reality it reflects reopening of closed airways. For reopening, atelectatic alveoli transpulmonary pressures of the order of 30 cm H2O are required (see Figure 3-1, curve A).
PROLONGED VOLUME CYCLING As long as cycling occurs at volumes above Pc,max, the lung adopts, in a single cycle, a new consistent configuration of the V–P curve when the inflation volume is changed (see Figure 3-1, curves A and B). In experiments on open-chest dogs and rabbits, ventilated with physiologic tidal volumes and positive end-expiratory pressure (PEEP) above Pc,max, it has been shown that such consistency is maintained also during prolonged volume cycling (up to 4 h).28–30 In fact, under these conditions, there were no changes in lung statics or dynamics. In contrast, when PEEP was reduced below Pc,max there was a significant time-dependent increase in lung elastance, airway resistance, and tissue resistance, which can be attributed to concurrent peripheral airway closure and increase in surface forces.29,30 After 3 to 4 hours of such lowvolume ventilation, both lung elastance and tissue resistance could be returned to the initial control values by administration of three to five full lung inflations followed by mechanical ventilation with PEEP. In contrast, airway
31
resistance remained high, and there was histologic evidence of injury in respiratory and membranous bronchioles, characterized by epithelial necrosis and sloughing.30 Thus, mechanical ventilation of normal open-chest rabbits at low lung volume (zero end-expiratory pressure), which entails cyclic airway reopening and closure, may result in damage to the noncartilaginous airways and a concurrent increase in airway resistance. Such a phenomenon has been previously shown after low-volume ventilation in both an ex vivo model of lavaged rat lung and in closed-chest rabbits with surfactant-depleted lungs.31,32 The latter results, which were obtained with abnormal lungs, have been used to explain the low-volume injury that may occur in patients with the adult respiratory distress syndrome during mechanical ventilation without PEEP.33 In this connection, it is tempting to speculate that bronchiolar injury may also occur in other diseases characterized by the presence of peripheral airway closure during tidal breathing, such as chonic obstructive pulmonary disease (COPD) and obesity (see Chapter 58, “Spirometric Predictions of Exercise Limitation in Patients with Chronic Obstructive Pulmonary Disease”). Persistent cyclic bronchiolar reopening and closure may, in fact, eventually lead to destruction of the peripheral airways, manifested by centrilobular emphysema in COPD, and by the unexplained increase of airway resistance reported in some obese subjects.34 Low-volume breathing also affects the distribution of ventilation and gas exchange within the lung (see Chapter 2, “Statics of the Respiratory System”).
NATURE
OF
LUNG HYSTERESIS
In the absence of airway closure (see Figure 3-3A, curves 1 to 4), the hysteresis exhibited by the V–P loops reflects surface phenomena, plastic behavior of tissue elements, and true tissue hysteresis.5–7 In the presence of airway closure, the hysteresis becomes much more pronounced (see Figure 3-3B) and may involve considerable work during lung inflation that is not recovered during lung deflation. On deflation, peripheral airways are c1osed with a liquid plug as a result of the surface tension forces operating on the liquid lining of the bronchioles. These airways will only open again on inflation at a considerably higher transmural pressure than that at which closure occurred. As each unit opens, it inflates rapidly to the volume it would have achieved had it been open from the start; thereafter, it inflates normally. In this way, the shape of the V–P curve is determined by the sequence of opening and closing of units superimposed on normal elastic stress–strain relationships. This model may be modified by the presence of collateral ventilation. Airway closure may occur but be undetected in the V–P curve, so long as collateral channels remain open. This is because the distal units would be in indirect communication with central airways and other patent lung units. Thus, closing pressures as estimated may reflect both collateral and primary airway closure. A similar situation will potentially occur on inflation. In the absence of collateral ventilation, atelectasis could only be obtained in situ by absorption of alveolar gas (after a period of oxygen breathing) into the bloodstream. This is
32
Mechanics of Breathing
because, in normal lung, Pc,min is lower for the alveoli than for the peripheral airways (see above). Collateral ventilation, however, offers another route for gas to reach the alveoli with closed airways.
STATIC BEHAVIOR OF THE LUNG IN SITU In the absence of airspace or airway closure, the isolated lungs or lobes expand relatively uniformly35; this is not the case when the lungs are inside the thorax.18,19,25,36 This different behavior can probably be accounted for by the fact that, whereas in excised preparations the pleural surface pressure (Ppl) is uniform, this is not the case in the intact thorax. Indeed, it is well recognized that, in situ, the pleural surface pressure is not uniform but that there is a vertical gradient in Ppl, with the more negative values at the upper parts. As a result of this gradient, the static transpulmonary pressure (PL), that is, the difference between the static alveolar pressure (Palv) and Ppl, is greater in upper lung zones, and consequently the upper lung units are normally more expanded than those in the lower zones. The effects of the vertical gradient of PL on regional ventilation distribution and on regional gas exchange are described elsewhere in the book (see Chapter 14, “Ventilation Distribution”). Here we briefly consider the implications of airway closure on conventional measurements of the static V–P properties of the lung in humans. Figure 3-5 shows the static V–P curves of a normal subject measured in situ using the esophageal balloon technique.35 As in Figure 3-2, the exponential V–P relationships during lung deflation and inflation are also found at
Volume (% TLC or % TLCr)
100
REFERENCES
80 60 FRC 40 RV
20 0 -5
high lung volumes. However, maximal Pc occurs at a higher volume (~50% TLC) than in the isolated lung (~20% V30) because of the vertical gradient in pleural surface pressure. Furthermore, with an intact thorax, some of the airways remain patent even at full expiration. Thus, in situ, the morphology of the static V–P curves of the lung is markedly altered by the pleural pressure gradient.15,36 It should be noted, however, that in situ artifacts in esophageal pressure measurements probably also affect the measured V–P curves of the lung, particularly in the supine position.15,37 The effect of the Ppl gradient on lung mechanics has also been extensively described by Glaister and colleagues in excised dog and monkey lungs and lobes subjected to an artificial “normal” gradient in pleural surface pressure.15 This study also showed that, under these conditions, the differences between minimal and maximal values of closing and opening pressures are much greater than in the absence of the gradient. In conclusion, from the clinical standpoint, peripheral airway closure is one of the most important hallmarks of pulmonary statics. In fact, when the static end-expiratory transpulmonary pressure is lower than Pc,max, there are the following effects: (1) gas trapping, characterized by a “knee” on the static lung inflation V–P curve and an inflection point (Pc,max) on the deflation curve; (2) increased hysteresis with a concomitant increase in hysteresis-related work (as reflected by increased hysteresis area); (3) time-related changes in respiratory mechanics; (4) cyclic reopening and closure of peripheral airways, with a risk of bronchiolar injury; and (5) maldistribution of ventilation and impaired gas exchange with the lung. Accordingly, assessment of pulmonary statics is important, particularly during mechanical ventilation.
0
5
10
15
20
25
30
35
40
Transpulmonary pressure (cm H2O)
FIGURE 3-5 Quasistatic pulmonary V–P curves of a normal, seated subject. Lung gas volume is expressed as a percentage of total lung capacity (%TLC) and regional total lung capacity (%TLCr). Broken lines represent experimental relationships derived from measurements of esophageal pressure. Solid lines represent relationships that should be obtained in the absence of the vertical gradient in transpulmonary pressure due to gravity. It is assumed that in the absence of such a gradient, small airway closure would not occur even at residual volume (RV). FRC ⫽ functional residual capacity. The points at which the experimental relationships during deflation and inflation deviate from the corresponding exponential curves indicate the maximal closing (Pc,max) and opening (Po,max) pressures. Adapted from Sutherland PW et al.36
1. Mead J. Mechanical properties of lungs. Physiol Rev 1961;41:281–330. 2. Radford EP Jr. Static mechanical properties of mammalian lungs. In: Fenn WO, Rahn H, editors. Handbook of physiology. Respiration. Vol. I. Washington, DC: American Physiological Society; 1964. p. 429–49. 3. Clements JA, Tierney DF. Alveolar instability associated with altered surface tension. In: Fenn WO, Rahn H, editors. Handbook of physiology. Respiration. Vol. II. Washington, DC: American Physiological Society; 1964. p. 1565–83. 4. Hutchinson J. Thorax. In: Todd RB, editor. Encyclopaedia of anatomy and physiology 4. London: Longmans; 1849–1852. p. 1059. 5. Hoppin FG Jr, Stothert JC Jr, Greaves IA, et al. Lung recoil: elastic and rheological properties. In: Macklem P, Mead J, editors. Handbook of physiology: the respiratory system. Vol. III, Part I. Bethesda, MD: American Physiological Society; 1986. p. 195–215. 6. Glaister DH, Schroter RC, Sudlow MF, et al. Bulk elastic properties of excised lungs and the effect of transpulmonary pressure gradient. Respir Physiol 1973;17:347–64. 7. Hoppin FG. Sources of lung recoil. In: Milic-Emili J, editor. Respiratory mechanics. Respir Monogr 1999;12:33–53. 8. Stigol LC, Vawter GF, Mead J. Studies on the elastic recoil of the lung in pediatric population. Am Rev Respir Dis 1972;105:552–63.
Statics of the Lung 9. Frank NR. Influence of acute pulmonary congestion on recoiling force of excised cat’s lung. J Appl Physiol 1959; 14:905–8. 10. von Basch S. Ueber eine Function des Capillardruckes in den Lungen alveoli. Wien Med Blatter 1887;10:465–7. 11. Kleinman LE, Poulos DA, Siebens AA. Minimal air in dogs. J Appl Physiol 1964;19:204–6. 12. Hughes JMB, Rosenzweig DY, Kivitz PB. Site of airway closure in excised dog lungs: histologic demonstration. J Appl Physiol 1970;29:340–4. 13. Cavagna GA, Stemmler EJ, DuBois AB. Alveolar resistance to atelectasis. J Appl Physiol 1967;22:441–52. 14. Milic-Emili J, Henderson JAM, Dolovich MB, et al. Regional distribution of inspired gas in the lung. J Appl Physiol 1966;21:749–59. 15. Glaister DH, Schroter RC, Sudlow MF, et al. Transpulmonary pressure gradient and ventilation distribution in excised lungs. Respir Physiol 1973;17:365–85. 16. Macklem PT, Proctor DF, Hogg JC. The stability of peripheral airways. Respir Physiol 1969;8:191–203. 17. Frank NR. A comparison of static volume–pressure relations of excised pulmonary lobes of dogs. J Appl Physiol 1963; 18:274–8. 18. Faridy EE, Kidd R, Milic-Emili J. Topographical distribution of inspired gas in excised lobes of dogs. J Appl Physiol 1967; 22:760–6. 19. D’Angelo E. Local alveolar size and transpulmonary pressure in situ and in isolated lungs. Respir Physiol 1972;14: 251–66. 20. Berend N, Shoog C, Thrulbeck WM. Exponential analysis of lobar pressure–volume characteristics. Thorax 1981;36:452–5. 21. Bake B, Bjure J, Grimby G, et al. Regional distribution of inspired gas in supine man. Scand J Respir Dis 1967;48: 189–96. 22. Dunnill MS. Effect of lung inflation on alveolar surface area in the dog. Nature 1967;214:1013–4. 23. Forrest JB. The effect of changes in lung volume on the size and shape of alveoli. J Physiol (Lond) 1970;210: 533–47. 24. Kuno K, Staub NC. Acute mechanical effects of lung volume changes on artificial microholes in alveolar walls. J Appl Physiol 1968;24:83–92.
33
25. D’Angelo E. Stress–strain relationships during uniform and non-uniform expansion of isolated lungs. Respir Physiol 1975;23:87–108. 26. Hughes JMB, Hoppin FG Jr, Mead J. Effect of lung inflation on bronchial length and diameter in excised lungs. J Appl Physiol 1972;32:25–35. 27. Anthonisen NR. Closing volume. In: West JB, editor. Regional differences in the lung. New York: Academic Press; 1977. p. 451–82. 28. Dechman G, Lauzon AM, Bates JHT. Mechanical behaviour of canine respiratory system at very low lung volumes. Respir Physiol 1994;95:119–39. 29. Taskar V, Evander JJ, Wollmer P, et al. Healthy lungs tolerate repetitive collapse and reexpansion. Acta Anaesthesiol Scand 1995;39:370–6. 30. D’Angelo E, Pecchiari M, Baraggia P, et al. Low volume ventilation induces peripheral airway injury and increased airway resistance in normal open-chest rabbits. J Appl Physiol 2002;92:949–56. 31. Muscedere JG, Mullen JBM, Gan K, et al. Tidal ventilation at low airway pressure can augment lung injury. Am J Respir Crit Care Med 1994;149:1327–34. 32. Taskar V, Evander JJ, Robertson B, et al. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med 1997;155:313–20. 33. Koutsoukou A, Bekos B, Sotiropoulou C, et al. Effects of positive end-expiratory pressure on gas exchange and expiratory flow limitation in adult respiratory distress syndrome. Crit Care Med 2002;30:1941–9. 34. Yap JCH, Watson RA, Gilbey S, Pride NB. Effects of posture on respiratory mechanics in obesity. J Appl Physiol 1995; 79:1199–205. 35. Katsura T, Rosenzwaig R, Sutherland PW, et al. Effect of external support on regional alveolar expansion in excised dog lungs. J Appl Physiol 1970;25:133–7. 36. Sutherland PW, Katsura T, Milic-Emili J. Previous volume history of the lung and regional distribution of gas. J Appl Physiol 1968;25:566–74. 37. Milic-Emili J, Mead J, Turner JM. Topography of esophageal pressure as a function of posture in man. J Appl Physiol 1964;19:212–6.
CHAPTER 4
ACT OF BREATHING: DYNAMICS Peter T. Macklem
T
he branch of mechanics that deals with motion, the forces or pressures, that produce it, and the resistances that must be overcome is called dynamics. This chapter deals with the dynamics of the lung during breathing, but it is beyond our scope to consider the dynamics of the chest wall and respiratory muscles. This is addressed in part elsewhere in this book (see Chapter 7, “Act of Breathing: The Ventilatory Pump”). A superb, timeless review of the dynamics of breathing is contained in Mead’s Physiological Review article.1 To analyze breathing dynamics, one needs to know the volume of gas inspired and expired at the mouth, the flow rates, and the pressures required to move the lungs. With this information, one can calculate the resistances to motion of the lungs. In health, under most circumstances, there are three types of resistance: (1) the resistance to the flow of air along the upper airway and the tracheobronchial tree between the mouth and the alveoli, determined by the physical properties of the gas, how fast the gas is flowing, and the geometry of the airways; (2) the elastic resistance of the alveoli, which is determined by the size of the breath, the elastic properties of the alveolar walls, and the surface tension of the alveolar lining liquid; and (3) the resistance due to tissue viscance. The last is also a property of the alveolar walls and results from the fact that the lung exhibits hysteresis, so that the pressures required to inflate the lung are greater than those at the same volume on deflation. When breathing is very rapid, the lung’s inertial properties may lead to additional resistance to motion. Inertance depends primarily on the mass of gas in the airways and how quickly the gas is accelerated and decelerated, given by the rate of change of airflow at the mouth. Finally, in certain disease states, the respiratory muscles, which produce the pressures required to inflate the lung, must overcome a “threshold” load that is similar in effect to the inertial loads that skeletal muscles must overcome when lifting an object. These muscles initially contract isometrically and develop a force equal to the weight of the object being lifted before any motion of the object takes place. Similarly, when the respiratory muscles have to overcome a threshold load, they must develop a finite pressure before any inspiratory flow starts.
THEORY EQUATION
OF
MOTION
OF THE
LUNG
The pressure difference across the lung between the mouth or airway opening and the pleural space, or transpulmonary pressure (PL), is the agency that moves the lung: PL Pao Ppl
(4-1)
where Ppl is pleural pressure and Pao is the pressure at the airway opening. The alveoli lie between the airway opening and the pleural space, and they have a pressure inside them (PA) that may be different from either Pao or Ppl. Thus: PL Pao PA PA Ppl
(4-2)
Pao PA is the pressure drop across the airways and thus is the pressure producing flow of air in and out of the lung. This is the pressure that overcomes the flow resistance of the upper airway and tracheobronchial tree (Pfr): Pfr* Pao PA
(4-3)
PA Ppl is the pressure difference between the alveoli and the pleural space, which contains tissue viscance and the elastic recoil pressure of the lung (Pel). Ignoring tissue viscance for the time being: Pel PA Ppl
(4-4)
Substituting in Equation 4-2: PL Pfr Pel
(4-5)
This is illustrated in Figure 4-1. Pfr is in phase with flow, whereas, when tidal volumes are small and hysteresis can be neglected, Pel is in phase with volume. The relationships between flow, volume, Pfr, Pel, and PL are shown in Figure 4-2. If one considers that one complete respiratory cycle constitutes 360° (like a circle), then one observes that flow is one-quarter of a cycle or 90° ahead of volume. Similarly, Pfr, which is in phase with flow, is 90° ahead of Pel, which is
*During spontaneous inspiration, this pressure is positive and alveolar pressure is negative, whereas during expiration, it is negative and alveolar pressure is positive.
36
Mechanics of Breathing
+ Inspiration Airway opening
Pao
Airways
Pleural space
Alveoli
Pfr
PA
Pel
Ppl
FIGURE 4-1 Simple one-compartment model of the lung in which the upper airway and tracheobronchial tree are represented by a single tube and the parenchyma by a single alveolus. The pressure producing flow (Pfr) is the difference between the pressure at the airway opening and the pressure in the alveoli (Pao PA). The elastic recoil pressure (Pel) is the pressure difference between PA and the pressure in the pleural space (PA Ppl).
0
Flow
Time
Expiration –
Volume
VT
+ Pfr = Pao - PA –
in phase with volume. The bottom panel of Figure 4-2 shows how PL can be calculated as the sum of Pel and Pfr, where Pfr is the hatched area between PL and Pel. Each of the variables flow (V), volume (V), Pfr, Pel, and PL has both a magnitude (its size) and a phase (when it occurs). It can be seen that the phase of PL lags behind that of V and Pfr but leads V and Pel. I will show that the phase and magnitude of PL in relation to the other variables depend, upon the lungs’ elastic, flow-resistive, and inertial properties, tidal volume (VT), V, and respiratory rate (fB). To have the phase and magnitude of a single variable depend on so many other variables may sound complicated. In reality, as will be seen, it is quite straightforward with the use of vector analysis. By definition, the resistance to flow of air into and out of the lung, airway resistance (Raw), is given by Pfr/V and: Pfr RawV
(4-6)
The elastic properties of the lung are characterized in part by lung compliance (CL): CL VT/Pel†
Pel PL = Pao - Ppl
Pfr
PL
FIGURE 4-2 Relationships between flow, Pfr, Pel, and the pressure difference across the lung, transpulmonary pressure (PL). Pfr is in phase with flow; Pel is in phase with volume; and PL is the sum of Pfr and Pel, and its phase is between that of Pfr and Pel. At zero flow points at the beginning and end of a breath, Pfr 0 and Pel PL. VT tidal volume; other symbols as in Figure 4-1.
PL VT/CL Raw · · j · VT
Equation 4-5 can be rewritten: (4-8)
Substituting for Pfr and Pel: PL VT/CL RawV
PL
phase. The quantity 2fB is denoted by the Greek letter omega. Thus:
Pel VT/CL PL Pfr Pel
Pel
(4-7)
and
‡
Pel = PA - Ppl
(4-9)
If breathing is quasisinusoidal, VT and fB must obviously determine V. This is given by the formula V 2fB · j · VT, where j √1 and is used to indicate V and V are 90° out of † Every lung volume has its particular values of P , depending on el
lung volume history (Chapter 3, “Statics of the Lung”). Here I am referring exclusively to the change in Pel over the tidal volume range, not absolute Pel; hence the use of the delta symbol. ‡ P and V both cycle in phase around zero, and therefore no fr delta sign is required.
(4-10)
For most purposes, Equations 4-9 and 4-10 can be used as equations of motion of the lung. Equation 4-10 can be used when breathing is nearly sinusoidal, and Equation 4-9 when it is not. However, at fB 1.5 Hz, the lung’s inertial properties come into play. Lung inertance (IL) depends upon the rate of change of flow or acceleration (V ). Again, if breathing is quasisinusoidal: V j · · V j2 · 2 · VT 2 · VT because (√1)2 1 This is illustrated in Figure 4-3. As V passes through zero, V is maximal; when V is maximal and for a brief instant it is not changing, V is zero. It can be seen that VL and V are 180° out of phase. The inertial pressure (Pin) is in phase with
Act of Breathing: Dynamics Y +
+ Inspiration Flow
37
VL, Pel
0 Time
Expiration
–
X V ¢, Pfr Volume
Acceleration
V ≤, Pin –
0
FIGURE 4-5 Determination of the phase relationships between lung volume (VL), Pel, flow (V), Pfr, acceleration (V ), and inertial pressure (Pin). See text for further explanation. FIGURE 4-3 Phase relationships between flow, volume, and acceleration for a sinusoidal breathing pattern.
V , and therefore Pel and Pin are 180° out of phase. Thus, at breathing frequencies 1.5 Hz, Pin subtracts from Pel in the determination of PL, and the equation of motion becomes: PL VT/CL · j · Raw · VT 2ILVT or PL VT(1/CL · j · Raw 2IL)
VECTOR ANALYSIS
OF THE
EQUATION
OF
(4-11)
MOTION
Circular Motion Imagine a frictionless pendulum with a pen at the bottom producing a tracing of its motion on a strip of paper moving at right angles to the pendular motion. The tracing would be a sine wave. If the paper speed were just right, the amplitude of the pendulum could be precisely equal to the period of one complete cycle, as shown in Figure 4-4A. If the time axis or direction of the paper changed every time the pendulum reached the midpoint of its motion, so that the tracing returned to its point of origin (Figure 4-4B), the pendular motion would be described as a trajectory traveling in a counterclockwise circle. The pendulum’s amplitude would be given by the circle’s diameter and A
B
FIGURE 4-4 A, Pendular motion represented by a sine wave. B, Pendular motion represented by a circle. See text for further explanation.
its phase at any instant by its position on the 360° of the circle’s circumference. It was from this sort of analysis that we concluded that VT and Pel lag V and Pfr by 90° and that Pel and Pin are 180° out of phase. The representation of a variable undergoing sinusoidal motion by a circle in which both amplitude and phase of the variable can be determined is called vector analysis. Vectors have both amplitude and phase. If, at any instant in time, V were to be aligned with the x-axis, then Pfr, in phase with it, would also be aligned on the x-axis. Both VL and Pel, which lag V and Pfr by 90°, would be aligned along the y-axis at positive values of y, whereas V and Pin would also be aligned along the y-axis at negative values of y. This is illustrated in Figure 4-5. Determination of Phase and Amplitude of Respiratory Variables Knowing VT, fB, Raw, CL, and IL, how does one measure the phase and amplitude of Pel, Pfr, and Pin by vector analysis? Assume a VT of 0.5 L and an fB of 15/min 0.25/s, an Raw of 1.5 cm H2O/L/s, and a CL of 0.2 L/cm H2O. Then, VT 0.785 L/s, Pfr 1.178 cm H2O, and Pel 2.5 cm H2O. When these values are plotted on the vector graph with V (closed square) and Pfr (open square) on the x-axis and VT (closed circle) and Pel (open circle) on the y-axis, the results shown in Figure 4-6 are obtained. Remember that the amplitude is the diameter of the circle, not the radius. Thus, the VT intersects the ordinate at a value of 0.25 not 0.5. Study this graph carefully until it is understood. It is the key to all the vector analysis that follows. The vector sum of Pel and Pfr provides the solution for the phase and magnitude of PL (outermost circle). PL is given by the intersection of the horizontal projection of Pel with the vertical projection of Pfr (point X on the graph). Its length from the origin to point X is half of its amplitude, and its phase is
38
Mechanics of Breathing
the number of degrees by which it lags V and Pfr. Note that the magnitude of PL is greater than that of either Pel or Pfr, and for the values of VT, fB, CL and Raw chosen, the phase of PL is closer to that of Pel than of Pfr. If breathing had been extremely slow, so that fB → 0, then VT would also be small, and PL would be almost in phase with volume and would have a magnitude almost equal to Pel, as shown in Figure 4-7A (we do not need the circles any more). On the other hand, if breathing had been
very rapid, say 1 Hz, and VT small, then PL would be nearly in phase with V and almost equal in magnitude to Pfr (Figure 4-7B). The phase and magnitude of PL depend importantly on the pattern of breathing. Because the amplitude of Pel is determined in part by CL (Equation 4-7) and the amplitude of Pfr by Raw (Equation 4-6), which are independent of the pattern of breathing, the mechanical properties of the lung are also important determinants of the phase and amplitude of PL. This is illustrated in Figure 4-8. When the lungs are stiff with pulmonary fibrosis or pulmonary edema, CL is small and Pel is large. The effect on PL is similar to the effect of a large VT and small fB (Figure 4-8A). On the other hand, with airways obstruction, as in asthma or chronic obstructive pulmonary disease (COPD), Pfr is large, and the result is similar to a rapid shallow breathing pattern (Figure 4-8B). If one knows the breathing pattern, lung compliance, and airways resistance, one can calculate the phase and amplitude of transpulmonary pressure, the pressure that is moving the lung, and partition it into its two components, Pfr and Pel, due to flow resistance and lung elastic recoil, respectively. Conversely, if one measures VT, fB, and PL (the usual measurements made when assessing lung mechanics), one can calculate CL and Raw as illustrated in Figure 4-9. The measured variables, VT and fB, from which V is calculated, and the measured values of phase and amplitude of PL are plotted on the graph, from which Pel (open circle) and Pfr (closed circle) are obtained by dropping perpendiculars from PL to the y- and x-axes, respectively. Knowledge of Pel, Pfr, VT, and VT then allows calculation of lung compliance and airways resistance. In practice, this approach has been used infrequently to measure the mechanical properties of lungs, probably
FIGURE 4-7 Influence of (A) slow, deep breathing and (B) rapid, shallow breathing on the phase and magnitude of PL.
FIGURE 4-8 Vector analysis showing the effect of stiff lungs (A) and airways obstruction (B) on Pel, Pfr, and PL. When the lungs are stiff, CL is low and Pel is large. The effect on PL is similar to that of slow, deep breathing (see Figure 4-7A). Conversely, when the airways are obstructed, Raw is large and the effect on PL is similar to that of rapid, shallow breathing (see Figure 4-7B).
X 1.0
-1.0
1.0
-1.0
FIGURE 4-6 Vector analysis of the dynamics of breathing. For explanation, see text.
Act of Breathing: Dynamics
39
VT/CL 2ILVT and fB 1⁄2 (CL · IL) ⁄ . This is the resonant frequency of the lung, and it is about 6 Hz. This is the frequency at which the impedance to the flow of air is minimal. It is also the frequency at which dogs pant. 1
2
HYSTERESIVITY
V′
FIGURE 4-9 Vector analysis solving for Pel and Pfr, knowing VT, V, and PL.
because breathing is not really sinusoidal. Determination of how accurately VT predicts measured flow would show how applicable vector analysis might be in the measurement of the dynamics of breathing. Certainly, the assumption that breathing is sinusoidal has been very useful in modeling the mechanics of breathing. At breathing frequencies 1.5 Hz, inertia cannot be ignored. Consider that Pin is given by 2ILVT, whereas Pel is independent of . For a given VT, Pin increases rapidly with breathing frequency, but Pel remains constant. Because Pin is 180° out of phase with Pel and subtracts directly from Pel, the vector sum of Pel and Pin affects the phase and magnitude of PL. This is illustrated in Figure 4-10A. As Pin increases at constant Pel, PL moves closer and closer to the phase of Pfr. It is evident that, at a particular value of , Pel and Pin will be equal and opposite. The resulting vector sum of the two will be zero. Under these circumstances, Pfr is the only determinant of PL, which becomes in phase with and of equal magnitude to Pfr (Figure 4-10B), and the equation of motion reduces to PL RawVT Pfr. When this occurs,
FIGURE 4-10 A, Vector diagram illustrating the importance of inertia at high breathing frequencies. When fB is greater than 90/min, Pin cannot be ignored. Because Pel and Pin are 180° out of phase, Pin subtracts from Pel, which makes Pfr the dominant vector determining the phase and magnitude of PL. B, Vector diagram illustrating resonant frequency when Pel and Pin are equal and opposite, canceling each other out, and leaving Pfr as the only component of PL.
Until now, I have ignored the problem of the resistance due to tissue viscance or hysteresivity. When PL is measured, it is not simply Pao PA Pel. This is because PA Ppl contains a term not in phase with volume. This is most easily seen when one measures the static pressure–volume curve of the lung. At any lung volume, Pel is greater on inflation from residual volume (RV) than it is on deflation from total lung capacity (TLC). Thus, the inflation pressure–volume curve is displaced to the right of the deflation curve. The pressure difference between inflation and deflation leads volume by 90° and is therefore in phase with flow. For this reason, the resulting pressure–volume curve has been thought to result from the viscous resistance of lung tissue. However, it is not flow dependent. The phenomenon is called hysteresis, and it quantifies the difference between the energy that is the product of pressure and volume stored in the lung on inflation and that recovered during deflation. This difference is the area contained between the two pressure–volume curves or, in other words, the energy dissipated in a respiratory cycle. Although the dissipated energy is greatest for vital capacity breaths, it is still finite during quiet breathing. The hysteretic pressure is well described by the expression: P j VT/CL
(4-12)
where j is the mathematical device indicating that P is 90° out of phase with volume and is hysteresivity defined as the dimensionless ratio of the hysteretic pressure difference at mid–tidal volume to the change in elastic recoil pressure for that particular breath, as shown in Figure 4-11.2 Equation 4-12 shows that the pressure is dependent on both tidal volume and 1/CL or lung elastance, and thus it specifically couples the energy dissipated by hysteresis to the lung’s elastic properties, which reflect the stress-bearing elements. How can this be? Fredberg and Stamenovic give several examples.2 Attached crossbridges in smooth muscle make the muscle stiffer. However, if the muscle is stretched during inspiration, some crossbridges may break, thereby dissipating stored energy and leading to hysteresis, but with the breakage, the muscle becomes more compliant. When atelectatic alveoli inflate, it takes a substantial pressure to overcome the surface tension and viscosity of the liquid lining the airspaces and allow them to open. When opened, they tend to remain open, so the energy required to open them is dissipated, but once the airspaces are open, the lung becomes more compliant. A third example of dissipative and elastic coupling is via the surface-lining layer of surfactant at the alveolar air–liquid interface. On inflation, the number of surface-active molecules lining the surface film may be inadequate to cover the film over the whole increase in surface area that occurs. As a result, the surface film breaks, and molecules with a higher surface tension form the lining layer until new surface-active molecules are
40
Mechanics of Breathing
PEL
VL
Ph VT
η=Ph/∆PEL
0 PEL
FIGURE 4-11 Static Pel–VL pressure–volume loop illustrating hysteresis. Hysteresivity ( ) is the ratio of the difference in Pel at mid-VT (Ph) and the difference in Pel at zero flow points: Ph/Pel.
adsorbed onto the surface from the hypophase. Thus, elastic recoil pressures are greater on lung expansion, and it takes greater force to expand the surface. On deflation, there is an excess of surface molecules, so that, as surface area decreases, the surface film may actually resist compression, so that it buckles and the surface-active molecules are forced into the hypophase, from whence they must be subsequently recruited during the following inspiration. In these ways, one obtains insight into how elastic and dissipative properties become linked in the lung.2 In order to take hysteresivity into account, the equation of motion of the lung must be modified to: PL VT/CL j VT/CL jRawVT 2ILVT or PL VT[1/CL j( /CL Raw) 2IL]
(4-13)
To express Equation 4-12 in terms of absolute PL, one writes: PL PLo VT[1/CL j( /CL Raw) 2IL] (4-14) where PLo is the absolute transpulmonary pressure at endexpiratory volume. From Equations 4-13 and 4-14, it can be seen that tidal volume, which, along with breathing frequency, determines flow and acceleration, affects every term in the equation of motion except PLo, which, during quiet breathing, is transpulmonary pressure at functional residual capacity (FRC). There are two terms in the equation of motion that are 90° out of phase with volume. When one uses the difference between mouth and esophageal pressure to measure transpulmonary pressure, the ratio of pressure in phase with flow and flow is called pulmonary resistance. This includes
VT/CL, which has nothing to do with the resistance to flow along the airways. The error induced in estimating airways resistance from pulmonary resistance can be substantial, particularly if tidal volumes are large and compliance low.3,4 The error can become very large if one is attempting to measure the resistance of only the peripheral airways because VT/CL is large relative to RawVT.5 The error can be minimized by using small tidal volumes, which is an attractive feature of the forced oscillation technique, in which the lungs are oscillated by a loudspeaker.5,6 Furthermore, if one wishes to measure flow-resistive pressure only during inspiration or expiration, then one can avoid pressures due to hysteresis by measuring the difference between the static inflation or deflation pressures and the dynamic pressures at the same volume.5 Nevertheless, the dependence of hysteretic pressures on VT/CL means that there are substantial errors in the older literature where pulmonary resistance was used to estimate the effects on the airways of interventions such as drugs, changes in lung volume, and disease. The situation becomes further complicated in that is not assumed to be constant but could vary with tidal volume and elastance, the reciprocal of compliance.4,7 Hysteretic and flow-resistive effects have been experimentally separated in tissue strips and by the direct measurement of alveolar pressure with the use of alveolar capsules. These two methods provided results that were in agreement with each other, and the roles of tidal stretching of alveolar walls, lung volume history,8 elastance,4 and hysteresivity3 have been measured. However, care should be taken in comparing the behavior of tissue strips with lung volume changes in the former. The forces required for stretching are determined by the shear modulus, whereas the pressures required for volume change are determined by the bulk modulus. The two moduli are not the same. The results of pharmacologic experiments proved surprising. Almost every intervention that influenced airway resistance also increased hysteresis.3,8–12 In some instances, the major effects of the drug appeared to be on the lung parenchyma rather than on the airways, so that interpreting pulmonary resistance in terms of bronchoconstriction can be misleading. In tissue strips, pharmacologic agents induced changes of stiffness and also changed . However, the relationship between the two was different for different agents.4 The authors pointed out that their experiments “demonstrated the existence of distinct mechanical states that differed according to the specific agonist by which the tissues were stimulated.” In whole lungs, elastance and hysteresis were changed by changing lung volume history and by pharmacologic interventions. These alterations were separated into two distinct components, changes in and changes in elastance. Again, changes in and elastance were dissociated. With changes in volume history, elastance changed but did not, whereas with smooth muscle agonists, both changed.13 When lungs were saline filled, to eliminate the surface effects, and elastance was altered by changing lung volume, hysteresis was still tightly coupled to elastance, but
remained constant.11
Act of Breathing: Dynamics
These experiments reveal a fundamental property of lung tissue and the parenchymal air–liquid interface, namely the coupling of dissipative properties to the stress-bearing elements of the lung responsible for their elastic properties. They also point out the importance of separating airway from lung tissue properties in disease states and in pharmacologic interventions. Too often, changes in the properties of one could mask or appear to indicate artifactual changes in the other. Unfortunately, very few attempts have been made to separate airway from parenchymal dissipative properties in living human lungs. The technology exists to do such experiments: whole body plethysmography can be used to measure alveolar pressure and airways resistance, and the difference between alveolar and esophageal pressure can be used to obtain the elastic pressure–volume curve. Thus, it should be possible to investigate the coupling of dissipative and elastic properties of the parenchyma, as well as to separate airway from parenchymal effects. This needs to be done particularly when the actions of pharmacologic agents and disease states on the human lung are being evaluated.
MEASUREMENT OF LUNG MECHANICS The measurement of the mechanical properties of lungs entails the measurement of flow, volume, and pressure.14 Flow is measured with a pneumotachygraph, and frequently this is integrated to obtain volume. The measurement of flow is accurate and reasonably straightforward, although care must be taken when gas physical properties, particularly viscosity change, and when very rapid flow transients need to be accurately measured. This usually requires a mouthpiece and noseclip, and thus the measurement of flow poses a problem when a mouthpiece and noseclip are either undesirable or impossible. The same problems apply to the measurement of volume, as discussed below.
LUNG VOLUME MEASUREMENTS As mentioned above, lung volume change is frequently measured by integrating a tracing of flow at the mouth. Volumes can also be measured with a spirometer or a bagin-box system connected to the mouth. None of these is entirely satisfactory. All integrators suffer from integrator drift, so absolute changes in lung volume, such as those that occur with exercise, cannot be measured accurately. Rebreathing from a spirometer requires scrubbing of carbon dioxide and, for a stable tracing, addition of oxygen at exactly the rate at which oxygen is taken up by the pulmonary capillaries. This is not usually possible. A bag-inbox system allows one to breathe in from a bag enclosed in a box with a spirometer attached to it, and then out into the box, because the inspiratory and expiratory lines are separated by valves. This provides a stable tracing without the need to scrub carbon dioxide or add oxygen. However, the time over which volume can be measured is determined by the volume of gas contained within the bag. When this is exhausted, the measurement of volume stops. Volume displacement or variable-flow whole body plethysmographs provide accurate measurements of
41
changes in body volume that, during normal quiet breathing, closely reflect the volumes of gas breathed in and out of the mouth. However, under circumstances when there are large swings in alveolar pressure, there may be significant compression and decompression of alveolar gas. When this occurs, changes in body volume (measured by plethysmography) are greater than the volumes exchanged at the mouth. This is a very useful feature in the measurement of maximal expiratory flow–volume curves because maximal expiratory flow is determined by absolute lung volume and not merely the volume expired at the mouth.15 During a forced expiration there is substantial gas compression, so the absolute lung volume is less than the volume of gas expired at the mouth. Thus, whenever the latter is used to measure flow–volume curves, maximal expiratory flow at the measured volume is underestimated. This can lead to substantial errors in the measurement of flow–volume curves if there is marked hyperinflation and the expiratory alveolar pressures are high.16 This is usually the case in COPD, when the errors can be very large indeed.16 Although these errors are avoided when volumes are measured by whole body plethysmography, the stability of the tracings is affected by heating and humidification. Furthermore, it is obvious that whole body plethysmography cannot yet be used during exercise or easily during sleep. Surprisingly in this era of high technology, the requirement for a mouthpiece and noseclip makes it remarkably difficult to measure ventilation in such conditions as sleep, phonation, and infancy and in critically ill patients. The same considerations apply to changes in absolute lung volume during exercise, for example. This problem has resulted in attempts to measure breathing based on body surface measurements. Two of these methods, magnetometry and inductance plethysmography, depend upon the abdomen and the rib cage, each acting as compartments with a single degree of freedom.17 This is an approximation leading to significant errors (generally ignored in the literature) when breathing exceeds the rather strict limits established by Konno and Mead.17 Furthermore, calibration changes with posture. This can be dealt with in part by measuring xiphipubic distance. However, the control of posture and respiratory effort necessary for reasonably accurate measurements renders these methods of limited value. A new technology, optoelectronic plethysmography, involves placing of reflective markers over the surface of the chest wall, tracking each one in three dimensions, and then reconstructing the whole chest wall, and its compartments, to measure volume changes dynamically without mouthpiece and noseclip.18,19 It has undergone extensive evaluation and appears to be highly accurate.20 It can be used to measure ventilation in all the problem situations listed above (not yet tried in infants). It requires no assumptions with regard to the number of degrees of freedom of the rib cage and abdomen. Because it measures chest wall volume, in contrast to whole body plethysmography, which measures body volume, it is sensitive not only to gas compression and decompression but also to blood shifts from the trunk to the extremities. This new feature has been used to demonstrate substantial blood shifts during exercise with
Mechanics of Breathing
expiratory flow–limitation, when expiratory pressures can be markedly positive.21 Although this technology has great promise, it is expensive and requires advanced electronic computations that need to be made user-friendly before the method will gain widespread use. Another new noninvasive method, phonospirometry, estimates tracheal flow from tracheal breath sounds, obtained simply with a microphone placed on the neck.22 It appears to be at least as accurate as magnetometry and inductance plethysmography but less sensitive to chest wall distortions and changes in posture. Considerably more research will be necessary to determine its applicability to clinical situations such as sleep-disordered breathing and investigation of the sudden infant death syndrome.
TLC
Lung volume
42
Dynamic pressurevolume loop
FRC Static pressure-volume curve of the lung
RV
0
PRESSURE MEASUREMENTS Esophageal pressure is an accurate measure of pleural pressure (Ppl ). Esophageal pressure is equal to the pressure outside the esophagus, or Ppl if there is no pressure difference across the esophageal wall. This is generally true if the esophagus is not distended by the pressure-measuring probe. For details concerning esophageal pressure measurements, see Baydur and colleagues23 (see also Chapter 55, “Esophageal Pressure Measurement”) From the measurement of the static pressure–volume curve of the lung, which defines Pel as a function of lung volume, and the dynamic pressure–volume curve, which encircles the static curve over the tidal volume range, one can obtain an approximate measure of PA as the difference between the static and the dynamic pressures at the same lung volume as shown in Figure 4-12. An accurate measurement of PA in intact humans requires the use of whole body plethysmography. In excised lungs or open-chested experimental animals, it can be measured directly with capsules glued on the surface of the visceral pleura; the pleura contain holes, so that the capsule connects directly with the subpleural alveoli. The principle of measuring PA from whole body plethysmography is most easily understood when one considers what happens when one rebreathes while sitting inside a constant-volume box. Assuming isothermal conditions and negligible humidification of inspired air (conditions that are satisfactorily met during panting), box pressure can only change to the extent that there is compression and expansion of alveolar gas. In a constant-volume plethysmograph, compression of alveolar gas requires expansion of gas within the box and thus a fall in box pressure. In order to find how much expansion is required to explain a given change in box pressure, a calibration procedure is performed in which a known volume of gas is introduced into and removed from the box with a syringe, and the resulting pressure changes are measured. Then box pressure and pressure at the mouth are measured while the subject pants against a closed airway. From Boyle’s law, the product of box pressure and box volume change (calculated from the calibration procedure) equals the product of mouth pressure (equal to alveolar pressure because no air is flowing) and lung gas volume. The last is the only unknown. This is the basis of
10
20
30
Transpulmonary pressure (cm H2O)
FIGURE 4-12 Static pressure–volume curve of the lung with superimposed dynamic pressure–volume loop. The hatched region represents the flow-resistive and hysteretic pressures during inspiration, and the dotted region represents the same pressures during expiration. The areas of these regions quantify the net work performed on the lung by the respiratory muscles.
measurement of absolute thoracic gas volume by whole body plethysmography. However, this measurement also serves to calibrate the relationship between box pressure, PA, and the degree of alveolar gas compression and expansion. Subsequently, the subject rebreathes to and from the box by panting through a pneumotachygraph while box pressure is measured, the magnitude of alveolar gas compression and expansion is calculated, and, because absolute thoracic gas volume is known, PA is derived. The ratio between PA and the measured flow then provides Raw.
RELATIONSHIP BETWEEN LUNG MECHANICS AND VENTILATION DISTRIBUTION TIME CONSTANTS Up to this point, I have considered the lung as a single tube representing the conducting airways and a single alveolus representing the millions of gas-exchanging airspaces making up the lung parenchyma. This model cannot be applied to the distribution of ventilation to multiple airspaces arranged in parallel. Let us pose the question: what determines how fast such a lung will fill when transpulmonary pressure is increased? Imagine a step square wave increase in transpulmonary pressure PL. Neglecting inertia, at the instant this pressure is applied to the lung, Pfr will equal PL, so that: PL Pfr RawV Once the lung has completely filled, flow will cease, Pfr will equal zero, and PL will equal Pel, so that: PL Pel V/CL and RawV V/CL
Act of Breathing: Dynamics
43
Cross-multiplying: RawCL time The product of airway resistance and lung compliance has the units of time, and its value is the lung’s time constant. The time constant is the parameter that determines how rapidly a lung will fill when PL increases.24 What it states is actually rather obvious. As airway resistance increases and flow decreases at a given Pfr, it takes longer and longer to fill the lungs, and as compliance increases at a given flow, it takes longer to inflate the lung because it requires more volume to do so for a given Pel. When both increase, the effects are more than additive; they are multiplicative. However, the lungs have many parallel airspaces, each with its own compliance and flow resistance. Therefore, each parallel airspace, whether or not one is considering a single acinus, lobule, segment, or lobe, has its own time constant. If these are markedly different one from another, as occurs in some diseases, then some units will lag behind their neighbors. The fast units will fill and start to empty before the slow units have finished filling.24 Thus, part of the latter’s inspired volume will be alveolar gas that their neighbors are expiring. Furthermore, because slow units will not have the time to fill completely before they start emptying, their tidal volume will fall, so that the fast units receive a larger fraction of the total tidal volume. This situation becomes progressively worse as breathing frequency increases and the respiratory cycle time progressively decreases relative to the time constants.24 This would be an unfortunate way to breathe, and it does not normally occur. What, then, is the condition for each of the parallel airspaces to fill and empty in synchrony with all its neighbors? For this to occur at all breathing frequencies, it is necessary for all the time constants of all similar-sized parallel airspaces, large or small, to be equal.24 Such a constraint is difficult to achieve. The pathways to perihilar airspaces are much shorter than those to the base of the lung posteriorly. Owing to the gravity-determined gradient in pleural pressure, both the resistance to the flow of air and the compliance of airspaces are less in superior lung regions than in dependent ones. Presumably, the time constants of parallel airspaces are not all equal, and they do not have to be for the airspaces in the lung to fill and empty synchronously at physiologic breathing frequencies. As long as the time constants are short relative to the respiratory cycle time, there can be inequality of time constants.5 Direct measurements of intrabronchial pressure have shown that in normal lungs most of the resistance to airflow is in the large central airways, and very little resistance is offered by the peripheral airways.5,25 The resistance common to parallel airspaces, namely the central airways for airspaces distal to the peripheral airways, plays no role in generating asynchrony among these peripheral units. Thus, the pertinent resistances that make up the time constants are the resistances of the peripheral airways. Because these are small, the time constants are small, on the order of 0.02 to 0.04 seconds. These are about two orders of magnitude less
FIGURE 4-13 Two-compartment lung model illustrating collateral ventilation in the presence of complete airway obstruction to one compartment. Inspired air follows the route shown by the arrow and exchanges gas in the unobstructed airspace before entering the collaterally ventilated airspace, which receives alveolar gas. The time required to ventilate the obstructed airspace is determined by the time constant for collateral ventilation, which is the product of the resistance of the channels connecting the two compartments and the effective compliance of the collaterally ventilated space. For further explanation see text.
than the respiratory cycle times of 2 to 4 seconds at physiologic breathing frequencies, which normally range from 15/min at rest to 30/min at maximal exercise. This allows for considerable inequality among the time constants of peripheral lung units with very little asynchrony or reduction in tidal volume of the slower units. However, even if time constant inequality were sufficient to lead to asynchrony, there are two powerful influences promoting synchrony in both normal and diseased lungs: interdependence among parallel lung units26 and collateral ventilation.27
COLLATERAL VENTILATION When airways become occluded, gas can enter into the subtended airspaces via collateral channels. In excised dog lungs, collateral ventilation is extremely rapid, providing normal tidal volumes to airspaces beyond completely obstructed airways at breathing frequencies as high as 1 Hz.28 A model of this situation is shown in Figure 4-13. The time taken for gas to flow from unobstructed airspaces into obstructed ones via collateral channels is given by the time constant for collateral ventilation (Tcol), or the product of the flow resistance of the collateral channels (Rcol) and the compliance of the collaterally ventilated space (Ccol). The fact that collateral channels deliver a normal tidal volume to airspaces beyond completely obstructed airspaces at a breathing frequency of 1 Hz indicates that Tcol in excised dog lungs must be considerably less than 1 second. This has been experimentally verified.27
44
Mechanics of Breathing
One can measure Rcol by wedging a catheter in a bronchus, passing air through it at a known constant rate (Vcol), and measuring the pressure at the catheter tip.29 If the flow is suddenly turned off, the pressure decays in a quasiexponential way. In most studies there is no sudden pressure drop, indicating that the resistance between the catheter tip and the alveoli beyond is negligible at the flow rate used. Thus, the pressure producing collateral flow (Pcol) is given by the pressure difference between the catheter tip and alveolar pressure in the rest of the lung: Rcol Pcol/Vcol. The quasiexponential fall in pressure at the catheter tip when flow is suddenly switched off allows the measurement of Tcol as the time needed for the pressure to fall by 63% of its initial value. Dividing Tcol by Rcol gives Ccol. Ccol measured in this way is considerably less than predicted by the estimated amount of lung tissue beyond the obstructed airways. The explanation for this is given below. For the present, the essential message is that the low value of Ccol is one of the major reasons why Tcol is surprisingly short. The time constant for collateral ventilation depends on a variety of variables, including species, lung volume, the size of the airway obstructed,27 oxygen and carbon dioxide concentrations in the airways,30,31 surface forces,32 and airway smooth muscle tone in the collateral channels.33 The lungs of large animals such as horses cattle, and swine are completely lobulated. Because each lobule is completely separated from its neighbors by connective tissue, there is no collateral ventilation between lobules. The lungs of smaller animals such as dogs, cats, and rabbits are nonlobulated and have extensive collateral ventilation. Human lungs lie between these extremes. They are partially lobulated, so that collateral ventilation occurs between lobules but is considerably slower than in nonlobulated lungs.27 Although, so far as I am aware, no direct comparisons of Tcol have been made in lungs in living animals and excised lungs, the literature strongly suggests that Tcol is substantially longer in living lungs in situ than after they are excised. The reasons for this are not known. Tcol is highly dependent on lung distending pressure and volume, more so even than airway resistance.27,34 Furthermore, the greater the volume of lung beyond the obstructed airway, the longer is Tcol.29,35 Thus, it takes longer to collaterally ventilate a part of the lung beyond an obstructed large airway than an obstructed small airway. Presumably, this reflects the external surface area/volume ratio of the collaterally ventilated space. The surface area available for collateral ventilation should be a major determinant of Rcol because it should determine the number of parallel collateral channels entering the obstructed units. As the surface area/volume ratio increases as the volume of the space decreases, it is to be expected that Tcol will be less with small airway occlusion than with large airway occlusion. However, with increases in lung volume, the surface area/ volume ratio decreases. Thus, it seems likely that the caliber of collateral channels increases considerably more than is necessary to offset the decrease in surface area/volume ratio. The collateral channels are probably not the pores of Kohn36 but are more likely to be the canals of Lambert and alveolar ducts that extend between lobules and acini.
Evidently, they are lined with smooth muscle because Rcol is sensitive to both smooth muscle agonists and antagonists,33,34 as well as oxygen and carbon dioxide concentrations.30,31
INTERDEPENDENCE Transpulmonary pressure or the pressure difference between the mouth and pleural space is somehow transmitted to all the airspaces and airways completely surrounded by lung tissue because in healthy lungs all alveoli expand and contract in synchrony with changes in transpulmonary pressure. This pressure is transmitted deep within lung tissue by tension transmitted by stretched alveolar walls to neighboring alveoli. At the pleural surface, the pressure applied to the visceral pleura by the attached alveolar walls is the sum of the forces transmitted by each alveolar wall divided by the surface area of the pleura over which they act, that is, F/A. The same ratio defines the pressure applied to the external surface of any structure or group of structures completely surrounded by lung tissue.26 To the extent that the lung is isotropic, this ratio should be the same throughout the lung. The pressure applied at the pleural surface is counterbalanced by Ppl, which keeps the lung applied to the chest wall and diaphragm, so that F/A Ppl. Thus, if F/A equals Ppl and is the same throughout the lung, Ppl is applied to the outer surface of all intrapulmonary structures, whether they are blood vessels, airways, acini, or lobules. This appears to be very nearly true.26 However, as discussed elsewhere in this book (see Chapter 14, “Ventilation Distribution”), there is a gravity-determined gradient in Ppl. Thus, within any given horizontal slice of healthy lung tissue, all airspaces, bronchi, bronchioles, and blood vessels are distended by very nearly the same transpulmonary pressure. Any normal variation in transpulmonary pressure is essentially in the vertical direction from top to bottom. As the lung expands, both F and A increase. But because Ppl becomes more negative, F must increase more than A. Now imagine what happens if one group of airspaces becomes smaller relative to its neighbors. Under these circumstances, its surface area decreases while the alveolar walls attached to its surface are stretched: F/A increases owing both to an increase in the numerator and a decrease in the denominator. Conversely, if the airspaces expand relative to their neighbors, F decreases while A increases. The interdependence of lung parenchyma tends to conserve the size of all structures within the parenchyma by increasing or decreasing the local distending pressure to maintain the homogeneity of lung parenchyma.26,37,38
SYNCHRONY
OF
HEALTHY LUNGS
In healthy lungs, all alveoli expand and contract in near synchrony at physiologic breathing frequencies. This is known because, as discussed above, dynamic lung compliance is the same as static lung compliance and does not change with breathing frequency,24 even in the presence of moderate time constant inequalities. In the presence of more substantial time constant inequalities, the filling and emptying of units with long time
Act of Breathing: Dynamics
constants will be delayed.24 However, any delay will make these units smaller than their neighbors on inflation and larger on deflation, immediately bringing into play forces of interdependence. These forces will make the alveolar pressures in the delayed airspaces more negative on inflation and more positive on deflation than in the rest of the lung. This, in turn, will increase the flow through the airways serving the delayed spaces and create a flow across the collateral channels. The collateral flow will be determined by the difference in alveolar pressure between the normal and the delayed airspaces and the resistance to collateral flow.27,28 The increased negativity of alveolar pressure in the collaterally ventilated space due to interdependence decreases the time needed for collateral ventilation to take place and explains the decrease in measured Ccol. Interdependence acts to make the compliance of the collaterally ventilated space seem less than it really is. Thus, the low value of Ccol is really an “effective” compliance resulting from interdependence of lung tissue.27,37–39 When time constant inequalities are such that delays occur, interdependence and collateral ventilation combine to act in concert to minimize phase lags in an attempt to maintain nearly synchronous filling and emptying of all alveoli.39
EFFECTS OF AIRWAYS OBSTRUCTION ON VENTILATION DISTRIBUTION The conservative mechanisms that maintain the normal synchrony fail in disease. If the peripheral airways only comprise 10% of airways resistance or ~ 0.1 cm H2O/L/s, compared to central airways with a resistance of ~ 0.9 cm H2O/L /s, and half of them become blocked, peripheral airway resistance will double to 0.2 cm H2O/L /s. The resistance of central airways, where no structural changes have occurred, will remain the same at 0.9 cm H2O/L /s. Total resistance, which is the sum of the two, will increase from 1.0 to 1.1 cm H2O/L /s, as illustrated in Figure 4-14. This change is within the error of measurement. The obstruction is therefore difficult to detect by measuring either maximal expiratory flows or airway resistance. Nevertheless, the pathophysiologic process is severe because the airways to half of the gas-exchanging region of the lung are completely blocked. For this reason, the peripheral airways are called the lung’s quiet zone40 because considerable disease may be present within them with only minimal effects on the usual tests of lung function.41 How can these structural alterations be detected by tests of lung function? Figure 4-13 illustrates this problem. It can be seen that the airspaces beyond the obstruction can receive gas only from the unobstructed airspace where gas exchange has already occurred. In the case of the excised dog lobes discussed above, the measured pulmonary resistance was only minimally increased as a result of small beads obstructing about half of the peripheral airways. There was no change in vital capacity or the static pressure–volume curves, and dynamic compliance did not change with frequency.28 Yet all fresh air breathed in had to enter the unobstructed airspaces before traversing the collateral channels and entering into obstructed ones. It is unlikely that the obstructed airspace
45
Rc = 0.9 cm H2O/LPS
Rc = 0.9 cm H2O/LPS
Rp = 0.1 cm H2O/LPS
Rp = 0.2 cm H2O/LPS
RL = 1.0 cm H2O/LPS
RL = 1.1 cm H2O/LPS
FIGURE 4-14 Two-compartment lung model illustrating the effect of complete occlusion of half of the peripheral airways on airways resistance. Left panel: unobstructed peripheral airways. Right panel: half of all peripheral airways completely obstructed. Because peripheral airway resistance is only ~10% of total flow resistance, obstructing half the peripheral airways increases total flow resistance by only 10%. LPS liters per second.
will receive any fresh gas. It will be ventilated by gas that has already exchanged oxygen and carbon dioxide. The distribution of inspired gas should be markedly abnormal. When one considers the possibility that there could be a phase lag between the two airspaces shown in Figure 4-13, it is evident that if Tcol is finite the obstructed airspace must lag behind the unobstructed one because it takes time for gas to cross the collateral channels and fill the obstructed space. However, if respiratory cycle time is long compared to Tcol, the phase lag will be small; the obstructed units could have a normal tidal volume, but an alveolar ventilation that approaches zero. The tidal volume, and alveolar ventilation of the unobstructed alveoli will be twice normal, but a volume of gas equal to half the tidal volume will escape across the collateral channels, and the alveoli will not be overdistended. The ventilation / perfusion ratio of the unobstructed units should be abnormally high and the obstructed units abnormally low, resulting in a broad and abnormal distribution of these ratios. Thus, one would predict that airways obstruction in the lung’s quiet zone should lead to measurable abnormalities of gas exchange and ventilation distribution. Finally, if Tcol is higher than in dogs, as it is in humans, one would predict that the obstructed airspaces would lag behind the unobstructed ones and that the lag would become progressively worse as Tcol became a progressively greater fraction of respiratory cycle time as breathing frequency increased. Accompanying the phase lag, there would be insufficient time for a normal tidal volume to cross the collateral channels. Whereas the total tidal volume might remain unchanged, the unobstructed units would become progressively overdistended, and the obstructed units progressively underdistended, as breathing frequency increased. An increased tidal volume of some airspaces requires an increased swing in Pel. However, the increase in the elastic recoil pressure swings would not be accompanied by an increased total tidal volume, so dynamic compliance would decrease, and this decrease should be progressive with increased breathing frequency. All of these predictions have been confirmed. Dogs with blocked airways have abnormalities in the distribution of inspired gas42 and gas exchange.43,44 Among smokers whose routine lung function tests are normal, a substantial percentage have abnormal gas mixing in the lung,45 abnormalities of gas exchange,46 and frequency dependence of compliance.47 The combination of a normal static
46
Mechanics of Breathing
C1 >> C2 R1 >>R2
R1
R2
C2 C1
FIGURE 4-15 Two-compartment lung model illustrating mechanical abnormalities in emphysema. The left-hand airspace is a large hypercompliant emphysematous region with an obstruction in the peripheral airways leading to it. The right-hand airspace represents normal unobstructed lung tissue. During slow breathing, the obstruction (R1) has little effect on the distribution of inspired air. Under these conditions, the relative compliance of the two compartments (C1 and C2) determines the distribution of inspired air. Because C1 C2, the emphysematous space is better ventilated than the normal airspace. As breathing frequency increases, the distribution of inspired air will become more and more dependent on the time constants (R1C1 and R2C2) of the two compartments. Because R1C1 R2C2, the normal lung compartment will become progressively more ventilated as breathing frequency increases. For further discussion see text.
ventilation–perfusion scanning with the use of technetium or other contrast agents. Breathing frequency is rarely controlled in these tests. The situation is further complicated because a significant percentage of smokers have subclinical emphysema that is not suspected during life. The alveolar destruction of COPD also decreases the resistance to collateral ventilation, so that it can become less than airways resistance.48,49 In this manner, collateral channels can become major ventilatory pathways in emphysema. This has led to the suggestion that the mechanics of breathing in patients with emphysema might be improved if they breathed through spiracles or tubes entering the lungs directly through the rib cage.50 Preliminary results in excised human emphysematous lungs removed during transplant surgery show that substantial volumes of trapped gas that cannot be removed through the airways can be removed via spiracles (unpublished data). This increases the vital capacity while decreasing the RV/ TLC ratio. In addition, these preliminary studies indicate that the distribution of inspired gas through the spiracles is as good as, and sometimes better than, the distribution through the airways. Cooper has tried this procedure in a few patients with end-stage COPD, although he brilliantly inserted the spiracle by making a hole in an airway wall directly into the lung parenchyma instead of through the rib cage ( J. Cooper, personal communication). This converts a major surgical operation into a relatively minor therapeutic bronchoscopic procedure. To date, the results are encouraging, but it must be stressed that this experimental therapy is very much in the earliest stages of development. It will be several years, if ever, before it becomes an established therapy for emphysema.
REFERENCES pressure–volume curve and pulmonary resistance with abnormal ventilation distribution, gas exchange and frequency dependence of compliance indicates peripheral airway obstruction. There are claims in the literature that abnormally low maximal expiratory flows at low lung volumes are also diagnostic of small airway obstruction, but there is no evidence that this is so, and there are cogent reasons to believe that changes in the lung’s elastic properties could account for this abnormality. In more advanced disease, when the forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) become abnormal, all these abnormalities become more pronounced. In addition, the alveolar destruction caused by COPD increases lung compliance where alveolar destruction is present, leaving other more normal regions relatively unaffected. During a slow inspiration, inspired gas should be preferentially distributed to the most compliant (ie, the most diseased) regions. However, as illustrated in Figure 4-15, because these regions have a high compliance as well as obstructed small airways serving them, they will be the units with the longest time constants. As a result, at rapid breathing frequencies they will become less well ventilated compared to their less diseased neighbors. This leads to major problems in the interpretation of ventilation and
1. Mead J. The mechanical properties of lungs. Physiol Rev 1961;41:281–330. 2. Fredberg JJ, Stamenovic D. On the imperfect elasticity of lung tissue. J Appl Physiol 1989;67:2408–19. 3. Ludwig MS, Robatto FM, Simard S, et al. Lung tissue resistance during contractile stimulation: structural damping decomposition. J Appl Physiol 1992;72:1332–7. 4. Fredberg JJ, Bunk D, Ingenito E, Shore SA. Tissue resistance and the contractile state of lung parenchyma. J Appl Physiol 1993;74:1387–97. 5. Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol 1967; 22:395–401. 6. Vincent NJ, Knudson R, Leith DE, et al. Factors influencing pulmonary resistance. J Appl Physiol 1970;29:236–43. 7. Kimmel E, Seri M, Fredberg JJ. Lung tissue resistance and hysteretic moduli of lung parenchyma. J Appl Physiol 1995; 79:461–6. 8. Ludwig MS, Dreshaj I, Solway J, et al. Partitioning of pulmonary resistance during constriction in the dog: effects of volume history. J Appl Physiol 1987;62:807–15. 9. Ludwig MS, McNamara JJ, Castile RG, et al. Lung inflation does not increase maximal expiratory flow during induced obstruction in the dog. J Appl Physiol 1988;65:415–21. 10. Nagase T, Dallaire MJ,Ludwig MS. Airway and tissue behavior during early response in sensitized rats: role of 5-HT and LTD4. J Appl Physiol 1996;80:583–90.
Act of Breathing: Dynamics 11. Navajas D, Moretto A, Rotger M, et al. Dynamic elastance and tissue resistance of isolated liquid-filled rat lungs. J Appl Physiol 1995;79:1595–600. 12. Nagase T, Martin JG, Ludwig MS. Comparative study of mechanical interdependence: effect of lung volume on Raw during induced constriction. J Appl Physiol 1993;75:2500–5. 13 Robatto FM, Simard S, Orana H, et al. Effect of lung volume on plateau response of airways and tissue to methacholine in dogs. J Appl Physiol 1992;73:1908–13. 14. Mead J, Whittenberger JL. Physical properties of human lungs measured during spontaneous respiration. J Appl Physiol 1953;5:779–96. 15. Mead J, Turner JM, Macklem PT, Little JB. Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol 1967;22:95–108. 16. Ingram RH Jr, Schilder DP. Effect of gas compression on pulmonary pressure, flow, and volume relationship. J Appl Physiol 1966;21:1821–6. 17. Konno K, Mead J. Measurement of the separate volume changes of rib cage and abdomen during breathing. J Appl Physiol 1967;22:407–22. 18. Ferrigno G, Carnevali P, Aliverti A, et al. Three-dimensional optical analysis of chest wall motion. J Appl Physiol 1994;77: 1224–31. 19. Carnevali P, Ferrigno G, Aliverti A, Pedotti A. A new method for 3D optical analysis of chest wall motion. Technol Health Care 1996;4:43–65. 20. Cala SJ, Kenyon CM, Ferrigno G, et al. Chest wall and lung volume estimation by optical reflectance motion analysis. J Appl Physiol 1996;81:2680–9. 21. Iandelli I, Aliverti A, Kayser B, et al. Determinants of exercise performance in normal men with externally imposed expiratory flow limitation. J Appl Physiol 2002;92:1943–52. 22. Que CL, Kolmaga C, Durand LG, et al. Phonospirometry for noninvasive measurement of ventilation: methodology and preliminary results. J Appl Physiol 2002;93:1515–26. 23. Baydur A, Behrakis PK, Zin WA, et al. A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis 1982;126:788–91. 24. Otis AB, McKerrow CB, Bartlett RA, et al. Mechanical factors in the distribution of ventilation. J Appl Physiol 1956;8: 427–43. 25. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968;278:1355–60. 26. Mead J, Takashima T, Leith D. Stress distribution in the lung: a model of pulmonary elasticity. J Appl Physiol 1970; 596–608. 27. Woolcock AJ, Macklem PT. Mechanical factors influencing collateral ventilation in human, dog, and pig lungs. J Appl Physiol 1971;30:99–115. 28. Brown R, Woolcock AJ, Vincent NJ, Macklem PT. Physiological effects of experimental airway obstruction with beads. J Appl Physiol 1969;27:328–35. 29. Menkes H, Lindsay D, Gamsu G, et al. Measurement of sublobar lung volume and collateral flow resistance in dogs. J Appl Physiol 1973;35:917–21.
47
30. Traystman RJ, Batra GK, Menkes HA. Local regulation of collateral ventilation by oxygen and carbon dioxide. J Appl Physiol 1976;40:819–23. 31. Traystman RJ, Terry PB, Menkes HA. Carbon dioxide—a major determinant of collateral ventilation. J Appl Physiol 1978; 45:69–74. 32. Menkes H, Gardiner A, Gamsu G, et al. Influence of surface forces on collateral ventilation. J Appl Physiol 1971;31:544–9. 33. Smith LJ, Inners CR, Terry PB, et al. Effects of methacholine and hypocapnia on airways and collateral ventilation in dogs. J Appl Physiol 1979;46:966–72. 34. Kaplan J, Koehler RC, Terry PB, et al. Effect of lung volume on collateral ventilation in the dog. J Appl Physiol 1980;49:9–15. 35. Woolcock AJ, Macklem PT, Hogg JC, et al. The response of central and peripheral airways to vagal stimulation in dogs. Aspen Emphysema Conf 1967;10:275–85. 36. Menkes H, Macklem PT. Collateral flow. In: Macklem PT, Mead J, editors. Handbook of physiology: the respiratory system; mechanics of breathing. Bethesda, MD: American Physiological Society; 1986. p. 337–55. 37. Menkes H, Lindsay D, Wood L, et al. Interdependence of lung units in intact dog lungs. J Appl Physiol 1972;32:681–6. 38. Menkes H, Gamsu G, Schroter R, Macklem PT. Interdependence of lung units in isolated dog lungs. J Appl Physiol 1972; 32:675–80. 39. Macklem PT. Airway obstruction and collateral ventilation. Physiol Rev 1971;51:368–436. 40. Mead J. The lung’s “quiet zone.” N Engl J Med 1970;282:1318–9. 41. Hogg JC, Williams J, Richardson JB, et al. Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease. N Engl J Med 1970;282:1283–7. 42. Hogg W, Brunton J, Kryger M, et al. Gas diffusion across collateral channels. J Appl Physiol 1972;33:568–75. 43. Flenley DC, Picken J, Welchel L, et al. Blood gas transfer after small airway obstruction in the dog and minipig. Respir Physiol 1972;15:39–51. 44. Flenley DC, Welchel L, Macklem PT. Factors affecting gas exchange by collateral ventilation in the dog. Respir Physiol 1972;15:52–69. 45. Dosman J, Bode F, Ghezzo RH, et al. The relationship between symptoms and functional abnormalities in clinically healthy cigarette smokers. Am Rev Respir Dis 1976;114: 297–304. 46. Levine G, Housley E, MacLeod P, Macklem PT. Gas exchange abnormalities in mild bronchitis and asymptomatic asthma. N Engl J Med 1970;282:1277–82. 47. Woolcock AJ, Vincent NJ, Macklem PT. Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest 1969;48:1097–106. 48. Hogg JC, Macklem PT, Thurlbeck WM. The resistance of collateral channels in excised human lungs. J Clin Invest 1969; 48:421–31. 49. Terry PB, Traystman RJ, Newball HH, et al. Collateral ventilation in man. N Engl J Med 1978;298:10–5. 50. Macklem PT. Collateral ventilation. N Engl J Med 1978; 298:49–50.
CHAPTER 5
RESPIRATORY MECHANICS IN INFANTS AND CHILDREN Peter D. Sly, Felicity S. Flack, Zoltán Hantos
P
ediatricians recognize that children are not miniature adults and that the structural and mechanical proportions of their respiratory apparatus change with growth and development throughout childhood. Children approximately double in body size from birth to 18 months of age, double again by 5 years of age, and double again to achieve their adult size. The shape, size, and composition of the respiratory system also change dramatically throughout childhood, with increases in lung volume paralleling the increases in body size. Alterations in the configuration of the rib cage, maturation and stiffening of the chest wall, development of the skeletal muscles of respiration, and changes in lung structure all occur within the first few years after birth. A human child has approximately 10% of the adult complement of alveoli present at birth. The first 18 postnatal months represent the period of rapid alveolarization, with increases in lung volume after this being accomplished mainly by increases in alveolar size.1,2 The changes occurring with growth and development of the respiratory system are accompanied by changes in the mechanical properties of the respiratory system. This chapter reviews recent data on respiratory mechanics in infants and children. For data from classic studies, the reader is referred to the excellent review by Bryan and Wohl in the 1986 edition of the Handbook of Physiology.3
STATIC PRESSURE–VOLUME CURVES The classic studies of Agostoni4 showed that the static pressure–volume (P–V) curve of a newborn infant’s respiratory system was substantially different from that of an adult. The outward recoil of the infant’s chest wall was very small and the inward recoil of the infant’s lung slightly lower than that of an adult. This resulted in the static balance of forces, that is, the static equilibrium of the infant’s respiratory system, occurring at a much lower proportion of total lung capacity (TLC) (approximately 10%) than in an adult (approximately 40% of TLC). The lack of chest wall stiffness may be necessary to facilitate passage through the birth canal. Clinically, the elastance of the infant’s chest wall can be recognized as sternal retraction. This is seen normally during breathing in the early postnatal period and is exaggerated by any lung disease in infants. Although Agostoni4 did not study
premature infants, sternal retraction during tidal respiration is more prominent in these infants, suggesting that their chest wall is even more compliant than that of infants born at term. Recently, Tepper and colleagues5 measured quasistatic P–V curves from near TLC to the passively determined static equilibrium point of the respiratory system (ie, passive functional residual capacity [FRC]) in 49 healthy infants ranging in age from 1 to 104 weeks. The infants were studied during spontaneous breathing under chloral hydrate sedation. Respiratory muscle relaxation was achieved by inflating the infant’s respiratory system several times to an airway pressure of 30 cm H2O. The volume exhaled from 30 cm H2O (V30) was calculated from passive deflations. In addition, passive expiration was interrupted at various points during deflation, and quasistatic P–V curves were constructed. The quasistatic compliance of the respiratory system (Crs) was calculated by linear regression of the data points between 5 and 15 cm H2O, the linear part of the P–V curve. Tepper and colleagues5 reported increases in V30 and in Crs with increasing length but a decrease in specific compliance (Crs /V30) with increasing length. They also reported a lower V30 in infants born to smoking mothers but no difference in specific compliance between the infants of smoking and nonsmoking mothers. These data highlight the complexity of the changes in the respiratory system occurring in the early postnatal period and show that these changes are not simply due to a change in lung volume during this period. Lanteri and Sly6 measured respiratory mechanics in 51 children with healthy lungs during general anesthesia and muscle relaxation. Crs was calculated from quasistatic P–V curves constructed with the use of multiple occlusions during relaxed expiration. The authors reported that Crs increased with increasing height, with a linear relationship being seen on a log–log plot (Figure 5-1). These authors also concluded that specific compliance decreased with increasing height, suggesting that the changes occurring in lung structure with growth continue to influence respiratory mechanics until adolescence.6
CHEST WALL EFFECTS The mechanical properties of the chest wall have a major impact on the overall mechanical behavior of the respiratory
50
Mechanics of Breathing A
Crs,st (ml/cmH2O)
150 50 20 7 3
0.6
0.7
0.8
1.0
1.2
1.5
1.8
B
Crs,st (ml/cmH2O)
150 50
Using a modification of the forced oscillation technique (FOT) that includes low frequencies (see next section for details), Hantos and Sly (unpublished data) have examined the contribution of the chest wall to respiratory impedance, measured between 0.5 and 21 Hz. Low-frequency impedance spectra were measured in six infants (aged 6 to 18 months) at a transrespiratory pressure of 20 cm H2O. The constant-phase model (see next section) was fitted to the impedance spectra to obtain estimates of airway and parenchymal mechanics. Esophageal pressure was measured with a miniature pressure transducer to separate ZrsS into ZL and ZW components. At 20 cm H2O, the lungs contributed the majority of newtonian resistance (82 ⫾ 9%) and inertance (68 ⫾24%), whereas the contributions of lung and chest wall to the coefficients of tissue damping and tissue elastance were approximately equal (lungs contributing 42 ⫾6% and 50 ⫾ 6%, respectively).
20
AIRWAY AND PARENCHYMAL MECHANICS 7 3
0.6
0.7
0.8
1.0
1.2
1.5
1.8
height (m)
FIGURE 5-1 Natural log of compliance plotted against natural log of height for all subjects. X, mean Crs measurement in one child; solid line, model best fitting these data; dotted lines, 85% confidence intervals of fit. Both axes are plotted with a natural log scale but are labeled with absolute numbers for clarity. A, ln Crs,st versus ln height. B, ln dynamic Crs (Crs,dyn) versus ln height. Reproduced with permission from Lanteri CJ and Sly PD.6
system in infants and children and change substantially in early life. Papastamelos and colleagues7 measured Crs , lung compliance (CL), and chest wall compliance (CW) in the tidal volume range, with respiratory muscles relaxed, in 40 sedated infants ranging in age from 2 weeks to 3.5 years. They found that the chest wall, relative to body size, stiffened progressively during early life, with a linear decrease in CW /kg with increasing age (r ⫽⫺0.495, slope ⫺0.037, p ⫽.001). Average CW was 16.5 ⫾ 7.5 mL/cm H2O (2.80 mL/cm H2O/kg) in children ⬍ 1 year old and 20.1 ⫾7.7 mL /cm H2O (2.04 mL/cm H2O/kg) for children ⬎1 year old. Furthermore, the chest wall was nearly three times as compliant as the lungs (CW/CL ⫽2.9 ⫾1.1) in infants during the first year of life. In the older children studied, the chest wall had stiffened to the point that the compliances of the chest wall and lung were approximately equal. These data are consistent with those reported by Nicolai and colleagues,8 who found that the chest wall contributed approximately 19% to the overall elastic behavior of the respiratory system in a small group of infants studied under general anesthesia. In premature infants, CW has been reported to vary from 3 to 10 mL/cm H2O⫺1.kg⫺1 and to decrease with increasing gestational age.9
Lanteri and Sly6 measured respiratory mechanics in 51 children with normal lungs, aged 3 weeks to 15 years, under general anesthesia, using multilinear regression to calculate dynamic respiratory system compliance (Cdyn,rs) and resistance (Rrs), and a midexpiratory airway occlusion to calculate Raw from the postocclusion changes in airway opening pressure. They reported linear decreases in both Rrs and Raw, when plotted on a log–log plot, with increasing height. The slopes of the decreases were ⫺1.706 for Rrs and ⫺1.285 for Raw6 (Figure 5-2). Following midexpiratory airway occlusion, a biphasic change in Pao is seen.10 Immediately after the occlusion, a rapid increase in Pao is seen, representing the resistive pressure drop across the conducting airways. This is followed by a secondary, slower increase in Pao, attributable to stress recovery in the respiratory tissues (a manifestation of viscoelasticity), together with any gas redistribution due to ventilation inhomogeneity. This secondary change in pressure has been called Pdif and is used to reflect viscoelastic properties of the lung tissues and chest wall.10 In the above study, Lanteri and Sly6 reported a biphasic change in Pdif with age (Figure 5-3). Pdif was highest in the youngest children, falling rapidly during the first year of life. The authors attributed this decrease to the rapid increase in the number of alveoli occurring during this period. They also reported that Pdif increased after approximately 5 years of age; they speculated that this might be due to increasing influence of the viscoelastic properties of the chest wall. A major limitation of the interrupter technique is that it requires mechanical ventilation and muscle relaxation to produce reliable data. A variety of FOTs have been used over the years to measure the mechanical properties of the respiratory system under conditions that more closely resemble normal “working” conditions. This methodology is essentially noninvasive as it does not rely on active subject cooperation. Forced oscillation, as used in most human studies, measures input impedance by applying a pressure waveform (forcing function) to the airway opening and measuring the resultant flow produced at the airway opening. The resulting impedance
Respiratory Mechanics in Infants and Children
oscillation to be used to partition ZL into airway and tissue components. The constant-phase model11 has provided an adequate description of the lungs in several species. This model consists of an airway component, represented by a frequency-independent airway resistance (Raw) and airway inertance (Iaw), and a constant-phase tissue component [(G ⫺ jH)/␣, where G and H are coefficients for tissue damping and elastance, respectively, is angular frequency, and ␣ determines the frequency dependence of the real (pressure change in phase with flow) and imaginary (pressure change in phase with volume) parts of the impedance]. Thus:
A 370
Rrs(cmH2O/l/s)
135 50 20 7
0.6
0.7
0.8
1.0
1.2
1.5
1.8
B 370
Raw(cmH2O/lI/s)
135 50 20 7
0.6
0.7
0.8 1.0 height (m)
1.2
1.5
1.8
FIGURE 5-2 Natural log of resistance plotted against natural log of height. x, mean resistance measurement for one child; solid line, model best fitting these data; dotted lines, 95% confidence interval of this fit. Both axes are plotted with a natural log scale but are labeled with absolute numbers for clarity. A, ln respiratory system resistance (Rrs) versus ln height. B, ln airway resistance (Raw) measured at 50% of expired volume versus ln height. Reproduced with permission from Lanteri CJ and Sly PD.6
1.6 1.4
Pdif
1.2 1.0 0.8 0.6 0.4 0.4
51
0.6
0.8
1.0 1.2 1.4 mean height (m)
1.6
1.8
FIGURE 5-3 Group mean values ⫾ standard error of secondary pressure difference (Pdif ; in cm H2O) versus height. Reproduced with permission from Lanteri CJ and Sly PD.6
Zrs ⫽ R ⫹ jI ⫹ [(G ⫺ jH)/␣
(5-1)
In an initial study,12 we demonstrated that measurements of Zrs could be made in infants between 0.5 and 21 Hz during short pauses in spontaneous breathing achieved by invoking the infant’s Hering–Breuer inflation reflex to inhibit respiratory muscle activity temporarily. Infants were studied supine, with the neck supported in the midline in slight extension following an oral dose of chloral hydrate (80 mg / kg). The Hering–Breuer reflex was invoked by inflating the infant’s lungs to a transrespiratory pressure of 20 cm H2O with a pump and closing a valve at the airway opening with the lungs inflated. This produced sufficient suppression of breathing efforts (6 to 10 s) to allow measurement of Zrs. At the end of each measurement, the occlusion valve was opened, allowing passive exhalation, and the infants resumed breathing immediately. The reproducibility of the measurements within an infant was very good at all frequencies, except those coinciding with the heart rate and its harmonics.12 The parameter values were reasonably consistent between the infants studied, the group mean values being as follows: Raw ⫽ 10.0 ⫾ 2.1 cm H2O/s/L; Iaw ⫽ 61.2 ⫾ 13.8 cm H2O/s2/ L; G ⫽ 28.6 ⫾ 4.9 cm H2O/ L; and H ⫽ 141.0 ⫾ 55.0 cm H2O/L. The normal pattern of growth and development of the respiratory system, in particular the relative growth of airways and lung tissues, was examined in 37 normal infants aged 7 weeks to 2 years, with use of the low-frequency FOT.13 Normality was defined as no history of asthma or bronchiolitis and fewer than three lower respiratory illnesses. All infants had been free of any respiratory illness for at least 4 weeks at the time of measurement. When plotted as a function of body length, both tissue parameters G and H showed a quasihyperbolic decrease with increasing length. In contrast, R showed a quasilinear decrease with increasing length (Figures 5-4 to 5-6). In addition, these studies have shown that changes in tissue mechanical properties occur at a more rapid rate than airway mechanics in the first 2 years of life and are consistent with the notion that airways and lung parenchyma grow at different rates.
VOLUME DEPENDENCE reflects the complex viscoelastic resistance of the respiratory system (Zrs). Lung impedance (ZL) can be estimated by measuring transpulmonary pressure. Recent developments in this field have led to new methods that allow low-frequency forced
Respiratory mechanical properties are known to be volume dependent in experimental animals and in adults. The volume dependence of low-frequency mechanics was studied in 8 infants (aged 7 to 26 months) by making measurements at the volumes achieved with transrespiratory pressures of 0,
52
Mechanics of Breathing
Tissue Elastance (cmH2O/L)
Airway resistance (cmH2Os/L)
45
30
15
0
300
150
0 50
60
70 Length (cm)
80
90
150
100
50
0 50
60
70 Length (cm)
50
60
70
80
90
Length (cm)
FIGURE 5-4 Raw plotted against body length. The solid line represents the fitted regression line; the long dashed line represents the 95% confidence interval for the individual data. Mean measurements for each child are also shown. The solid lines connecting individual data points represent those infants with repeated measurements showing tracking of airway mechanics. Reproduced with permission from Hall GL et al.13
Tissue Damping (cmH2O/L)
450
80
90
FIGURE 5-5 G plotted against body length. The solid line represents the fitted regression line; the long dashed line represents the 95% confidence interval for the individual data. Mean measurements for each child are also shown (closed circles). Individual data connected by solid lines are included, indicating those infants with repeated measurements showing tracking of tissue mechanics. Reproduced with permission from Hall GL et al.13
10, and 20 cm H2O.14 Volume dependence of Zrs was demonstrated, with a similar pattern being evident in all infants studied. Raw decreased progressively with increasing lung volume, from a group mean of 20.6 ⫾ 4.9 cm H2O/s/L at FRC (transrespiratory pressure of 0 cm H2O) to 12.5 ⫾ 2.7 cm H2O/s/L at 10 cm H2O and 8.7 ⫾ 2.4 cm H2O/s/L at 20 cm H2O, reflecting the increases in airway diameter with lung volume. There were no consistent changes in Iaw. The values of G and H were the smallest at 10 cm H2O; that is, the minima of tissue resistance and elastance are reached in
FIGURE 5-6 H versus body length. The solid line represents the fitted regression line; the long dashed line represents the 95% confidence interval for the individual data. Mean measurements for each child are also shown (closed circles). Individual data connected by solid lines are included, indicating those infants with repeated measurements showing tracking of tissue elastance. Reproduced with permission from Hall GL et al.13
the tidal volume range. The changes seen in both the airway and tissue parameters are consistent with the results of previous studies, in both animals and humans (usually adults), in which different methodologies have been used. The mechanical parameters estimated from oscillations imposed at FRC or at moderate inflation volumes (eg, that achieved at 10 cm H2O) are more relevant to the conditions characterizing spontaneous respiration and theoretically are preferable to those obtained at higher volumes (eg, that achieved at 20 cm H2O). However, from a practical point of view, making measurements of low-frequency mechanics at the volume achieved at a transrespiratory pressure of 20 cm H2O is advocated as these measurements can be more reliably obtained and are more likely to be obtained in infants with lung disease. The clinical importance of volume dependence frequently becomes manifest during mechanical ventilation. As demonstrated by Kano and colleagues,15 the linear portion of the P–V curve is relatively small in infants and young children. It is easy to “push” them onto the flattened upper portion of the curve when using clinically necessary ventilator settings. This phenomenon was demonstrated by investigating the influence of nonlinearities on the P–V curves obtained during mechanical ventilation on the estimates of respiratory mechanics obtained from multilinear regression analyses. When the children’s lungs were overdistended, the fits obtained by multilinear regression were improved significantly by the inclusion of a volume-dependent elastance term in the regression model, that is: Pao ⫽(E1 ⫹ E2V)V ⫹RrsV⬘⫹PA,ee
(5-2)
where Pao is the airway opening pressure, V is the volume excursion during tidal ventilation, E1 ⫹ E2V represents the total elastance over the tidal volume range, E1 represents
Respiratory Mechanics in Infants and Children
the volume-independent portion of elastance, E2V represents the volume-dependent portion of elastance (the change in elastance with increasing volume), and PA,ee is the alveolar pressure at end-expiration. The authors concluded that measuring the volume-dependent behavior of the respiratory system by including a volume-dependent elastance term in the multilinear regression model provided a useful method for estimating respiratory system overdistention during mechanical ventilation.15
FREQUENCY DEPENDENCE Studies in both animals16 and adult humans17 in which sinusoidal forcing at different frequencies was employed have demonstrated characteristic changes in the resistive and elastic properties of the respiratory system with frequency. Frequency dependence can also be studied by making measurements at different ventilation frequencies, keeping tidal volume and inspiratory/expiratory ratio constant. Nicolai and colleagues8 demonstrated frequency dependence of the mechanical properties of the respiratory system, lungs, and chest wall in children aged 2 to 56 months undergoing cardiac surgery. Dynamic elastance (Ers) and resistance (Rrs) of the respiratory system and of the lung (EL and RL) were calculated with the use of a multilinear regression technique under anesthesia prior to the onset of surgery, and the procedure was repeated with the chest wall opened via a midline sternotomy. Esophageal pressure (Pes) was measured with the chest wall intact to allow partitioning of Ers and Rrs into components representing the mechanical properties of the lung and chest wall. The total respiratory system and lungs exhibited typical frequency-dependent behavior, with elastance increasing and resistance decreasing with increasing ventilation frequency. The pattern of frequency dependence was essentially the same whether the chest wall was intact or opened, suggesting that this is not solely a property of the chest wall but that the lungs contribute as well. Kano and colleagues18 demonstrated that the respiratory mechanics of a group of newborn infants (mean gestational age 37 ⫾ 2.7 weeks) showed the same pattern of frequency dependence as described in the previous paragraph. When ventilation frequency was increased from 30 to 80 breaths per minute, Ers increased by a mean of 8.3% and Rrs decreased by a mean of 17.5%. The data presented by Nicolai and colleagues8 and by Kano and colleagues18 show the clinical importance of understanding the frequency dependence of respiratory mechanics. Ventilator settings are most commonly changed in response to changes in disease status. These changes in ventilator setting will result in changes in the estimates of respiratory mechanics obtained during ventilations and can complicate the interpretation of changes in lung function. The frequency dependence of respiratory mechanics can most readily be explored using FOTs. As discussed above, small amplitude oscillations containing multiple frequency components simultaneously applied can be used to measure Zrs. Forced oscillations applied over a wide range of frequencies in infants have revealed that the mechanical behavior of
53
the respiratory system is dominated at lower frequencies (⬍5 Hz) by the lung tissues and at higher frequencies (⬎10 Hz) by the airways.12–14,19
UPPER AIRWAY/NASAL CONTRIBUTION Infants are preferential nose-breathers, and the mechanical properties of the nose and upper airway therefore play an important part in determining the mechanical behavior of the respiratory system.